The relationship between the severity of obstructive sleep apnoea hypopnoea syndrome and the craniofacial morphology in adults by Mageet, Adil Osman
The Relationship between the Severity of Obstructive
Sleep Apnoea Hypopnoea Syndrome and the
Craniofacial Morphology in Adults
by
Adil Osman Mageet






Obstructive Sleep Apnoea / Hypopnoea Syndrome (OSAHS) is a potentially life-
threatening breathing disorder, caused by recurrent upper airway obstruction during
sleep. OSAHS is associated with an increased risk of cardiovascular disease and
stroke, and there is a strong suspicion that untreated sleep disordered breathing
precipitates greater mortality (Marin et al., 2005).
OSAHS affects 4-7% of the general adult population (Casero et al., 1999). Owing to
its prevalence, it is currently considered a major public health concern, with severe
physical and social consequences if not properly treated (Casero et al., 1999; Barthel
SWand Strome M, 1999).
These disorders affect mainly middle-aged patients that are professionally active and
may generate high losses and absences from work (Pieters T and Rodenstein DO,
2001). Medical costs of OSAHS may be significantly reduced when effective
diagnosis and treatment are performed early (Kapur et al., 1999). However, the
increasing demand for apnoeic diagnosis has begun to place strain upon services
based on overnight laboratory studies. This situation has been clearly reflected at the
Edinburgh Sleep Clinic where new referrals for polysomnography testing were found
to have increased ten fold between 1990 and 1996, (Whittle et al., 1997).
Evidence suggests that the discrepancy between demand and available resources is
steadily widening. The development of alternative diagnostic methods would
therefore appear to be a worthy goal, and indeed this subject has received a great deal
of attention within the recent literature.
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Differences in cranio-cervico-facial morphology in the OSAHS subjects as compared
to their 'normal' counterparts has been a consistent finding and more recent
investigations have aimed to prove the existence of a relationship between cranio-
cervico-facial morphology and severity of the OSAHS condition. Evidence has been
equivocal, and although a number have been suggested a correlation, none have yet
converted this into a tool of clinical diagnostic significance.
In this present investigation, sixty five (65) lateral cephalometric radiographs of
subjects who had been referred to Edinburgh Royal Infirmary Sleep Centre for
polysomnographic testing were retrospectively selected at random. To determine the
existence of any correlation between the cranio-cervico-facial morphology and
OSAHS severity as measured by the Apnoea Hypopnoea Index (AHI), a number of
anatomic reference planes and points were used.
Statistically significant correlations were found when measuring angular and linear
variables between the OSAHS subjects and the control group. Investigation of the
angular and linear relationship between the measurements and the OSAHS severity,
revealed significant results of clinical interest.
The findings thus provide evidence that subjects with obstructive sleep apnoea
hypopnoea syndrome demonstrated significant alterations in cranio-cervico-facial
form that may reduce the upper airway dimensions and subsequently impair upper
airway stability and function.
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It is said that in 1843 John Wesley Hardin, the infamous Wild West gunfighter
from Texas, shot and killed a loud snorer sleeping in the next room in a hotel in
Abilene. He just could not put up with the noise any longer.
Dement WC, (1988) quotes a wise twentieth century physician who once said:
"The practice of medicine ends when the patient falls asleep". His intention was
to highlight the disenfranchisement of the sleeping patient, which grew from the
attitude that sleep represented a boundary that physicians may not cross. He
describes the 'prehistoric' phase in understanding of sleep apnoea as existing prior
to 1952, acknowledging apparently indiscriminate references to the condition
during this period.
His colleague, Guilleminault C, (1985) observes that sleep apnoea syndrome
provides an excellent example ofwhat he describes as 'syndrome rediscovery' by
astute clinicians in the twentieth century. With each, the new description of the
'discovered' syndrome is refined and the acknowledgement of the underlying
pathophysiology has grown.
Obstructive Sleep Apnoea / Hypopnoea Syndrome (OSAHS) is a life threatening
breathing disorder characterized by repeated collapse of the upper airway during
sleep, with cessation of breathing. Patients with OSAHS are at risk of severe
cardio-vascular and hypercapnia in addition to an overall reduced quality of life
for sufferers and their families.
The aetiology appears to be a blend of anatomical and pathophysiological
features. During sleep, the combination of a reduction in lingual and pharyngeal
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muscle tone, alterations in breathing control, the supine position and reduced
pharyngeal space may lead to airway occlusion in susceptible patients.
"...it is time for the nation to wake up to the staggering impact of (sleep apnoea)
on the health and welfare of our society, an impact that rivals that of smoking"
(Phillipson EA, 1993).
With increasing realization of prevalence and hence demand for treatment
(Stradling JR, Crosby JH, 1991; Gleadhill et al., 1991; Young et al., 1993),
perhaps the most significant rate limiting factor for the provision of treatment
involves accurate diagnosis. The development of'Polysomnography' in 1972, and
later the 'Multiple Sleep Latency Test (MSLT) (Carskadon et al., 1986 and 1987)
has provided the scientific standard for diagnosis (Dement WC and Bilwise NG,
1988).
Diagnostic methods are also available to determine pharyngeal morphology in
OSAHS patients: Lateral cephalometric radiographs, acoustic reflection,
fluoroscopy, endoscopic observation, and computed tomography. Magnetic
resonance imaging (MRI) is an innovative technique that produces high-resolution
images without the use of ionizing radiation, making it especially well suited for
soft tissue studies and diagnosis. Lateral cephalometric radiographs have been
used by several investigators in an attempt to identify morphological parameters
that might be characteristic ofOSAHS.
The cranial base may be short (Bacon et al., 1988) and the cranial base angle
reduced (Jamieson et al., 1986). Battagel JM, (1996) reported that cranial base
angle (Ba-S-N) was significantly smaller 3.7° in OSAHS subjects and the length
of the anterior cranial base reduced 2.4mm. This indicates a shortening of the
antero-posterior dimension of the cranium and thus a more retruded face.
2
Rivlin et al., (1984), reported decrease in mandibular body length. Battagel JM,
(1996) found reduced mandibular body length (Go-Me) by 5.9mm in the OSAHS
group (P=0.002). Recording this distance in the horizontal plane, to take into
account variations in mandibular plane inclination, the same differences were
found. Gonion to menton was 6.6mm shorter and Gonion to point B was 5.6mm
less in apnoeic individuals.
Bimaxillary retrusion (Lowe et al., 1986a; De Berry-Borowiecki et al., 1988) or
retrognathia of the mandible alone have been reported (Jamieson et al., 1986;
Tsuchiya et al., 1992). Battagel JM, (1996) found that intermaxillary space length-
the distance between the posterior pharyngeal wall and the lingual aspect of the
lower incisor at the level of the occlusal plane-was 5.7mm shorter in OSAHS
subjects (P=0.001). The intermaxillary space area was reduced by 4.1cm ,
indicating a lack of vertical compensation for the diminished antero- posterior
development.
Treatment involves non-surgical and surgical techniques:
The non-surgical techniques include: elimination of the aggravating factors,
weight reduction, training, pharmacological therapy, electrical stimulation of the
upper airway, ENT assessment plus any necessary treatment, continuous positive
airway pressure, intra-oral mandibular advancement appliances and nasal-valve
dilator.
The surgical techniques include: tracheostomoy, nasal surgery, pharyngeal
surgery (uvuluo-palato-pharyngoplasty), maxillofacial surgery, tonsillectomy,





Sleep apnoea syndrome was first described as early as 360 BC (Aelianus, 1666)
and highlighted as 'Pickwickian Syndrome' (Dickens, 1836; Osier W, 1901).
Reintroduced into modern medicine some decades ago (Spitz H, 1937; Burwell et
al., 1956; Gastaut et al., 1966) the syndrome in recent years received copious
attention in the medical literature. The term "apnoea" is derived from the
Greek word "apnoia" meaning, "want of breath".
Sleep apnoea may be described as a potentially life-threatening breathing disorder
in which periods of cessation of breathing (apnoeas) occur in the presence of
inspiratory effort (Guilleminault et al., 1978; Douglas et al., 1982; Lowe et al.,
1986a; Deegan et al., 1995; Battagel et al., 1996).
Three types of sleep apnoeas are reported by Gastaut et al., (1966): -
• Central sleep apnoea.
• Obstructive sleep apnoea hypopmoea syndrome (occlusive or peripheral).
• Mixed sleep apnoea.
2.1.1 Central Sleep Apnoea (CSA)
Central sleep apnoea (CSA) is defined as the cessation of both airflow and
breathing effort and it is usually the result of neurological disorders. The
condition can occur without identifiable causes; fortunately its occurrence is rare.
Most sufferers have intermittent obstructive episodes. When more than 50% of
events are central in nature, the form of the condition is defined as central.
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Central sleep apnoea (CSA) is mainly due to an instability of the breathing control
system, and its causes include alveolar hypoventilation disorders, heart failure,
neurologic autonomic disorders and idiopathic forms of central sleep apnoea
(Wisskirchen T and Teschler H, 2000). Patients with idiopathic CSA often
complain of insomnia and awakening during sleep but may also suffer from
daytime sleepiness. Cheyne-Stokes-Respiration or periodic breathing is often
associated with heart failure and neurological disorders especially those involving
the brain stem.
2.1.2 Obstructive Sleep Apnoea / Hypopnoea Syndrome (OSAHS)
Obstructive sleep apnoea / hypopnoea syndrome (OSAHS) is defined by the
occurrence of five or more abnormal respiratory events per hour; these abnormal
events include apnoeas (breaks in respiration for at least 10 seconds) and
hypopnoeas (reduction in tidal volume accompanied by a 4% or greater fall in
blood oxygen saturation, lasting more than 10 seconds), (Guilleminault et al.,
1978).
Tangugsorn V, (1995) has defined obstructive sleep apnoea / hypopnoea
syndrome as repetitive cessation of breathing, at the level of the nostrils and
mouth lasting for at least 10 seconds, and occurring 30 times or more during 7
hours of nocturnal sleep in both rapid eye movement (REM) stage and especially
in non-rapid eye movement (NREM) stage.
Obstructive sleep apnoea hypopnoea syndrome is also known as occlusive apnoea
which is characterized by cessation of airflow because of upper airway
obstruction despite simultaneous respiratory effort. This respiratory effort
continues despite obstruction until the individual is aroused from sleep.
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If the number of apnoeas / hypopnoeas exceeds 20 per hour, the condition is
regarded as clinically significant (Riley et al., 1987). The Apnoea Hypopnoea
Index (AHI) calculates the number of apnoea and hypopnoea divided by the hours
of sleep, with a figure of "between" 5 to 10 being the upper end of normal (He et
al., 1988).
The Scottish Intercollegiate Guidelines Network (SIGN) report (2003) on OSAHS
has defined:
Apnoea - a ten second breathing pause.
Hypopnoea - a ten second event where there is continued breathing but
ventilation is reduced by at least 50% from the previous baseline during sleep.
Obstructive sleep apnoea / hypopnoea syndrome (OSAHS) - the coexistence of
excessive daytime sleepiness with irregular breathing at night.
Apnoea / hypopnoea index (AHI) - the frequency of apnoeas and hypopnoeas
hourly (used to assess the severity of OSAHS).
Severity of OSAHS - (may be subdivided into varying degrees of breathing
abnormality, depending on the AHI):
o Mild - (AHI 5-14/hr).
o Moderate - (AHI 15-30/hr).
o Severe - (AHI > 30/hr).
2.1.3 Mixed Sleep Apnoea (MSA)
Mixed sleep apnoea is described as a period of central apnoea followed by an
obstructive apnoeic episode and is seen in aound 5% of cases (Guilleminault C,
1976); it combines both obstructive and central apnoeas. The most common and
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serious disorder in terms of morbidity and mortality is claimed to be obstructive
sleep apnoea / hypopnoea syndrome (Phillipson EA, 1993).
2.2 PREVALENCE
Estimates of the prevalence of OSAHS depend on the age, sex of subjects studied
as well as the definition and the method of diagnosis. OSAHS has a suggested
prevalence of 2% in the general population (Shapiro CM, Dement WC, 1993).
OSAHS is more prevalent in middle-aged overweight men and has a lower
incidence in women (Kaplan R, 1990).
However the results of the most recent and comprehensive study suggest that 4%
of middle-aged men (30-60 years) and 2% of middle-aged women have
obstructive sleep apnoea hypopnoea syndrome (Young et al., 1993).
It is estimated that as many as 70% of adults with obstructive sleep apnoea
hypopnoea syndrome (OSAHS) snored during childhood (Guilleminault et al.,
1978; Koskenvuo et al., 1985; Hoffstein V, Mateika S, 1994; Ulfberg et al., 1996;
and Young et al., 1996).
This high prevalence together with claims of wide ranging medical sequelae have
led to the suggestion that sleep apnoea may be as significant a public health
hazard as smoking (Phillipson 1993).
Prevalence rates may vary between different populations according to factors such
as the prevalence of obesity. Age is also important and prevalence rates from 20%
to 60% have been reported in the elderly (Ancoli-Israel 1994).
Epidemiological studies of habitual snoring in children suggest prevalence
between 7% and 12% (Ali et al., 1993 and 1994). Children who snore are
reportedly mouth breathers (McDonald JP, 1995; Carroll et al., 1995) or restless
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sleepers, have excessive daytime sleepiness, are hyperactive, (Ali et al., 1993 and
1994), have poor hearing (Owen et al., 1996) and present with bilateral dental
maxillary crossbite (McDonald JP, 1995). Although snoring has been reported to
be a common finding in children only a subgroup of habitually snoring children
have OSAHS.
2.3 PATHOGENESIS
Apnoeas are caused by obstruction of the airway during sleep at the level of the
soft palate and tongue. (Royal College of Physicians Working Party Report,
1993).
Three broad factors determine upper airway patency during sleep; upper airway
muscle activity, neuromuscular coordination, the size relationship of the upper
airway and surrounding tissues (Remmers JE, 1978; Lowe AA, 1990b).
Contraction of the genioglossus muscle moves the base of the tongue ventrally.
Since the position of the anterior wall of the pharynx is determined in part by the
tongue, contraction of the genioglossus muscle enlarges the volume of the
oropharynx. Neuromuscular coordination ensures that contraction of the upper
airway dilating muscles precedes the inspiratory onset of diaphragmatic activity.
This provides a stable and distal upper airway before the onset of negative
intraluminal pressure during inspiratory effort. Abnormal size relationship
between the upper airway and its surrounding skeletal and soft tissues predisposes
to upper airway occlusion during sleep. When an individual is lying down and
asleep, the dimensions of the airway are modified by both posture and muscle
tone. This occurs whether OSAHS is present or not, but the effects are greater in
this condition (Horner et al., 1989; Pae et al., 1994). Not only is the effective
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airway smaller in OSAHS subjects, but the tissue may be inherently more
collapsible (Gleadhill et al., 1991). The pattern of heavy snoring which leads to
airway narrowing and arousals has been termed the upper airway resistance
syndrome.
Precipitation ofOSAHS durins pregnancy
Kowall et al (1989) reported a case of severe obstructive sleep apnoea developing
during pregnancy. A 27-year-old primigravida was well until the sixth month of
pregnancy, when she developed loud snoring and excessive daytime sleepiness.
Polysomnography was performed at 36 weeks' gestation and revealed severe
obstructive sleep apnoea. The patient was treated successfully during pregnancy
with nasal continuous positive airway pressure, but continued to suffer from
moderate obstructive sleep apnoea after delivery. This case suggests that sleep
apnoea may be either precipitated or exacerbated during pregnancy.
A case report of OSAHS during pregnancy suggests a possible association with
both intrauterine growth retardation and pre-eclampsia (Lefcourt LA, Rodis JF,
1996).
Obstructive sleep apnoea /hypopnoea syndrome in children
Marcus CL and Loughlin GM (1996) reported that obstructive sleep apnoea /
hypopnoea syndrome is a common cause of morbidity during childhood.
Childhood obstructive sleep apnoea syndrome is usually secondary to
adenotonsillar hypertrophy. Other risk factors include craniofacial anomalies,
obesity, neuromuscular disease and compressed maxillary arch with consequent
approximation of the lateral turbinates and nasal septum (McDonald JP, 1995).
Symptoms include snoring and difficulty in breathing during sleep. Definitive
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diagnosis is made by polysomnography. Normative polysomnographic parameters
vary with age; thus, age-appropriate norms must be used. In contrast to adults,
children often manifest a pattern of persistent partial airway obstruction during
sleep, rather than cyclical, discrete obstructive apnoeas. Most children are cured
by tonsillectomy and adenoidectomy (Guilleminault C, Pelayo R 1998), or rapid
palatal expansion (McDonald JP, 1995). However, some children require further
therapy, such as continuous positive airway pressure (Guilleminault C and Pelayo
R, 1998).
Guilleminault C and Pelayo R, (1998) stated that there is a familial predisposition
to sleep-disordered breathing. Nasal obstruction and mouth breathing influence
facial growth, which may further lead to difficulty in breathing while asleep.
Symptoms include an increase in total sleep time, non-specific behavioural
difficulties, hyperactivity, irritability, bed-wetting and morning headaches
(Guilleminault C and Pelayo R, 1998). Clinical signs include failure to thrive,
increased respiratory effort with nasal flaring and suprasternal or intercostal
retractions (Guilleminault C and Pelayo R, 1998). In addition, abnormal
paradoxical inward motion of the chest may occur during sleep (Guilleminault C
and Pelayo R, 1998). Excessive daytime sleepiness and obesity are not always
present (Guilleminault C and Pelayo R, 1998). Untreated children may develop
cardiovascular complications (Guilleminault C, Pelayo R, 1998). The condition is
treatable with continuous or bilevel positive airway pressure , and may be cured
with surgery (Guilleminault C and Pelayo R, 1998).
Sleep-related breathing disorders (SRBD) can occur at any age. Obstructive sleep
apnoea, upper airway resistance syndrome and obstructive hypopnoea syndrome
all lay on the pathological continuum of SRBD (Messner AH, Pelayo R, 2000).
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These disorders can have a great impact on a child's quality of life and can
progress to significant complications.
Adenotonsillectomy remains the mainstay of treatment. Nasal continuous positive
airway pressure is effective and well tolerated in those who do not respond to
adenotonsillectomy. In selected cases, additional surgery or supplemental oxygen
(with careful monitoring) may play a role (Marcus CL, 1997), and in cases with
compressed maxillary arches, rapid palatal expansion should be considered
(McDonald JP, 1995).
Mogayzel et al., (1998) have studied sleep breathing disorders in 88 children with
achondroplasia and concluded that:
• Children with achondroplasia often have sleep-related respiratory
disturbances, primarily hypoxaemia.
• The majority do not have significant obstructive or central apnoea; however, a
substantial minority are severely affected.
• Tonsillectomy and adenoidectomy decrease the degree of upper airway
obstruction in most but not all children with achondroplasia and obstructive
sleep apnoea.




The aetiology of OSAHS and the abnormalities that underlie the narrowing of the
upper airway at the level of the pharynx is complex. OSAHS is thought to arise
from a combination of pathophysiological and anatomical factors.





Functional impairment of the muscles that dilate the upper airway is thought to be
particularly important in the development of OSAHS and these patients
demonstrate lower tonic and phasic contraction of these muscles during sleep than
unaffected people (Deegan et al., 1995).
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Table 2.1 Factors contributing to the pathophysiology of OSAHS
General factors 1. Anthropometrics (sex, age and obesity).











2. Upper airway resistance.
3. Upper airway compliance.
Upper airway
muscle function
1. Abnormal upper airway dilator muscle activity.




1. Response to negative pressure.
2. Response to positive pressure.
3. Feedback from the lungs.
Central factors 1. Chemical drive.
2. Periodicity of central drive.
3. Response to breath loading.





Normal males have significantly higher pharyngeal and supraglottic resistance
than normal females (White et al., 1985), which makes them more susceptible to
pharyngeal collapse and OSAHS, and may contribute to the male predominance
of the syndrome (Guilleminault et al., 1976). The mechanism underlying this
higher upper airway resistance in males is unclear, but could be related to a
possible protective effect of female sex hormones (Block et al., 1980), a possible
deleterious effect of male sex hormones (Johnson et al., 1984), or to the greater
incidence of obesity among males (White et al., 1985).
2.4.1.1.2 Age.
Pharyngeal resistance increases with age in normal men, possibly related to
greater body weight (White et al., 1985), and it is widely believed that risk of
developing OSAHS increases with age in men. However, this assumption is far
from conclusive. One study has shown that, although there may be an increased
incidence of sleep-disordered breathing among older (>50 years), when otherwise
healthy subjects are compared to younger controls, the frequency of such sleep
disordered events is not within the range of the OSAHS syndrome (Bixler et al.,
1985). Another study demonstrated that 28% of randomly selected patients (>65
years) had apnoea frequencies ofmore than 5 episodes.h"1, but many of these were
asymptomatic, and it was suggested that an apnoea frequency in excess of 5




It has long been recognized that there is an association between obesity and
OSAHS (Walsh et al., 1972), and that weight loss can be very beneficial in the
management of OSAHS (Harman et al., 1982, Suratt et al., 1987). One
explanation for the relationship between obesity and OSAHS is that the upper
airway is narrowed in obese patients as a result of increased fat deposition in the
pharyngeal walls (Remmers et al., 1980). Studies using conventional computed
tomography (CT) failed to identify any abnormal fat deposition in the immediate
vicinity of the upper airway (Haponik et al., 1983; Suratt et al., 1983). However,
the development of magnetic resonance imaging (MRI), which can make use of
specially "weighted" images to detect fat, has led to the demonstration of
increased fat deposition surrounding the collapsible segment of the pharynx in
patients with OSAHS (Horner et al., 1989; Shelton et al., 1993).
The amount of fat detected also correlates with the subject's apnoea / hypopnoea
frequency (Shelton et al., 1993). Another possible explanation for the fact that
obese subjects often have smaller lung volumes, particularly functional residual
capacity (FRC), than non obese, which in turn indirectly influence upper airway
size and contribute to upper airway narrowing (Hoffstein et al., 1984). The upper
airway may also be narrowed in obese patients with OSAHS as a result of
external compression by superficially located fat masses (Koeing et al., 1988;
Koopman et al., 1981), and this could explain the finding that increased neck
circumference correlates more closely than general obesity with the incidence and
severity ofOSAHS (Davies et al., 1990; Stradling et al., 1991).
In an experimental model, hard-filled bags, simulating cervical fat accumulation,
were applied to the anterior neck of supine anaesthetised rabbits and were found
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to increase upper airway resistance and decrease closing pressures (Koenig et al.,
1988).
Genetics.
Ostructive sleep apnoea hypopnoea syndrome (OSAHS) is considered as a
complex genetic disorder. Descriptive studies from several countries have
consistently show familial aggregation of the apnoea hypopnoea index (AHI) and
symptoms of OSAHS in both adults and children. Phenotypic markers of OSAHS
have been identified, such as upper airway anomalies, abnormal breathing control,
and obesity through which genes might act to increase susceptibility to OSAHS.
The genetics of OSAHS may differ among racial groups. Two approaches have
recently been used to investigate the genetics of OSAHS: a segregation analysis
and a whole genome scan. Data suggested a common causal pathway regulating
both OSAHS and obesity in Caucasian families (Gaultier C, 2003).
Patel SR, (2005) on his review article concluded that both obesity and sleep
apnoea are heavily influenced by underlying genotype. Some susceptibility genes
act directly on one phenotype and through the causal relationships between
obesity and sleep apnoea have indirect effects on the other. Other loci have
pleiotropic effects, impacting susceptibility to both obesity and sleep apnoea via
independent mechanisms (Fig. 2.2). Sleep apnoea susceptibility genes may
interact with obesity through numerous mechanisms to influence sleep apnoea
predisposition. Genetic polymorphisms may modulate the degree to which obesity
alters ventilatory drive, reduces lung volume, or narrows the upper airway. Other
polymorphisms may affect the degree to which these stresses result in the
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development of sleep apnoea. Similarly, obesity susceptibility genes may interact
with sleep apnoea in its potential effect on obesity (Patel SR, 2005).
2.4.1.1.5 Substances which depress the central nervous system.
Substances which depress the central nervous system (CNS), such as alcohol,
sedatives and tranquillizers support relaxation of pharyngeal musculature and
therefore airway occlusion (Battagel JM, 1996).
Alcohol.
Rossner et al., (1991) found high alcohol level in patients who had died of acute
myocardial infarction, suggesting this may be an important factor contributing to
OSAHS. Issa et al., (1982) found acute alcohol consumption promotes the
development of apnoea during late sleep. Alcohol is a CNS depressant and as
such will contribute to the hypotonicity of muscles with the pharynx, soft palate
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and muscles of the tongue. Ethanol reduces genioglossus muscle activity during
both quiet breathing and hypercapnia in healthy normal subjects. It is believed to
have a depressant effect on the reticular activating system (RAS), and appears to
have more profound effects on the upper airway muscles than on the ventilatory
pump muscles (Kroll et al., 1984).
Hypnotics and tranquillizers.
Hypnotics and tranquillisers have an effect similar to that of alcohol. These agents
promote relaxation of the pharyngeal musculature and therefore airway occlusion.
Diazepam is one of a group of medicines called benzodiazepine tranquillizers and
are some instances used specifically for the relief of muscular spasm (British
National Formulary 1998). Side effects of these drugs are to further relax any
postural reflexes including those ofmuscles supporting the pharyngeal area.
Chloral hydrate and anaesthetics have a depressant effect on the reticular
activating system (RAS), with hypnotic doses of chloral hydrate preferentially
depressing genioglossus activity as compared with diazepam activity (Hershensen
et al., 1984). This selective depression of upper airway muscle activity suggests
that the respiratory activities of these muscles may be more dependants on the
(RAS) than the bulbo-spinal phrenic system (Bonora et al., 1984).
Caffeine.
Bardwell et al., (2000) studied 61 subjects including normotensives and
hypertensives with and without OSAHS: 38 men, 23 women, aged 30-60 y; 100-
150% of ideal body weight; without other major illness. Patients were studied
using polysomnography, caffeine consumption was assessed, 24-h urinary NE
levels were examined and ambulatory blood pressure (BP) was recorded. Patients
with OSAHS (N=27) reported significantly greater caffeine consumption than
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those without OSAHS (N=34) (295 vs. 103 mg, P=0.010), but caffeine was not
significantly correlated with their ambulatory BP. In contrast, NE excretion
correlated with caffeine consumption (r =0.24, P=0.041), apnoea severity (r
=0.65, P <0.001) and BP (r =0.34, P <0.005). Significant OSAHS-NE and BP-NE
relationships remained even after controlling for caffeine consumption. Patients
with OSAHS consumed nearly three times the amount of caffeine as patients
without OSAHS. While caffeine partially explains the increased adrenergic tone
in patients with OSAHS and the relationship between BP and NE, it does not
appear to contribute significantly to the relationship between OSAHS and
elevated BP.
2,4.1.2 Reduced upper airway calibre
2.4.1.2.1 Specific anatomical lesions.
Factors that reduce upper airway calibre lead to increased upper airway resistance,
with the generation of a more negative pharyngeal pressure during inspiration
(Lopes et al., 1983), and thereby predispose to upper airway occlusion during
sleep. There are a number of recognised anatomical abnormalities that are
associated with narrowing of the upper airway and predispose to OSAHS.
Specific anatomical abnormalities are more frequently seen in children,
particularly adenotonsillar enlargement (Orr et ah, 1981; Sussman et ah, 1975).
Conditions associated with facial dysmorphism and/or mandibular abnormalities
show a predisposition to OSAHS, and include choanal atresia (Schafer et ah,
1982), micrognathia (Schafer et ah, 1982; Conway et ah, 1977), and craniofacial
dysostosis (Schafer et ah, 1982; Lauritzen et ah, 1986). Micrognathia is
particularly associated with OSAHS, as a small and/or retropositioned mandible
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places the base of the tongue closer to the posterior pharyngeal wall and interferes
with the efficiency of the genioglossus muscle in keeping the tongue out of the
narrowed pharynx (Sher et ah, 1992). Surgical correction of specific anatomical
abnormalities, such as adenotonsillar removal, can result in partial or complete
resolution ofOSAHS (Guilleminault et ah, 1989).
Infiltration of upper airway muscles and soft tissues can impair muscle function
and reduce the upper airway lumen, as in myxoedema (Orr et al., 1981),
acromegaly (Grunstein et al., 1991), involvement by neoplastic processes (Zorick
et al., 1980), and mucopolysaccharidosis (Perks et al., 1980), all of which have
been associated with a predisposition to OSAHS. Treatment of the underlying
process can reverse upper airway obstruction (Orr et al., 1981; Zorick et al.,
1980). Most adult patients with OSAHS, however, have no specific skeletal or
soft-tissue lesion obstructing the upper airway, but often have a small-congested
oropharyngeal airway.
2.4.1.2.2 Headposition.
The position of the head and neck is an important factor in pharyngeal patency,
with neck flexion capable of producing considerable increases in pharyngeal
resistance during wakefulness and anaesthesia, particularly in obese subjects
(Safar et al., 1959; Spann et al., 1971). Varying head position between flexion and
extension can cause significant variations in size of the retroglossal space and
hyoid position on lateral cephalometry (Davies et al., 1990). Neck flexion makes
the upper airway more susceptible to collapse, whilst neck extension makes the
upper airway more resistant to collapse (Wilson et al., 1980), irrespective of
changes in general body posture.
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Mouth opening can cause increased upper airway resistance, since this results in
dorsal movement of the ventral attachments of upper airway dilator muscles, with
resultant shortening in muscle length and reduction in efficiency (Morikawa et ah,
1981).
2.4.1.2.3 Nasal Obstruction.
In normal individual, the nose is the primary route of breathing during
wakefulness, and more particularly during sleep (Gleeson et al., 1986), and the
nose accounts for about half of the total respiratory resistance to airflow (Proctor
et al., 1977). A marked increase in nasal resistance is seen in patients with acute
or chronic rhinitis when they become recumbent (Rundcrantz H, 1969). Unilateral
nasal disease, such as polyps, can also cause increased nasal resistance in the
lateral recumbent position if present in the upper - most nostrils (Cole et al.,
1984). Nasal resistance is elevated in OSAHS patients (Martin et al., 1980; Irvine
et al., 1984), and the use of nasal decongestants can reduce supraglottic resistance
in OSAHS (Anch et al., 1982). Nasal occlusion in normal subjects leads to
increased numbers of apnoeic episodes, sleep arousals, and awakenings (Suratt et
al., 1986), and increased numbers of apnoeas and hypopnoeas are also seen in
patients with seasonal allergic rhinitis when symptomatic (McNicholas et al.,
1982), or with deviated nasal septum (Lavie et al., 1982).
Nasal packing for epistaxis may induce OSAHS or exacerbate pre-existing
OSAHS (Wetmore et al., 1988) whilst topical anaesthesia of the nose significantly
increases the number of disordered breathing events in normal sleeping subjects
(McNicholas et al., 1987; White et al., 1985).
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The capacity to sense both pressure and airflow in the upper airway may be
important in the maintenance of respiratory rhythm during sleep (Zwillich et al.,
1981), and nasal airflow has been reported to have a stimulant effect on breathing
(McNicholas et al., 1993). There is strong evidence, therefore, from a number of
different perspectives, to support an important role for nasal dysfunction in the
pathophysiology ofOSAHS.
2.4.1.3 Mechanical factors
Fibroptic studies during obstructive sleep apnoea / hypopnoea syndrome have
shown abrupt collapse of the airway at the onset of inspiration, with opposition of
the lateroposterior oropharyngeal walls in the pharynx and no evidence of glottic
obstruction (Guilleminault et al., 1978). On lateral fluoroscopy (Suratt et al.,
1983), upper airway obstruction during inspiration is seen when the soft palate
touches the posterior pharyngeal wall and the tongue. This obstruction usually
ends when the tongue moves forward, the mandible lifts and the posterior
pharyngeal wall moves posteriorly. This sequence of events enlarges the
pharyngeal airway.
2.4.1.3.1 Posture.
Most individuals assume the supine posture when they are asleep, despite the
disadvantageous effects that this posture has on upper airway patency. Pharyngeal
cross sectional area is reduced from the upright to the supine position in normal
subjects (Brown et al., 1987; Yildirim et al., 1991). Supraglottic resistance is also
greater in the supine than in the sitting position, both for normal subjects and
patients with OSAHS (Anch et al., 1982).
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The effect of supine posture on upper airway patency does not result from
decreased upper airway dilator muscle activity, since these muscles increase their
electro-myo-graphic (EMG) activity with the transition from the upright to the
supine posture both in OSAHS and normal subjects (Safar et ah, 1959; Yildirim et
ah, 1991; Douglas et ah, 1993).
There is also no evidence that the decrease in lung volume observed in supine
posture contributes to upper airway narrowing, since maintaining functional
residual capacity (FRC) at a constant level in normal subjects whilest changing
from upright to supine does not prevent the fall in cross sectional area
(Rundcrantz H, 1969). Thus, the supine posture effect appears to be due to
gravitational forces acting to narrow the upper airway (Rundcrantz H, 1969).
However, patients with OSAHS often have a reduced FRC when upright, and the
further fall in FRC when assuming the supine position may be associated with a
significant fall in upper airway calibre (Hoffstein et ah, 1984).
2.4.1.3.2 Upper airway resistance.
Patients with OSAHS have smaller upper airways than nonapnoeic subjects and
this is reflected in the finding of a higher awake inspiratory airflow resistance
during wakefulness within the nasopharynx, in OSAHS patients when compared
to controls (Anch et ah, 1982; Stauffer et ah, 1987).
The onset of sleep leads to an increase in respiratory system resistance in healthy
humans (Lopes et ah, 1983; Hudgel et ah, 1984; Tabachink et ah, 1981; Weigand
et ah, 1989 and 1990; DeWeese EL, Sullivan TY, 1988), the increase being
located almost entirely in the upper airway above the larynx (Hudgel et ah, 1984),
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primarily at either the level of the palate or oropharynx (Hudgel DW, Hendricks
C, 1988).
Although the nose can contribute significantly to upper airway resistance on
assuming the supine posture due to increased nasal mucosal congestion (Anch et
al., 1982), there is little increase in nasal resistance with the change from
wakefulness to sleep (Hudgel et al., 1988). The further increase in upper airway
resistance with sleep onset is thought to result instead, from a decline in upper
airway dilator muscle tone during sleep (Hudgel et al., 1988).
Non-obese snorers have a greater increase in total airway resistance during non-
REM sleep than matched control subjects (Skatrud JB, Dempsey JA, 1985), and
there is a highly significant correlation between awake nasopharyngeal resistance
and AHI during sleep (Stauffer et al., 1987; Suratt et al., 1985). Inspiratory
oropharyngeal resistance can reach high levels between apnoeas in patients with
OSAHS (Remmers et al., 1978; Martin et al., 1980), and expiratory resistance
increases significantly, as an apnoeic episode approaches (Sanders MH, Moore
SE, 1983; Sanders et al., 1985).
2.4.1.3.3 Upper airway compliance and collapsibility.
The upper airway extends from the nasal choanae to the epiglottis in humans. It
lacks rigid or bony support, and may thus collapse in the absence of forces to
maintain patency (Hudgel DW, 1986).
Marked variability in upper airway collapsibility is seen among normal men
during sleep (Wiegand et al., 1989), and is thought likely to be related to both
anatomical factors and alterations in ventilatory control during sleep. Pharyngeal
compliance in snorers with OSAHS is increased compared to nonapnoeic snorers
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(Brown et al., 1985 and 1987), and patients with OSAHS have more collapsible
upper airways whilst awake than control subjects (Suratt et al., 1984 and 1985).
Increased pharyngeal compliance may, therefore, be more closely related to the
development of OSAHS than pharyngeal cross sectional area (Brown et al.,
1985).
Patients with OSAHS have lower tonic muscle activity than snoring non-apnoeic
controls, which appears to make their pharynx "floppier" (Brown et al., 1987).
This concept has been extended by viewing the upper airway as a Starling
resistor, with a collapsible segment in the oropharynx and flow through the upper
airway governed by changes in pressure occurring upstream (nose) rather than
downstream (hypopharynx) to the collapsible segment (Smith et al., 1988;
Schwartz et al., 1988). Patients with OSAHS may, therefore, have an elevation of
the critical collapsing pressure surrounding the upper airway, rather than changes
in the resistive properties of the upper airway (Smith et al., 1988; Schwartz et al.,
1988).
Overall, the data points to important differences in upper airway mechanics
between normal subjects and patients with OSAHS, which are evident during
wakefulness, but become more during sleep.
2.4.1.4 Upper airway muscle function
2.4.1.4.1 Abnormal upper airway dilator muscle activity.
Patency of the collapsible segment of the upper airway is believed to be
dependant on the function of pharyngeal dilator muscles (Remmers et al., 1978;
Block et al., 1984), which act to stiffen or distend the collapsible pharyngeal
airway during inspiration, as suggested by the presence of EMG activity
25
coordinated with respiration (Strohl KP, 1981). Activity of these upper airway
muscles is modulated by chemical stimuli, vagal input, changes in upper airway
pressure, and baroreceptor activity (Brouillette et al., 1979 and 1980).
Breathing through a narrowed upper airway generates a greater suction pressure
and, thus, greater collapsing force, and pharyngeal dilator muscles must,
therefore, contract more forcefully to prevent upper airway obstruction.
Progressive hypercapnia, hypoxia, asphyxia and negative pressure application all
produce an augmenting drive to upper airway dilator muscles (Brouilette et al.,
1980; Horner et al., 1991). Defects in such upper airway muscle responses, or in
coordination of upper airway and diaphragm activity, have each been proposed as
factors predisposing to OSAHS (Wilson et al., 1980; Brouilette et al., 1980;
Weiner et al., 1982; Onal et al., 1981 and 1982; Issa et al., 1983).
The alae nasi (AN) dilate the anterior nares during inspiration, and the degree of
preactivation of the AN EMG ahead of the DIA EMG may be used as an index of
ventilatory drive to the upper airway (Strohl et al., 1980). During NREM sleep,
AN preactivation increases from the beginning to the end of an apnoeic episode
suggesting that ventilatory drive to the AN increases with apnoeic duration (Suratt
et al., 1985). This increase in preactivation, which also be seen in other upper
airway muscles (Strohl et al., 1980), could represent a compensatory attempt to
open the airway before airway pressure is lowered by contraction of the DIA and
the ribcage (RC) muscles.
The genioglossus (GG) pulls the tongue forward and opposes pharyngeal collapse
due to inspiratory negative pressure (Remmers et al., 1978; Brouillette RT, Thach
BT, 1979; Sauerland EK, Harper RM, 1976; Issa et al., 1988), as shown by earlier
peaking of GG EMG activity ahead of DIA EMG activity during inspiration
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(Brouillette RT, Thach BT, 1980). Phasic inspiratory GG activity decreases with
sleep in normal subjects (Martin et al., 1980; Strohl KP, 1981; Onal et ah, 1982),
and almost ceases during REM sleep (Sauerland EK, Harper RM, 1976; Parisi et
ah, 1987); It, however increases significantly from wakefulness to NREM sleep,
between apnoeas in OSAHS patients, and in older obese control subjects (Suratt et
ah, 1988). Thus, normal subjects have less activity than patients with OSAHS yet
do not have occlusive apnoeas, and such augmented activation of GG in OSAHS
subjects may be viewed as a protective mechanism that occurs when patency of
the pharyngeal airway is compromised. Any factor that interferes with this
increase in GG activity, such as onset of phasic REM sleep or periodicity of
central drive, can predispose to upper airway collapse. Indeed, GG EMG activity
is reduced or abolished at apnoea onset, and increased at the termination of the
obstruction (Remmers et ah, 1978; Suratt et ah, 1988).
Muscles that cause forward movement of the hyoid bone [geniohyoid (GH),
sternohyoid (SH), thyrohyoid (TH)], are thought to enlarge and stabilise the
pharyngeal airway (Weigand et ah, 1990; Van de Graaf et ah, 1984; Van Lunteren
et ah, 1987; Weigand et ah, 1990; Roberts et ah, 1984). In both normal subjects
and those with OSAHS, adoption of a supine posture is associated with forward
movement of the hyoid bone (Yildirim et ah, 1991). These muscles show phasic
inspiratory activity, and greater mechanical activity with significant hypercapnia
(Van de Graaf et ah, 1984; Van Lunteren et ah, 1987). Both the GH and TH show
augmented and prolonged activity after occlusion at end-expiration (Van de Graaf
et ah, 1984). Phasic inspiratory activity of the GH is seen in normal awake
subjects, with a sleep - related fall in tonic activity in all stages of sleep, and there
is a negative correlation with upper airway resistance (Weigand et ah, 1990).
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Pharyngeal volume in anaesthetised cats displays an inverse relationship with
hyoid muscle (GH, SH) length (Van Lunteren et al., 1987). Factors that influence
hyoid position, such as neck flexion or mandibular abnormalities, can adversely
affect the function of these muscles leading to narrowing of the hypopharynx.
Reduced activity of the tensor palatini (TP) muscle, which retracts the palate from
the posterior pharyngeal wall, thereby maintaining pharyngeal patency during
nasal breathing, may also play an important role in the pathogenesis of OSAHS
(Sauerland et al., 1981; Tangel et al., 1991; Anch et al., 1981; Hariston LE,
Sauerland EK, 1981). Tonic activity of the TP decreases during sleep and
correlates with increased upper airway resistance during sleep (Tangel et al., 1991
and 1992).
The overall conclusion that can be drawn from the above studies is that a variety
of different muscle groups play an important role in the maintenance of upper
airway patency. Muscles that control the tongue, palate and hyoid all appear to be
involved in this process, but the literature so far gives differing views on the
relative importance of these muscle groups. Furthermore, it has been argued that
airway compliance, independent of upper airway dilator muscle activity, may be
the principal determinant of upper airway collapsibility (Strohl KP and Olson LG,
1987). The ability of the upper airway to resist collapse may, therefore, be
dependant upon the relative juxtaposition of the mandible and hyoid bones, which
allow for a specific pharyngeal size, and on the properties of the airway wall in
the collapsible segment of the upper airway, rather than on upper airway dilator
muscle activity (Strohl KP and Olson LG, 1987).
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2.4.1.4.2 Impaired relationship ofupper airway muscle and diaphragm
contraction.
The EMG activities of upper airway muscles and diaphragm respond in a
qualitatively similar manner to hypercapnia (Patrick et al., 1982), hypoxia (Onal
et al., 1981), and airway occlusion (Weiner et al., 1982). This suggests that central
control mechanisms of upper airway and respiratory pump muscles in humans are
intimately related.
Inspiratory activation of upper airway muscles occurs earlier than activation of the
DIA (Block et al., 1984), which stabilises and counterbalances the collapsing
force on the upper airway by DIA and RC muscle activity (Block et al., 1984).
Any reduction or delay in upper airway inspiratory muscle contraction, relative to
DIA and RC muscle activity, predisposes to upper airway narrowing or collapse
during sleep.
Activity of the hypoglossal nerve at lower levels of chemical drive (hypoxia and
hypercapnia) is less than, and at higher levels of chemical drive greater than,
phrenic nerve activity in anaesthetised dogs (Weiner et al., 1982), although
allowance must be made for the fact that anaesthesia selectively inhibits neural
input to the upper airway (Hwang et al., 1983). Oxygen breathing in rabbits
decreases GG more than DIA EMG, whilst hypercapnia and prolonged occlusions
preferentially activate GG compared to DIA (Brouillette RT, Thash BT, 1980).
Non-specific respiratory stimuli (light, sound, touch) preferentially increase
phasic inspiratory GG activity (Brouillette RT, Thash BT, 1980), similar to that
seen with electroencephalographic (EEG) arousals at the termination of
obstructive apnoeas (Remmers et al., 1978). Peripheral chemoreceptors appear to
affect phasic inspiratory activity in the GG and DIA in qualitatively similar, but
quantitatively different, ways. Nitrogen breathing and cyanide injection increase
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phasic inspiratory activity in the GG more than in the DIA (Brouillette RT, Thash
BT, 1980), and these responses are abolished by carotid body denervation.
Some reports have suggested that respiratory motor drive to the pharyngeal
musculature decreases during sleep, whereas output to the diaphragm is
unchanged (Remmers et ah, 1980, Orem et al., 1977). Others have suggested that
a preferential decrease in upper airway muscle activity is not necessary for the
development of occlusive apnoeas (Onal E, Lopata M, 1982, Onal et al., 1985).
It has been hypothesised that patients with OSAHS have instability of ventilatory
control similar to periodic breathing, and that occlusive sleep apnoeas occur when
DIA and GG inspiratory EMG activity are both near the nadir of the cycle, which
is lower than awake or sleep onset values (Onal et al., 1982). After apnoea onset,
these EMG activities tend to decrease further for the first 1 -3 inspiratory efforts,
and then progressively increase until resolution of the apnoea, at which time GG
EMG appears to increase to a greater degree than DIA EMG and for 1-2
postapnoeic breaths. The period immediately following resolution of the apnoea is
usually characterised by hyperventilation of several breaths, which normalises
arterial oxygen saturation (Sa, O2). Both EMGs then decrease in activity, which
predisposes to further occlusive apnoeas (Onal et al., 1982).
In addition, it has been speculated that the relative timing of inspiratory EMG
activity of the upper airway to DIA and RC activity fluctuates during sleep in
OSAHS (Hudgel DW, Harasick T, 1990). As an obstructive sleep apnoea
approaches and upper airway inspiratory resistance progressively increases,
inspiratory EMG activity of the upper airway muscles moves closer to and then
falls behind RC EMG inspiratory activity (Hudgel DW, Harasick T, 1990).
Activity of the upper airway muscles remains behind the RC muscles during the
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apnoea, but precedes activity of the RC muscles when the upper airway opens.
This could represent periodicity of the respiratory controller (Longobardo et al.,
1982), with reduced damping and increased gain. During tests of upper airway
collapsibility in sleeping subjects with OSAHS, there was no evidence of
increased drive to upper airway dilator muscles during progressive asphyxia,
despite an apparent increase in drive to the DIA (Issa FG and Sullivan CE, 1984).
A clinical model of a disturbed timing relationship between upper airway and
diaphragmatic contraction predisposing to OSAHS is seen in patients with
diaphragmatic palsy treated with an electrophrenic pacemaker. About 50% of
such patients develop OSAHS after insertion of this pacemaker (Glenn et al.,
1978; Hyland et al., 1981), since the pacemaker results in DIA contraction at
times other than when upper airway muscles contract. The relationship between
GG and DIA is discussed further in "periodicity of central drive".
2.4.1.5 Upper airway reflexes
Several reports indicate a role for upper airway reflex mechanism in the
maintenance of patency (Horner et al., 1991). Evidence suggests that these reflex
mechanism are pressure sensitive (Mathew et al.,1982 & 1984), and interference
with them could lead to an imbalance between intra-pharyngeal pressure and the
contraction of upper airway dilating muscles, resulting in obstructive apnoeas
(Remmers et al., 1978). The importance of such protective reflexes is supported
by the finding of fatal pharyngeal airway closure in rabbits, in which upper airway
reflexes are abolished by topical anaesthesia (Abu-Osba et al., 1981).
Topical oropharyngeal anaesthesia (TOPA) in normal human subjects results in
increased frequency of obstructive apnoeas (McNicholas et al., 1987) and
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pharyngeal resistance during sleep, independent of any direct effect of lignocaine
on the upper airway muscle themselves (De Weese EL and Sullivan TY, 1988).
A significant increase in obstructive events was seen after TOPA in a group of
otherwise asymptomatic snorers (Chadwick et al., 1991), with several subjects
developing AHIs that fall within the range of OSAHS as conventionally defined
(Guilleminault et al., 1976). In contrast, TOPA did not produce any significant
increase in AHI or apnoea duration among patients with OSAHS, which supports
the possibility that upper airway reflexes are defective in OSAHS (Deegan et ah,
1993).
Defective upper airway reflexes may be a primary abnormality in OSAHS,
contributing to the development of upper airway occlusion during sleep.
However, such a defect could also be a secondary phenomenon, since the
mechanical vibration of the upper airway, associated with loud snoring, might
also blunt the afferent receptors for the reflex, which are presumed to lie in the
oropharyngeal wall. Data from the above studies (Chadwick et ah, 1991; Deegan
et ah, 1993) favour a primary abnormality in upper airway reflexes among
OSAHS patients, since subjects with loud snoring would also be expected to have
a mechanical vibration in the upper airway similar to that among patients with
OSAHS.
Temperature sensitivity in the oropharynx in OSAHS patients is significantly
impaired compared to age-matched nonsnoring control subjects (Larsson et ah,
1992), which further supports the notion that upper airway reflexes are impaired
in patients with OSAHS.
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2.4.1.5.1 Responses to negative pressure.
Upper airway muscle EMG activity increases when negative pressure is applied to
the isolated upper airway of tracheotomised rabbits (Mathew et al., 1982),
probably through reflexes involving mechanoreceptors located above the trachea,
and via several afferent pathways. Small but consistent changes in respiratory
frequency were also seen in many of the animals, suggesting some involvement of
the respiratory centre in these changes (Mathew et al., 1982).
In awake human subjects, the administration of sudden negative airway pressure
to the upper airway leads to a pronounced and repeatable reflex increase in
genioglossus activity (Horner et al., 1991). Contribution from both supra-glottic
and sub-glottic receptors appears to be involved, and topical anaesthesia blocks
the response when the glottis is closed (Horner et al., 1991). This response is
reduced during NREM sleep (Wheatly et al., 1993). Normal awake subjects
exposed to continuous negative airway pressure (CNAP) whilst supine, are able to
preserve tidal volume both by immediate and sustained increases in upper airway
and diaphragm muscle activity (Aronson et al., 1989).
However, during NREM sleep no immediate muscle or timing responses areseen
with CNAP, and hypopnoeas and occlusive apnoea result. Re- establishment of
upper airway patency is dependent on arousal and increased muscle activity.
These findings suggest that protective reflexes, which act to maintain upper
airway patency in the presence of negative airway pressure during wakefulness,
are compromised by sleep.
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2.4.1.5.2 Responses to positivepressure.
Continuous positive airway pressure, applied through the nares (nCPAP), is an
effective therapy for OSAHS (Sullivan et al., 1981), and yet reduces upper airway
dilator EMG activity (Deegan et al., 1993 and 1994). The efficacy of nCPAP,
despite the association with reduced upper airway dilator muscle contraction, is
fully consistent with the concept that suction pressures in the upper airway during
inspiration cause the collapsible upper airway to occlude. This inspiratory
suction pressure is abolished by nCPAP, and the reduction in upper airway
dilator EMG activity during nCPAP administration is probably a consequence of
the reduced need for upper airway dilating muscle contraction in the absence of
any inspiratory negative suction pressure and to a possible splinting effect of the
positive pressure. End-expiratory positive airway pressure has been shown to
reduce the frequency and duration of apnoeas and the degree of nocturnal oxygen
desaturation, in patients with OSAE1S (Mahadevia et al., 1983). However, as
negative pressures are still developed in the upper airway during inspiration while
on external positive airway pressure (EPAP), this improvement could not be
attributed to simple splinting of the upper airway. This observation suggests an
improvement in other factors that may be contributing to the development of
upper airway occlusion during sleep, such as decreased FRC and / or hypoxaemia
(Cherniack NS, 1981).
2.4.1.5.3 Feedbackfrom the lungs.
Pharyngeal cross sectional area (CSA) is abnormally small in obese patients with
OSAHS, and varies considerably with changes in lung volume (Rubenstein et al.,
1989). The mean CSA of the upper airway in snorers with OSAHS appears to be
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significantly less than in non-apnoeic snorers at residual volume, but not at FRC
(Brown et al., 1985).
Upper airway resistance tends to decrease with increasing lung inflation and with
increasing breathing rates at low volumes (Brown et al., 1985). The above
observations support the notion the vagally mediated reflexes related to lung
volume can have an important influence on upper airway calibre (Van Lunteren et
al., 1984).
2.4.1.6 Central factors
Abnormalities of respiratory control have been implicated in the pathogenesis of
OSAHS (Onal et al., 1982), and could conceivably occur at several levels ranging
from the respiratory centre to peripheral upper airway reflex mechanism.
2.4.1.6.1 Chemical drive.
The sleeping state is associated with a reduction in minute ventilation (Douglas et
al., 1982), and in the ventilatory responses to hypoxia and hypercapnia (Berthon-
Jones et al., 1982 and 1984), compared with wakefulness. The mechanism
underlying these reductions is not thought to be due exclusively to decreased
central respiratory drive (White et al., 1986), and may relate, at least in part, to
mechanical changes, such as reduced upper airway patency during sleep (Skatrud
et al., 1985; Hudgel et al.,1984). Support for this possibility comes from the
observation that mouth occlusion pressure, which is a better index of respiratory
drive than the ventilatory response (Whitelaw et al., 1975), increases from
wakefulness to NREM and REM sleep in men, with little change in women; and
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the mouth occlusion pressure response to hypercapnia is generally maintained
during NREM sleep in comparison to wakefulness (White et al., 1986).
Upper airway resistance in OSAHS appears to be influenced by the intensity of
the central respiratory drive (Series et al., 1989). At specific levels of respiratory
drive post-hyperventilation, a similar decrease in central respiratory drive leads to
a greater increase in pharyngeal resistance among OSAHS patients than among
normal subjects, which is not explained by differences in weight and age (Series
et al., 1989).
Eucapnic OSAHS patients have been reported as having a normal (Kryger et al.,
1974), or reduced (Gold et al., 1993), awake hypercapnic ventilatory response,
whilst obese OSAHS patients with daytime hypercapnia have reduced awake
ventilatory responses to hypercapnia (Garay et al., 1981). Most patients with
OSAHS are eucapnic and demonstrate augmented ventilation after apnoeas, with
tidal volume of breaths as much as double that of breaths preceding apnoeas;
whilst hypercapnic patients do not display this "big breath phenomenon" (Garay
et al., 1981). In another study, hypercapnic ventilatory responses in obese patients
with OSAHS, and in patients with obesity-hyperventilation, were significantly
lower than in normal non-obese subjects subjected to abdominal mass loading,
and in subjects without OSAHS (Lopata M, Onal E, 1982). However, mean DIA
EMG responses in this study shows that obesity may be associated with impaired
respiratory neuromuscular coupling, which in turn may impair transfer of
ventilatory drive to muscle contraction (Lopata M, Onal E, 1982). Thus
ventilation may be an inadequate parameter to assess central respiratory drive in
these patients, and a significance (P=0.1) responses are likely to give a better
indication of central respiratory drive in obese subjects.
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It is uncertain whether the observed reduction in chemical drive is a primary
defect (El Bayadi et al., 1990), or secondary to sleep apnoea, as suggested by
some improvement in the ventilatory response to CO2 in hypercapnic OSAHS
patients after long-term nCPAP therapy (Berthon-Jones et al., 1987).
2.4.1.6.2 Periodicity ofcentral drive.
Variability in inspiratory muscle timing among patients with OSAHS could result
from periodicity of the central respiratory controller (Hudgel et al., 1990). During
the hypopnoeic portion of the periodic breathing cycle, when ventilatory drive is
low, both the relative amplitude and the relative timing of the inspiratory activity
of the upper airway and chest wall muscles favour upper airway occlusion, since
there is a greater fall in amplitude of upper airway muscle EMG than
diaphragmatic EMG, and the normal pre-activation of upper airway EMG is not
apparent (Deegan et al., 1995). On the other hand, an obstructive apnoea is
terminated when the drive to the upper airway muscles is stimulated to a degree
such that the magnitude of increase in upper airway dilator muscle activity
exceeds that of the respiratory muscles, allowing opening of the upper airway and
resumption of airflow (Deegan et al., 1995).
In addition, total pulmonary resistance can double in the period from immediately
after an upper airway occlusion to immediately before the next one (Martin et al.,
1980).
An arterial carbon dioxide tension (Pa, C02) threshold well above the eupnoeic
level is observed for GG muscle stimulation during all stages of sleep and
wakefulness, whilst the DIA shows increased activity at even minor degrees of
hypercapnia (Parisi et al., 1987).
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The maintenance of rhythmic breathing in hypoxia is dependent upon the neuro-
physiological state of the higher central nervous system (CNS) (Berssenbrugge et
ah, 1983). Hypoxia causes periodic breathing during all stages of NREM sleep,
and apnoea is produced when end-tidal CO2 is reduced by l-3mmHg below
spontaneously breathing awake levels, with apnoea length positively correlated
with the magnitude of hypocapnia. These findings point to a highly sensitive CO2
- dependent apnoeic threshold during NREM sleep. It has been proposed that the
combination of augmented peripheral chemoreceptors "gain" in hypoxia, together
with the hypocapnia-induced apnoeic threshold in NREM sleep, provides the
basis for the initial occurrence of apnoea, in addition to the hyperventilation that
immediately follows the termination of apnoea. This hyperventilation
subsequently leads to hypocapnia, which predisposes to further apnoea and
contributes to the self-sustaining nature of periodic- breathing (Berssenbrugge et
al„ 1983).
2.4.1.6.3 Response to breath loading.
Resistive load detection thresholds during wakefulness are significantly
greater among patients with OSAHS than control subjects, and the degree of load
detection impairment correlates with the severity of OSAHS (McNicholas et ah,
1984). A significant negative correlation between the awake ventilatory response
to hypercapnia and load detection threshold was seen in both patients and control
subjects. Furthermore, since awake inspiratory load compensation in patients with
OSAHS is normalised after a period of nCPAP treatment, such impairment may
be a reversible consequence, rather than a cause, of OSAHS (Greenberg HE,
Scharf S, 1993).
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If conscious factors are important in ventilatory load compensation, then the loss
of these influences with sleep onset may result in an inadequate response. Normal
subjects can fully compensate for external sensitive loads (Iber et al., 1982;
Santiago et ah, 1981; Wiegand et ah, 1988) and external elastic loads (Wilson et
ah, 1984) during wakefulness by immediate adjustments in ventilatory timing, and
minute ventilation is maintained at preloading levels. During NREM sleep,
however, there is an immediate fall in minute ventilation following load
application, largely due to a reduction in tidal volume. This fall becomes less
marked with time due to a rise in (Pa, CO2) that results in augmented ventilatory
effort (Wilson et ah, 1984).
However, it has been speculated that this lack of augmentation of respiratory
drive, when a partial airway occlusion occurs during sleep, may permit forward
motion of the tongue rather than the tongue being sucked backwards into the
pharynx by the higher suction pressures generated with greater respiratory effort.
This balance of forces could prevent the progression from partial to complete
upper airway obstruction (Santiago et ah, 1981).
Another factor in ventilatory load compensation is thought to be a reflex
originating in respiratory muscles that are fatiguing and / or developing high intra¬
thoracic pressure. Neural information from these respiratory muscles is fed back
to the respiratory centre, which in turn may modulate output so that the
respiratory muscles are unloaded. A fatiguing respiratory pattern may occur
during an obstructiveapnoea (Guilleminault C, 1980), with each occluded
inspiratory effort associated with increasing tension time index of the diaphragm.
When this index reaches or exceeds the fatigue threshold, arousal may result,
followed by opening of the upper airway (Vincken et ah, 1987; Kimoff et ah,
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1994). Thus, the airways may be triggered to open by a protective reflex
originating in the larynx, or the inspiratory muscles, upon reaching a certain
degree of contraction.
If perception of upper airway occlusion during sleep, by mechanoreceptors or
inspiratory muscles, is involved in eliciting the arousal response that terminates
each apnoeic event, it could be argued that elevation of the threshold for load
detection might contribute to prolongation of sleep apnoeas and result in a more
severe degree of asphyxia. However, the lack of prolongation of apnoea with
topical anaesthesia among normal subjects (McNicholas et al., 1987), loud snorers
(Chadwick et al., 1991). Patients with OSAHS (Deegan et al., 1993) could argue
against the possibility of increased duration of apnoeas due to reduced upper
airway pressure detection, although another preliminary report has indicated
prolongation of apnoeic episode with such anaesthesia in OSAHS patients (Berry
et al., 1993).
Ventilatory breathholdins.
There are a number of chemical and mechanical factors that affect the duration of
voluntary breathholding, a manoeuvre that stimulates some features of an
obstructive apnoea (Godfrey et al., 1968). These include hypoxaemia and
hypercapnia, both of which shorten maximum breathhold time. Hyperventilation
lengthens the breathholding time by lowering the initial (Pa, CO2). In addition, if
a few breaths of a gas that does not alter (Pa, CO2) are taken at the breaking point
of a threshold, the subject will be able to resume the breathhold. Thus, the
unpleasant sensation experienced as the breaking point is reached is not due solely
to hypercapnia (Godfrey et al., 1968).
40
In another study, involuntary respiratory muscle contractions (recorded as waves
of negative pressure) were found in most individuals during breathholding, and
increased in amplitude and frequency throughout the breathholding time
(Whitelaw et al., 1981). The slopes of the pressure waves (dP / dt) during
breathholding were found to be greater than those in the same subjects at the same
CO2 level during rebreathing. This suggested that the response is due, in part, to a
number of other, possible non-chemical stimuli (Whitelaw et al., 1981).
Effect ofoxygen supplementation.
The role of O2 desaturation in the pathophysiology of OSAHS may be assessed
indirectly by observing the effects of O2 supplementation. Nocturnal oxygen
improves (Sa, O2) in patients who have sleep-disordered breathing (Phillips et al.,
1990), but there is no objective evidence of any improvement in daytime
sleepiness (Gold et al., 1986), although some patients report greater alertness.
Administration of 100% O2 acutely (Martin et al., 1982), and O2 at 4L. min"1
throughout the night (Alford et al., 1986), eliminates (Martin et al., 1982) or
reduces (Alford et al., 1986) bradycardia associated with sleep apnoea. Added
oxygen increases the length of apnoeas and hypopnoeas (Gold et al., 1986), as
well as increasing (Pa, CO2), and this results in a lower pH at the end of apnoeic
events (Gold et al., 1986; Alford et al., 1986). Supplemental oxygen can reduce
apnoea frequency, possibly by reducing postapnoeic hyperventilation and
stabilizing ventilatory drive (Gold et al., 1986).
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2.4.1.7 Arousal
2.4.1.7.1 Impaired arousal responses.
Arousal from sleep in normal males is accompanied by an immediate fall in upper
airway resistance to wake values (Wiegand et al., 1989), whilst termination of an
obstructive apnoea is believed to depend heavily on arousal (Issa et al., 1984).
Thus, arousal mechanisms may have an important role to play in the
pathophysiology ofOSAHS (Phillipson EA, Sullivan CE, 1978).
In normal individuals, when relief of upper airway occlusion is accompanied by
arousal, there is a fall in pharyngeal resistance and a drop in end-tidal carbon
dioxide tension (Pet, CO2) due to hyperventilation (Nolan et al., 1993). However,
when no arousal occurs, hyperventilation is obtunded and both (Pet, CO2) and
pharyngeal resistance rise.
In patients with OSAHS, evidence of arousal usually precedes or coincides with
the preferential increase in upper airway tone that restores airway patency and
terminates the obstructive apnoea (Remmers et al., 1978). However, the
mechanisms by which airway occlusion, hypoxia, and hypercapnia lead to arousal
from sleep remain unclear and it is unlikely that any single factor is responsible
for arousal.
It has been hypothesised that airway occlusion activates pressure-sensitive upper
airway mechanoreceptors and that these play an important role in arousal from
upper airway occlusion, as nasal occlusion leads to shorter times to arousal
compared to tracheal occlusions in sleeping dogs (Issa et al., 1987). The finding
that topical upper airway anaesthesia significantly prolongs the time to EEG
arousal in response to induced airway occlusion in normal human subjects
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(Basner et al., 1992) also supports an important role for upper airway receptors in
facilitating the arousal response. Responses to irritant receptor stimulation are
blunted during sleep compared to wakefulness, with the degree of laryngeal and
tracheo-bronchial stimulation required to produce arousal during REM sleep
higher than in slow wave sleep (SWS) (Sullivan et al., 1979 and 1978). Cough
and smooth muscle contraction in response to broncho-pulmonary irritant stimuli
appear to be dependent on arousal, and arousal responses to such stimuli are
depressed in REM sleep (Sullivan et al., 1979). Pulmonary stretch receptors
stimulated by lung inflation do not cause arousal, but readily produce apnoea and
tracheal smooth muscle relaxation during SWS (Sullivan et al., 1979).
Total airway occlusion during NREM sleep in normal subjects is characterized by
a breath-by-breath progressive increase in suction pressure prior to arousal that is
achieved by an increase in the rate of inspiratory pressure generation (Issa et al.,
1983). In contrast, during REM sleep, arousal occurs after a shorter duration of
airway occlusion than NREM, and the period of occlusion is associated with a
rapid shallow breathing pattern. These findings are surprising, and contrast with
the clinical situation in OSAHS, where apnoeas during REM sleep tend to be
longer than during NREM sleep. The increasing ventilatory effort associated with
the obstructive apnoea may also be an important factor that contributes to arousal,
mediated by mechanoreceptors feedback from the respiratory system, probably
from respiratory muscles (Kimoff et al., 1994; Gleeson et al., 1990).
Hypoxaemia stimulates specific receptors in the carotid body (Bowes et al.,
1981). However, hypoxia has been shown to be poorly related to arousal in
normal humans (Douglas et al., 1982), and in patients with chronic obstructive
pulmonary disease (Fleetham et al., 1982). In addition, increased upper airway
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resistance during sleep, below the threshold for frank apnoeas or hypopnoeas, can
still produce frequent brief arousals and significant daytime sleepiness in the
absence of O2 desaturation (Guilleminault et al., 1993).
Hypercapnia, which activates receptors in the upper airway and medulla, appears
to be a much more potent stimulus to arousal than hypoxia (Douglas et al., 1982).
In normal subjects, exposed to hypoxia, hypercapnia and inspiratory resistive
loading during sleep, arousal occurred at different levels of blood chemistry (Sa,
O2 and CO2) but the ventilatory effort for each subject was similar at the point of
arousal regardless of the stimulus (Gleeson et al., 1990). It has, therefore, been
concluded that increasing ventilatory effort may be the stimulus to arousal from
sleep independent of the source of this rising drive to breathe (Gleeson et al.,
1990).
At present, any definition of arousal from sleep will be arbitrary, since there is no
universal agreement as to what exactly constitutes an arousal. This difficulty in
defining arousal relates largely to the limitations of the standard Rechtschaffen
and Kales (Rechtschaffen A and Kales A, 1968) criteria, which remain the current
gold standard for staging sleep. Newer criteria, based on spectral analysis of the
EEG during sleep (Salinsky et al., 1988), will almost certainly improve the ability
to classify arousal, and the advent of computerised software for EEG analysis will
facilitate this development. A preliminary report, based on spectral analysis of the
EGG, has demonstrated that the arousal associated with the termination of
obstructive apnoea is not a sudden event that occurs at the termination of apnoea,
and that there is evidence of partial arousal developing from much earlier on
during the course of the apnoeic episode (Rees et al., 1993).
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The arousal response does not usually lead to complete awaking, but rather may
cause lightening of sleep, with a shift from a deeper sleep stage to higher stage.
Alternatively, there may be no formal change in sleep stage by conventional
definition, but short bursts of alpha waves may occur at the termination of apnoea.
These sleep stage / state changes lead to sleep fragmentation, which in turn can
worsen the underlying OSAHS (Guilleminault C, Rosekind M, 1981).
2.4.1.7.2 Postapnoeic hyperventilation.
All apnoeic events do not necessarily end with an EEG arousal, whilst EEG
changes are not essential for an arousal response to have occurred. Nevertheless,
the above data support the view that arousal represents a protective mechanism to
restore ventilation, and normalise blood gasses, whenever the upper airway is
occluded. Thus, any factor that interferes with the arousal mechanism could lead
to more profound and prolonged apnoeas. However, arousal alone could
potentially predispose to further apnoeas by virtue of the hyperventilation that
occurs with relief of upper airway occlusion (Nolan et al., 1993). The resultant
fall in (Pet, CO2) and (Sa, O2) will predispose to further occlusion of a
compromised upper airway.
Integrated PathophysiologV ofOSAHS
The foregoing discussion indicates the complexity of the pathophysiology of
OSAHS. Various factors, ranging from upper airway anatomy to central
respiratory control mechanisms, interact to produce the clinical syndrome of
OSAHS. Different factors will predominate in individual patients, but it is likely
that all patients with clinically significant OSAHS have a multifactorial aetiology,
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rather than any single causative factor. Specific anatomical narrowing of the
upper airway occurs in only a subgroup of patients with OSAHS (Guilleminault et
al., 1976), and thus other factors are likely to play a role in the development of the
clinical OSAHS syndrome. However, these factors, such as defects in ventilatory
control and protective upper airway reflexes, are less easily defined and further
research is needed to elucidate their precise role in maintaining upper airway
patency during sleep.
The role of central factors in the development of OSAHS is underlined by reports
in the early literature related to OSAHS that successful relief of OSAHS by
tracheostomy is frequently followed by evidence of central sleep apnoea
(Guilleminault C, Cummiskey J, 1982). Furthermore, the division between central
and obstructive sleep apnoea / hypopnoea syndrome is not as clear cut as it might
appear, since many patients with central sleep apnoea present with clinical
features more suggestive of OSAHS (Bradley et al., 1986), and it is possible that
in some patients, upper airway occlusion reflexly triggers a central, rather than an
obstructive apnoea. Support for this notion comes from the finding that some
patients with central sleep apnoea can be successfully treated with nCPAP
(Bradley et al., 1986).
A better understanding of the interacting factors that lead to the development of
clinically significant OSAHS will hopefully, lead to the development of better
modalities of therapy.
A schematic illustration of the integrated pathophysiology of OSAHS is given in
figure 2.3 (Deegan et al., 1995). This illustration underlines the complexity of the
overall pathophysiology, but emphasizes the central features, with factors that
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compromise upper airway patency and promote obstruction on one hand and other
factors, principally arousal, which acts to restore upper airway patency.
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Fig 2.3 Schematic illustration of the integrated pathophysiology of OSAHS
UA: Upper airway
H/N: Head and neck
Z?UA: Upper airway resistance
PCSA: Phaiyngeal cross sectional area
FRC: Functional residual capacity
Pa, O2: Arterial oxygen tension
Pa, Co2: Arterial carbon dioxide tension
X: Impairment of arousal mechanism
MRA: Mandibular Repositioning Appliance
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2.4.2 Anatomical Factors
A number of cephalometric studies have demonstrated characteristic differences
in the craniofacial anatomy and oropharyngeal dimensions of people suffering
from OSAHS (Lyberg et al., 1989: Lowe et ah, 1986: Solow et al., 1993:
Jamieson et al., 1986; Tangugsorn et al., 1995; Battagel et al., 1996; Ozbek et al.,
1998; Kulnis et al., 2000).
2.4.2.1 Reduced cranial base length
It is a consistent finding of cephalometric studies of OSAHS subjects, (Bacon et
al., 1988). As a logical consequence, the lengths of the maxilla and of the bony
pharynx are diminished. These measurements are confirmed by Battagel et al.,
(1996), who suggests a mean decrease in cranial base length of some 2.4mm and
identifies a consequential of the antero-posterior dimensions of the cranium with
subsequent 'Retrusion of the face'.
2.4.2.2 Reduced cranial base angle
This has been detected in a significant proportion of OSAHS subjects (Jamieson
et al., 1986). Battagel et al., (1996) measure this decrease (Ba-SN) as being
approximately 3.7° in OSAHS subjects as compared with controls. Jamieson and
his colleagues, hypothesize that the more acute cranial flexure, is associated with
a lower hyoid position and abnormal development of the hypo-pharyngeal soft
tissues.
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2.4.2.3 Increased cranio-cervical angle
De-Berry Borowiecki et al., (1988), suggest that abnormal growth and
pathological changes in the cervical column to influence the axial posture and can
also affect the position of the hyoid bone and other related structures. He found
that a significant number of OSAHS patients showed distinctive changes in the
body of the cervical vertebra compared to a control groups. In all of these cases,
the abnormality appeared as a flattening of the body of the fourth vertebrae and an
extra bony ridge on its anterior border. Whilst Solow et al., (1993) detected an
increased cranio-cervical angle; he related this to a probable postural response to
reduced upper airway patency, rather than to a specific cervical anatomical
abnormality. He cites Cote (1988), who states that 'although no formal description
of the head posture in this condition has been made; an extended head posture is
generally recognised by clinicians as being a characteristic appearance of patients
with OSAHS'. Although the cranio-cervical angle appears particularly sensitive to
differences in recording methodology (Solow and Tallgren 1971), it has become
obvious that a significant increase is associated with reduced patency of the upper
airway. Indeed, Solow measured a mean increase of 12°, which he attributed to a
forward inclination of the vertebral column rather than an upward rotation of the
head itself. This contrasts with his earlier findings in growing patients with
adenoidal hyperplasia and other upper airway patency problems, where measured
increases were smaller (2° mean) and mediated by a true extension of the head.
This is explained by the need for non-growing individuals to maintain the visual
axis in its horizontal position. This concept of postural compensation to upper
airway obstruction is very much aligned with the earlier realisation that airway
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patency, or lack there of, can lead to certain specific growth patterns of the facial
skeleton.
2.4.2.4 Inferiorly positioned hyoid bone
Hyoid bone position has been reported to be significantly inferior in OSAHS
subjects as compared to control groups (De-Berry Borowieki et al., 1988;
Tsuchiya et al., 1992; Johns et al., 1998; Battagel et al., 2000). In 1987,
Djupesland concluded that, 'with regard to skeletal morphology, the most
outstanding feature in OSAHS subjects is the more inferior position of the hyoid
bone. In such patients, the hyoid is consistently located at the level of the cervical
vertebra C4-C6, compared with the C3-C4 level in controls'. He suggests that as
the hyoid is an anchor for the musculature comprising the tongue, a more inferior
hyoid position would result in a greater mass of the tongue being located at the
hypopharyngeal level and therefore the base of the tongue would be in a more
upright position. The altered hyoid position has been suggested by some to be
strictly vertical with no indications for its mal-alignment in the antero-posterior
dimension (Kuna et al., 1988). Others have reported an infero-anterior position
(Rivlin et al., 1984), which may involve some slight rotation.
Partinen (1988) suggests a link between hyoid position relative to the cervical
vertebrae to the severity of OSAHS (in terms of RDI/AHI) and to Posterior
Airway Space, (the measured distance from the base of the tongue to the posterior
pharyngeal wall).
Young and McDonald (2002) found also the hyoid bone to be more inferiorly
positioned in the OSAHS than the controls.
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2.4.2.5 Bimaxillary retrusion
Bimaxillary Retrusion or retrognathia of the mandible alone has been reported
(Jamieson et al., 1986; Tsuchiya et ah, 1992) in up to 42% of subjects in a number
of OSAHS investigations, and recent work undertaken by Battagel JM, (1996),
has shown significant reductions in mandibular length Go-Me reduction of up to
5.9mm), and even variations among mandibular plane inclinations are accounted
for similar results were obtained. Other studies (De-Berry Borowieki et ah, 1988)
have shown no indication of this trait and we must accept that while a decrease in
mandibular body length has often been described, this does not appear to be a
universal finding.
2.4.2.6 Increased lower facial height
Lowe et ah, (1986); Bacon et ah, (1990); Tsuchiya et ah, (1992) found that there
is increase in the lower facial height with concomitant increase in the maxillo-
mandibular planes angle.
2.4.2.7 Reduced width of oropharynx
Djupesland et ah, (1987) found that up to 50% reduction in diameter at the level
of the soft palate. More recently, Battagel et ah, (1996) found that for all
measurements, the mean airway dimensions in OSAHS subjects are
approximately 66% of those found in control groups. Interestingly, these
dimensions are reported to be consistently reduced, regardless of the subject being
erect or supine (Yildirim et ah, 1991).
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2.4.2.8 Increased soft palate dimensions
The soft palate has been found to be longer (Jamieson et al., 1986; Bacon et al.,
1988; Partinen et al., 1988; Lyberg et al., 1989; Riley et al., 1988), larger and in
contact with a wider area of the tongue (Lyberg et al., 1989). Interestingly,
comparison of two sleep disordered groups, (OSAHS and simple snorers without
OSAHS) reveal very few significant differences in cephalometric measurements,
however, the soft palate in OSAHS subjects is found to be larger and thicker as
compared to those in patients who snore in isolation (Battagel et al., 2000).
2.4.2.9 Increased tongue size
Data regarding the tongue is ambiguous. Whilst Lyberg (1989) found no
difference in tongue size in OSAHS subjects, De-Berry-Borowieki et al., (1988)
and Lowe et al., (1986 and 1991) found it to be significantly larger as compared to
control groups. Among others, Partinen et al., (1988) has suggested that although
the tongue size may be normal, very often a reduced inter-maxillary space means
that the area in which it functions is smaller. That is, in relative terms the tongue
is enlarged.
Lowe et al., (1986a) found moderate to severe sufferers of OSAHS tended to
have a posteriorly positioned maxilla and mandible, a steep occlusal plane,
overerupted maxillary and mandibular teeth, proclined incisors, a steep
mandibular plane, a large gonial angle, high upper and lower face heights and
an anterior open bite in association with a long tongue and a posteriorly
placed pharyngeal wall (Cistulli, 1996).
Palatal flutter has been reported to be the most important cause of snoring (Ellis et
al., 1993). In situations of airway obstruction, the blockage is often located at the
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level of the soft palate, but has also been identified elsewhere within the entire
extent of the pharynx (Ellis et al., 1993; Croft et al., 1991; Lugaresi et al., 1989).
Colmenro et al., (1991) found OSAHS associated with maxillofacial
abnormalities such as temporomandibular joint (TMJ) ankylosis with
micrognathia, Treacher Collins Syndrome and Long Face Syndrome. The
combination of a retropositioned facial skeleton and reduced oropharyngeal
dimensions, at one or more sites between the soft palate, tongue and pharyngeal
wall, partly explains the underlying aetiology of this condition.
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2.5 CLINICAL SYMPTOMS
Clinically, patients exhibit a number of characteristics, which may be considered








The most obvious night-ime problem is loud snoring, although this frequently
more of a dilemma for the rest of the family than the subject himself. A
characteristic pattern in OSAHS is that of loud snoring with associated snorting,
interrupted by episodes of silence (apnoeic episodes) and breaks off suddenly
as air finally enters the lungs (Guilleminault C et al., 1976; Kales A et al.,
1985).
Whilst a high percentage of OSAHS subjects snore, the majority of people who
snore do not have OSAHS (Battagel, 1996). A significant percentage of these
people who snore suffer from OSAHS (Lowe et al., 1992). Woodhead et al.,
(1991), correlated factors with OSAHS such as excessive loud snoring, a decrease
O2, narrow oropharynx, marked obesity, and increased neck dimension.
Snoring was once considered to be harmless; (Kleitman N, 1963) but now is
suggested to be indicative of a significant clinical problem, whose medical
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consequences range from no physical debilitation to failure to thrive (Loughlin
GM, 1992; Marcus et al., 1994). It has been estimated that as many as 70% of
adults with OSAHS snored during childhood (Guilleminault C, Dement WC,
1978). Those with OSAHS are at increased risk for hypertension, cardiovascular
disease, cerebro-vascular disease, and impaired function caused by sleepiness
(Guilleminault C, Dement WC, 1978; Koskenvuo et ah, 1985; Hoffstein V,
Mateika S, 1994; Ulfberg et ah, 1996; Young et ah, 1996).
Epidemiologic studies of habitual snoring in children suggest a prevalence of
between 7% and 12% (Ali et ah, 1993 and 1994; Owen et ah, 1996; Corbo et ah,
1989). Snoring children are reportedly mouth breathers (Owen et ah, 1996; Carroll
et ah, 1995) or restless sleepers, (Ali et ah, 1993 and 1994; Owen et ah, 1996)
have excessive daytime sleepiness, (Ali et ah, 1993 and 1994) are hyperactive,
(Ali et ah, 1993 and 1994) have poorer hearing, (Owen et ah, 1996) and present
with previous adenoidectomy and enlarged tonsils (Nieminen et ah, 1997).
Although snoring has been reported to be a common finding in children with
symptomatic OSAHS, (Nieminen et ah, 1997; Westbrook PR, 1983; Brouillette et
ah, 1982; Gastaut et ah, 1966; Lugaresi et ah, 1978; Bacon et ah, 1990) only a
subgroup ofhabitually snoring children have OSAHS (Carroll et ah, 1995).
Genetic and environmental factors influence snoring, and many studies support an
anatomic origin (Bacon et ah, 1990; Isono et ah, 1996). Palatal flutter has been
reported to be the most important cause of snoring (Ellis et ah, 1993). In situations
of airway obstruction, the blockage is often located at the level of the soft palate,
but has also been identified elsewhere within the entire extent of the pharynx
(Ellis et ah, 1993; Croft CB, Pringle M 1991; Lugaresi et ah, 1989).
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2.5.1.2 Choking
A sensation of choking or dyspnea that interrupts sleep is reported by 18% to 31%
of patients (Coverdale SGM et al., 1980; Kales A et ah, 1985; Maislin G et ah,
1995). During episodes of upper airway obstruction, progressively more vigorous
inspiratory efforts lead to more negative intrathoracic pressure swings, with an
increase in venous return. This may increase the pulmonary capillary wedge
pressure and contribute to the sensation of dyspnea (Buda AJ et ah, 1981).
Nocturnal dyspnea from OSAHS usally resolves quickly on awakening, whereas
the paroxysmal nocturnal dyspnea that is characteristic of congestive heart failure
patients takes much longer to resolve.
2.5.1.3 Abnormal motor activity
About half of OSAHS patient report restless sleep (tossing and turning) and
diaphoresis, usually in the neck and upper chest area (Coverdale SGM et ah,
1980; Maislin G et ah, 1995), and involuntary leg movement during sleep (Johal
A, 1998). These symptoms are probably related to the increased breathing efforts
during periods of upper airway obstruction.
2.5.1.4 Nocturia
Nocturia is a relatively common symptom in OSAHS (Hoffestein V and Szalai
JP). Twenty eight percent (28%) of patients with OSAHS reported 4-7 nightly
trips to the bathroom (Hajduk IA et ah, 2003). Increased intra-abdominal
pressures, confusion associated with arousals, and increased secretion of atrial




About 74% of patients with OSAHS reported dry mouth and the need to drink
watereither in the morning or during the night (Kales A et ah, 1985). Drooloing
occurs in 36% (Kales A et al., 1985). These symptoms are most likely the result
ofmouth breathing, commonly seen in patients with OSAHS (Ohayon MM et ah,
2001).
2.5.2 Diurnal (daytime) symptoms
The daytime symptoms are associated with the poor quality of the previous
night's sleep and include
■ Hypersomnolence (excessive daytime sleepiness)
■ Depression and psychological dysfunction
■ Headaches
■ Sexual problems (Decreased lipido)
■ Impaired concentration
■ Renal failure
2.5.2.1 Hypersomnolence (Excessive daytime sleepiness)
Excessive daytime sleepiness (EDS) is a frequent symptom of patients with
obstructive sleep apnoea / hypopnoea syndrome (OSAHS). Poor quality of nightly
sleep may have a profound effect upon the subject during their daily activity.
Upon working, subjects often report feeling unrefreshed and 'not having slept
well', (Johal A, 1998). Findley et ah, (1988), acknowledged the frequent finding,
that in extreme cases, subjects may fall asleep if not being physically or mentally
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stimulated. Often the sleepiness is more obvious to others in the environment than
to the subjects themselves.
Driving a car presents an additional danger and reports of falling asleep at the
wheel are not uncommon (Battagel et al., 1996). In a study by Findley et al.,
(1988), 24 per cent of a group ofOSAHS sufferers reported feeling drowsy whilst
driving, at least once per week. Aldrich MS, (1989) found that 31 per cent of
drivers with OSAHS had been involved in a road traffic accident with in the last 5
years. Stradling et al., (1991) suggested that snoring alone causes
hypersomnolence without associated sleep apnoea or hypopnoea. Long distance
lorry driving and piloting aircraft are occupations, which can prove fatal (Battagel
et al., 1996).
The Royal College of Physicians of England (1993) report stated that 20-25% of
motorway accidents in U.K are due to drivers falling asleep at the wheel; OSAHS
may have a very important role in causing accidents.
Sauter et al., (2000) claimed that excessive daytime sleepiness (EDS) is a high-
risk factor for accidents at work and on the road. Thirty untreated patients with
different levels of severity of OSAHS were studied concerning night sleep and
EDS. The criterion for severity was the respiratory disturbance index (RDI): 15
patients were classified as 'moderately' apnoeic (RDI<40), 15 as 'severely'
apnoeic (RDI>40). Following nighttime polysomnography, objective and
subjective aspects of EDS were studied. To assess objective EDS the Maintenance
of Wakefulness Test (MWT) and a computer-based vigilance performance test
were used. Subjective EDS was determined using the Stanford Sleepiness Scale
(SSS), the Epworth Sleepiness Scale (ESS) and the Visual Analogue Scales for
Performance (VAS-P) and Tiredness (VAS-T). Well-being was assessed using the
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Scale of Weil-Being by von Zerssen (Bf-S/Bf-S'). Severe apnoea patients spent
more time in stage 1 and less in slow-wave sleep. MWT latencies tended to be
shorter in the severe apnoea group. Vigilance testing revealed no group
differences. Patients with moderate apnoea described themselves as more
impaired in all subjective scales, but only SSS scores reached statistical
significance. Their results suggest that there is no simple correlation between
polysomnographic and respiratory sleep variables at night on the one hand, and
the extent of EDS on the other hand. Furthermore, subjective and objective
evaluation ofEDS does not yield the same results.
2.5.2.2 Depression and psychological dysfunction
Sleep changes, most notably disturbances ofREM sleep, is intrinsic to depression;
OSAHS causes predominantly REM sleep disturbances, (Kaplan R, 1990). Relief
of mild to moderate sleep and breathing disorders in children is associated with
improved behaviour and psychological functioning (Ali et al., 1996).
Personality changes and abnormal behaviour have both been reported as a
consequence of nocturnal sleep fragmentation and subsequent EDS. Aggressive
and irritable behaviour is typical, with elevated level of anxiety, paranoia and
depression is also reported (Wright et al., 1997). Hypnagogic hallucinations have
also been reported as a possible consequence of a severe OSAHS condition
(Wright et al., 1997).
2.5.2.3 Headaches
Morning headaches is reported in about half pf the OSAHS patients and often are
described as dull and generalizes (Kales A et al., 1985). They usually last 1-2
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hours and may prompt the ingestion of analgesics. A study from the headache
clinic found OSAHS to be the main cause of nocturnal or morning headache
(Paiva et al., 1997).
2.5.2.4 Sexual problems
Abatement of sexual drive or impotence has been reported in patients with
OSAHS (Karacan et al., 1995). One third of the patients report decreased lipido or
impotence, which tends to improve with treatment (Kryger et al., 2005).
2.5.2.5 Impaired concentration
Many reported inability to concentrate, poor memory and temporal disorientation
(Johal A, 1998), which further complicate the situation, leading to an inability to
remember everyday items such as appointments and telephone numbers (Battagel
JM, 1996). Personality changes, such as aggressiveness, irritability, anxiety, or
depression may also be observed (Kryger et al., 2005).
2.5.2.6 Renal failure
Hui et al., (2000) studied patients with end-stage renal failure (ESRF) who are
reported to have a high prevalence of sleep disorders, such as daytime sleepiness,
insomnia, restless legs syndrome (RLS), and obstructive sleep apnoea /
hypopnoea syndrome (OSAHS). However, there is published data from Southeast
Asia. A sleep questionnaire was administered to 201 patients (103 men) at
continuous ambulatory peritoneal dialysis (CAPD) outpatient clinic to assess
sleep problems. Patients had a mean age of 56.7 ± 12 (SD) years, with a mean
body mass index (BMI) of 23.6 ± 3.5 kg/m (2). Daytime sleepiness was the most
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frequent symptom (77.1%), and frequent awakening occurred in 69% of the
patients. Sleep-onset insomnia and sleep-maintenance insomnia occurred in 73%
and 60% of the patients, respectively. Sixty-two percent of the patients reported
symptoms of RLS, which significantly correlated with sleep-onset insomnia (odds
ratio [OR], 2.9; 95% confidence interval [CI], 1.5 to 5.5; P = 0.001) and sleep-
maintenance insomnia (OR, 2.1; 95% CI, 1.2 to 3.8; P = 0.014). The prevalence
ofOSAHS was estimated by the frequency of the following symptoms: extremely
loud snoring, 7 patients (3.5%); observed choking, 21 patients (10.5%); witnessed
apnoea, 11 patients (5.6%); snoring and witnessed apnoea, 6 patients (3%);
disruptive snoring, 29 patients (14.4%); and disruptive snoring and witnessed
apnoea, 3 patients (1.5%). This questionnaire survey confirmed a high prevalence
of daytime sleepiness, insomnia, and RLS in patients with ESRF undergoing
CAPD but showed a relatively low prevalence of OSAHS of up to 14.4%, which
may be related to the low BMI of these patients with ESRF compared with other
populations.
The dominant symptoms of OSAHS are excessive daytime sleepiness, impaired





• Coronary heart disease and left ventricular hypertrophy




Blood pressure and number of patients with hypertension increased linearly with
severity of sleep apnoea, as shown by the apnoea/hypopnoea index. Multiple
regression analysis of blood pressure levels of all patients not taking
antihypertensives showed that apnoea was a significant predictor of both systolic
and diastolic blood pressure after adjustment for age, body mass index, and sex.
Multiple logistic regression showed that each additional apnoeic event per hour of
sleep increased the odds of hypertension by about 1%, whereas each 10%
decrease in nocturnal oxygen saturation increased the odds by 13% (Lavie
Peretz et al., 2000).
Lavie et al., (2001) have demonstrated that hypertensive patients with sleep
apnoea whose blood pressure responds beneficially to treatment have less severe
sleep apnoea than those patients whose blood pressure remains elevated despite
anti-hypertensive therapy. Since neither obesity nor nocturnal hypoxaemia appear
to be important determinants of ineffective treatment, we suggest that resistant
hypertension may be caused by frequent intermittent sympathetic stimulation.
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2.6.1.1 Systemic hypertension
Short-lasting rises in blood pressure are a recognized feature associated with
nocturnal apnoeas (Fletcher EC, 1995), however such rise have not, as yet, been
linked with adverse prognostic outcomes. Kales et al., (1984) found a high
prevalence ofOSAHS in hypertensive patients. Hirshkowitz et al., (1989) found a
higher level of OSAHS only in the subgroup of hypertensive patients receiving
drug therapy with erectile complaints.
Hoffstein et al., (1988) found AHI positively associated with diastolic blood
pressure but in contradiction, mean oxygen saturation was also positively
associated. Levinson et al., (1991) concluded that the evidence of a link between
obstructive sleep apnoea / hypopnoea syndrome and hypertension is conflicting
and at present inconclusive.
2.6.1.2 Pulmonary hypertension and right sided heart failure
• 1 ^
Patients with OSAHS had a high prevalence of pulmonary hypertension [ I22
(59%) and 8/i2 (67%)] (Schroeder et al., 1978; Tilkian et al., 1976). Pulmonary
hypertension (PH) and daytime hypoxaemia were associated with either chronic
airway obstruction or with severe obesity (Apprill et al., 1991).
Kreiger et al., (1989) and Weitzenblum et al., (1988) found a prevalence of
pulmonary hypertension (pulmonary arterial pressure > 20 mmHg) in about 20%
of patients studied. After regression analysis, significant correlation was found
between pulmonary arterial pressure and arterial blood gas levels {Pa, 02 and Pa,
CO2) and indices of lung function.
Bradley et al., (1985) did find a significantly lower nocturnal O2 saturation in six
patients clinically diagnosed as having right heart failure, as well as Pa, O2 and
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lung function indices. All six were smokers and the classification or heart failure
is of uncertain validity.
2.6.2 Cardiac arrhythmias
Cardiac arrhythmias (Dysrhythmias) is the disturbance of the heart rhythm or
gross disturbances of heart rate which are usually caused by lesions of the sino¬
atrial or atrioventricular nodes, or of the cardiac conducting tissues, sometimes by
drugs. Most dysrhythmias reduce cardiac efficiency and cardiac output.
Shepard et al., (1985) documented arrhythmias in 74% of a group of OSAHS
patients. Patients with severe apnoea may experience cardiac arrhythmias
associated with oxygen desaturation below 70% (Miller WP, 1982). Extreme
sinus bradycardia (heart rate less than 30), tachycardia (abnormally rapid heart
rate), sinus arrest and atrio-ventricular block have been observed in patients with
OSAHS. These may result in anoxic seizure, cardiac arrest and sudden death
(Kryger et ah, 1974).
Flemons et ah, (1993a) however concluded that currently no evidence to suggest
that patients with OSAHS are at increased risk of cardiac arrhythmias during
sleep.
2.6.3 Coronary heart disease and left ventricular hypertrophy
Hedner et ah, (1990) found that OSAHS patients had a significantly higher left
ventricular mass index than controls (Approx. 15% higher), but no
polysomnography was carried out to diagnose OSAHS and the influence of
important confounding variables was poorly assessed. Hanly et ah, (1992) found
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no significant association even without consideration of confounding variables
such as age, smoking and hypertension.
Schmidht-Nowara (1990) studied the association of apnoeic index and coronary
heart disease in the general population but the results are of limited validity.
Davies et al., (1994) concluded that there is no good evidence that patients with
OSAHS have an increased risk of left ventricular hypertrophy, cardiac failure or
coronary heart disease.
2.6.4 Stroke (Cerebro-vascular accidents)
Strokes are a common cause of disability and death, especially in the elderly
(Scully C and Cawson RA, 2000).
Mohsenin V and Valor R, (1995) reported statistically significant difference in the
AHI between 10 patients with hemispheric strokes and 10 matched controls. The
major difficulty in these associations between sleep apnoea and stroke is in
distinguishing which comes first as a consequences or cause.
Patients with OSAHS have been estimated to suffer cerebro-vascular accidents at
three to six times the rate of controls (Friedlander et al., 1998). Atherosclerosis of
the cervical portion of the carotid artery has been suggested as the possible cause
of these strokes. Calcified lesions are found typically in the region of C3 and C4
(Friedlander et al., 1998). These atheromas are visible on lateral cephalograms
and the prevalence has been recorded as high as 21.3% in patients with OSAHS
(Friedlander et al., 1998).
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2.6.5 Psychotic disorders
There is increasing recognition of the link between OSAHS and depression. Sleep
changes are intrinsic to depressive orders, most notably in REM sleep. The
features of depression are similar or indicated by the symptoms of OSAHS
(Kaplan R, 1990). The author suggested the implications are two fold - OSAHS
needs to be excluded in cases of chronic or resistant depression and treatment of
OSAHS will make it easier to treat the primary depressive disorder.
2.6.6 Mortality
One of the key issues about OSAHS and its effect on health is whether patients
have an increased risk of mortality from the disease compared to the general
population.
Gonzalez-Rothi et al., (1988) produced the best-designed study, including a
control group, full follow-up of the study sample, validation of deaths from death
certificates and use of regression analysis. There was no significant difference in
mortality for patients with OSAHS whether treated or untreated.
Partinen et al., (1988) found that conservatively treated patients had a
significantly greater risk of vascular mortality compared to patients treated with
tracheostomy.
Bliwise et al., (1988) found no significant association between AHI and risk of
mortality with age having the main association. Ancoli-Israel et al., (1989) found
a significant association between mortality and AHI in women but not in men.
There is little evidence from the available studies to conclude that OSAHS is




Table 2.2 Conditions associated with sleep apnoea
Oropharyngeal narrowing


























From: Nasser S, Rees PJ. Consequences of sleep apnoea. BJCP, 1992; 46:1
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2.7 DIAGNOSIS
The clinical diagnosis of OSAHS depends on the identification of several
symptoms and causes so that treatment can be appropriately directed to the cause.
These include:
History and Clinical Examination
Investigations:
♦ Cephalometric radiography
o Measurements ofThe Face and The Cranium
o Soft Tissues Measurements
o The Cervical Spine and Hyoid Bone
o Oral andpharyngeal Measurements
♦ Computer tomography scanning




♦ Acoustic reflectance technique
♦ Fibroptic and nasal endoscopy
♦ Nasal capnography
♦ Questionnaires
2.7.1 History and Clinical Examination
In term of diagnosis, a comprehensive history and clinical examination may be
suggestive of OSAF1S, but for confirmation, other investigations are required. The
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examination should include an ear, nose and throat assessment, so that any
physical obstructions to breathing may be identified. History taking and physical
examination are the simplest methods used to diagnose OSAHS. For complete
history data capture, it is essential that the subject to be accompanied by his
sleeping partner. Whilst the subject will be aware of how he/she feels during the
day, a partner is more likely to be able to describe the degree of nocturnal
disturbances.
2.7.1.1 History
The history should include the patients 'and the partners' summary of symptoms
such as choking attacks, morning headaches, gastro-oesophageal reflex, nocturia,
impotence, poor memory and concentration and mood changes (McNamara et al.,
1993). The cardinal features of OSAHS are however snoring and daytime
sleepiness (Kaplan R, 1990; McNamara et al., 1993).
Indices have been developed to aid diagnosis, the first of which is the most
commonly used.
2.7.1.1.1 Epworth sleepiness scale (ESS)
This is a questionnaire which has been designed to assess how likely a person
would be to doze off in the following eight situations:-
sitting and reading;
watching television;
sitting inactive in a public place (eg. a theatre or meeting);
a passenger sitting in a car for an hour;
lying down to rest in the afternoon;
71
sitting and talking to someone;
sitting quietly after lunch, without having consumed alcohol;
and as the driver of a car, stopped for few minutes in traffic.
Scores run from zero (no chance) to three (high chance) with one equalling a low
likelihood and two a moderate probability. The maximum possible score therefore
is 24. Scores ofmore than 15 (that is over 50%) suggest that the subject is sleepier
than would be considered normal and perhaps should seek treatment.
2.7.1.1.2 Apnoea /hypopnoea index (AHI)
This calculates the number of apnoea and hypopnoea divided by the hours of
sleep, with a figure of "between" 5 to 10 being the upper end of normal (He et al.,
1988).
2.7.1.1.3 Multiple latency sleep test (MLST)
It is a measure of the ability to stay awake, rarely used.
2.7.1.1.4 Flow - volume loops
Sanders et al., (1981) first reported that flow-volume loops could be helpful in
identifying OSAHS. A saw-tooth pattern, defined as three or more consecutive
peaks and troughs of similar configuration occurring at regular intervals of no
greater than 300cc 'during the middle half of the vital capacity in expiration,
inspiration or both', was thought indicative of variable extrathoracic airway
obstruction. However, further studies using this technique (Riley et al., 1983;
Tammelin et al., 1983) gave false results for OSAHS. It seems that flow-volume
loops appear to correlate with the amount of fatty infiltration of the upper airway
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in obese subjects-a phenomenon that is associated with OSAHS - rather than
integrally part of OSAHS itself.
2.7.1.1.5 The REM sleep index
The rapid eye movement sleep index yields the number of abnormal respiratory
events per time unit ofREM sleep.
2.7.1.1.6 Indices ofoxygen saturation measurements
One measures the number of events with saturation below a certain oxygen level
(<90 per cent, 80 per cent, 70 per cent); another measures the amount of time
asleep below a specific level of oxygen saturation. Generally, these indices are
useful for determining the severity of the patients' initial problem and the
effectiveness of the treatment or treatment chosen.
2.7.1.1.7 Indexfor cardiac arrhythmias
This index gives the number of arrhythmias per hour of sleep, independent of
type.
2.7.1.1.8 Additional tests
Once a diagnosis of OSAHS has been established, a complete blood count may
reveal secondary polycythemia. Serum electrolytes may also show bicarbonate
retention due to carbon dioxide retention. Thyroid studies may be considered, to




The patient should be examined in the supine positions, as well as seated or
standing. In the absence of any maxillofacial malformation, the presence or
absence of dentures and other prostheses should be identified and oveijet noted.
An ear, nose and throat assessment is indicated to identify any obvious physical
obstructions to breathing such as septal deviation, turbinate hypertrophy, and / or
nasal polyp or tonsillar enlargement.
Other factors upon which our attention must focus include:
■S Size, colour and covering consistency of the tongue.
S Presence or absence of pharyngeal oedema or abnormal colouring of the
pharynx.
•S Appearance of the soft palate and the size, length and position of the uvula.
^ Aspects of the nares, including morphology and collapsibility of the nostril
during inspiration whilst supine.
■S Evidence of trauma,
2.7.1.2.2 Evaluation of obesity and its distribution
Height and weight are recorded, and used to calculate the subject's body mass
index (BMI). This is calculated as weight (Wt) in kilos divided by the square of
• 2 •





The normal range for body mass index (BMI) is considered to be between 20 and
25. Subjects with a BMI of greater than 25 are overweight, whilst those whose
index is greater than 30, are obese (Davies et ah, 1990 and 1992; Battagel et ah,
1996).
Fatty infiltration around the neck should also be investigated, and usually a simple
neck circumference measurement is used to reflect upon obesity in the region of
the upper airway. Neck circumference (NC), is at the level of the cricothyroid
membrane. Percentage of the predicted neck size (PPNC) allows compensation
for the increase in neck circumference expected to be associated with increase in
height (Davies et ah, 1990).
100 x Neck circumference (mm)
PPNC =
[0.55 x height (cm)] + 310
Fatty infiltration of the neck will limit the 'normal' reflex of the mandible and
tongue position during sleep, and will subsequently decrease the pharyngeal
space. It is important to note that NC correlates with several later cephalographic
soft - variables, and correlates better with apnoea than does BMI (Davies et ah,
1992).
Distribution of atmospheric pressure upon the body tissues differs from an erect to
a supine position. Therefore, the patient must be observed whilst in the supine
position associated with sleep, to determine if the abdomen adopts a pear shaped
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appearance, which is associated with restriction, which subsequently leads to
detrimental changes in blood gases.
2.7.2 Investigations
2.7.2.1 Cephalometric radiography
Several investigators have used lateral cephalometric radiographs in an attempt to
identify morphological parameters that might be characteristic ofOSAHS.
2.7.2.1.1 Measurements oftheface and cranium
The cranial base may be short (Bacon et al., 1988) and the cranial base angle
reduced (Jamieson et ah, 1986). Battagel et ah, (1996) reported that the cranial
base angle (Ba-SN) was significantly smaller (3.7°) in OSAHS subjects and the
length of the anterior cranial base was reduced (2.4mm). This indicates a
shortening of the antero-posterior dimension of the cranium and thus a more
retruded face.
Rivlin et ah, (1984), reported decrease in mandibular body length. Battagel et ah,
(1996), found reduced mandibular body length (Go-Me) by 5.9mm in the OSAHS
group (P = 0.002). Recording this distance in the horizontal plane, to take into
account variations in mandibular plane inclination, the same differences were
found. Gonion to menton was 6.6mm shorter and gonion to point B 5.6mm less in
apnoeic individuals.
Bimaxillary retrusion (Lowe et ah, 1986a; De Berry-Borowiecki et ah, 1988) or
retrognathia of the mandible alone have been reported (Jamieson et ah, 1986;
Tsuchiya et ah, 1992). Battagel et ah, (1996) found that intermaxillary space
length - the distance between the posterior pharyngeal wall and the lingual aspect
of the lower incisor at the level of the occlusal plane - was 5.7mm shorter in
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OSAHS subjects (P=0.001). The intermaxillary space area was also reduced, by
4.1cm2, indicating a lack of vertical compensation for the diminished antero¬
posterior development.
2.7.2.1.2 Soft tissues measurements
The soft palate is longer (Jamieson et al., 1986; Bacon et al., 1988), larger and in
contact with a wider area of the tongue in OSAHS subjects (Lyberg et al., 1989).
Whilst Lyberg et al., (1989) found no difference in tongue size in OSAHS
subjects, De Barry-Borowiecki et al., (1988) found it to be significantly larger
than in control.
Pracharktam et al., (1994) concluded that although the tongue was no larger in
their OSAHS group, the space in which it had to function was reduced.
2.7.2.1.3 The cervical spine and hyoid bone
Battagel et al., (1996) found that the distance from the C2 (second cervical
vertebra) to a perpendicular dropped from S (sella turcica) was significantly
smaller (3.6mm) in OSAHS subjects. Evaluation of the cranio-cervical angle
revealed this to be increased (Solow et al., 1993).
Hyoid bone position has been found to be more inferior to normal in relation to
the mandibular plane (Jamieson et al., 1986; Partinen et al., 1988).
Young JW and McDonald JP, (2004) identified a statistically significant
coorelation between the vertical position of the hyoid bone and the severiry of
(AHI) of the OSAHS condition. The vertical distance between the hyoid bone and
the S (sella turcica) upon the anterior cranial base demonstrates the highest
correlation with OSAHS severity (AHI). Their evidence suggest a possible
77
overloading of the postural system associated with efforts to maintain upper
airway maintenance (reflected by hyoid bone position ) as OSAHS severity (AHI)
reaches extreme values (>100).
A statistically significant difference is apparent at a sella to hyoid distance of
approximately 120mm, between subjects who are deemed to suffer from a mild to
moderate form of the OSAHS condition and are subsequently referred for MRA
management (<120), and those who are deemed to suffer from a severe form of
the condition (>120). The linear measurement is proposed to be of clinical value
in terms of its application in diagnostic triage and subsequent management
decisions. (Young JW, McDonal JP, 2004).
2.7.1.1.4 Oral andpharyngealmeasurements
Battagel et al., (1996) found that measurements taken at all four levels of the post-
palatal airway, from the upper limit of the oropharynx to the tip of the uvula,
showed high degrees of statistical differences between the OSAHS and the control
groups. These differences were greatest (/MhOOl) where the soft palate was at its
thickest, at the level of the lower incisor tip and at the zone ofmaximal protrusion
of the soft palate into the airway. For all measurements, the mean airway
dimensions in OSAHS subjects were approximately 66 per cent of those in the
control individuals.
In the post-lingual area, by contrast, the difference in airway size between the two
groups was very much smaller (Battagel et al., 1996). The dimensions of the
pharynx are consistently reported to be reduced, whether the subject has been
investigated in the upright or supine position (Yildirim et al., 1991).
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Fig 2.5 Lateral cephalometric analysis
Highly significant craniofacial abnormalities have been found in the upper and
lower pharynx in young OSAHS patients. These include significantly increased
mid-facial height, narrowed middle airway space, steep mandibular plane angle,
elongated pharynx and inferiorly placed hyoid bone (Johns et al., 1998). OSAHS
patients were also found to have multiple sites of abnormality of both upper and
lower pharynx, which may suggest that one mode of treatment such as palatal
surgery alone might not be adequate treatment for these patients.
Lowe AA and Fleetham JA, (1991) evaluated whether measurements from lateral
cephalometric head films are accurate predictors of these dimensional CT
structures. The volumes of the tongue, nasopharynx and soft palate were
accurately predicted by their cross sectional areas, but the volumes of the
oropharynx and hypopharynx were not. Therefore, they suggested that
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cephalogram may be useful to estimate the volume of the tongue, nasopharynx
and soft palate but CT and MRI methods were superior for calculating the volume
of the oropharynx and hypopharynx.
Riley et al., (1987) also recognized the limitations of using a two-dimensional
radiograph to assess a three dimensional area. They found a statistically
significant correlation between pharyngeal airway space measured by
cephalometrics and the volume of the pharyngeal airway. Posterior-anterior
cephalometry can add a third dimension to the information from lateral
cephalogram to assess the shape, size and position of the turbinates and any
apparent septal deviation.
Several studies have used cephalometrics to examine for anatomic differences in
snoring and apnoeic subjects (Bacon et al., 1990; Nelson S, Hans, M 1997;
Zucconi et al., 1992 and 1993; Maltais et al., 1991; Partinen et al., 1988). Most
frequently, cephalometric radiographs of adults with apnoea were compared with
radiographs of non-apnoeic adults. The tendency was for apnoeic adults to have
an increased hyoid to mandibular plane (H-MP) distance, longer soft palates, a
diminished sagittal cranial base dimension, and narrower posterior airways.
Few studies have investigated differences in cephalometric factors in children. A
Japanese study (Shintani et al., 1992) found that children with apnoea had an
inferiorly positioned hyoid. In the most severe apnoeics, the children presented
with enlarged adenoids and narrow airways.
An Italian study (Zucconi et al., 1999) reported that habitually snoring children
with apnoea and adenotonsillar hypertrophy had increased craniomandibular
intermaxillary, lower and upper gonial angles with retropositioning, and posterior
rotation of the mandible (high-angle face), together with a reduction in the nasal
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posterior airway space because of enlarged adenoids. Most previous reports have
used a sample of children suspected of having OSAHS, who were referred to
either Sleep Disorder Centre or the Otolaryngology Department.
Randall et al., (2000) reported that there are craniofacial differences between
snoring and non-snoring children. Their results manifest a significantly narrower
antero-posterior dimension of the pharynx at the superior and most narrow widths.
Snoring children also had a greater distance between the hyoid to the mandibular
plane.
Battagel et al., (2000) studied 115 subjects. Forty-five subjects exhibited proven
obstructive sleep apnoea / hypopnoea syndrome (OSAHS), 46 were simple
snorers, and the remaining 24 subjects, who had no history of respiratory disease
and did not snore, acted as controls. Radiographs were traced and digitised,
comparisons were made of the dento-skeletal, soft tissue, and oropharyngeal
features of the three groups. Differences were also sought between the snoring
and OSAHS subjects. Of the hard tissue measurements, only the cranial base
angle and mandibular body length showed significant inter-group differences
(P<0.001 and P<0.05, respectively). When the airway and associated structures
were examined, both snorers and OSAHS subjects exhibited narrower airways,
reduced oropharyngeal areas, shorter and thicker soft palates, and larger tongues
than their control counterparts did. Comparison of the two sleep disordered
breathing groups showed no differences in any of the skeletal or dental variables
examined. However in OSAHS subjects, the soft palate was larger and thicker (P
<0.05), both lingual and oropharyngeal areas were increased (P <0.01 and P
<0.05, respectively) and the hyoid was further from the mandibular plane (P
<0.05).
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2.7.2.2 Computer tomography scanning
Computer tomography (CT) scanning is used for imaging the upper airway. The
CT scan provides soft and hard tissue images, and three- dimensional
reconstruction of principal parts of craniofacial skeleton, muscles and airway
space is possible. The radiation exposure limits the scope of this examination
technique. As a base line, for typical effective radiological dose equivalents, an
orthopantomogram delivers approximately 0.007 mSv (Equivalent to 13 days
natural background radiation) whilst a CT skull delivers 2.0 mSv (Isaacson and
Jones, 1994). This would make routineuse of those for diagnostic purposes
unethical, unless specific information, which will benefit the patient, can be
obtained.
Fat deposits were seen in the collapsible segment of the pharynx in OSAHS
subjects in CT studies (Horner et al., 1989).
Lowe et al., (1986) quantified the interaction between airway and tongue
structures in OSAHS patients by three-dimensional reconstruction of preoperative
CT slices. The majority of constrictions occurred in the oropharynx, but double
constrictions were also seen in the oropharynx and hypopharynx. Large tongues
appeared to cause postoperative upper airway obstructions.
2.7.2.3 Magnetic resonance imaging
Magnetic resonance imaging (MRI) uses the property of the nuclear magnetic
resonance (NMR) of hydrogen nuclei in water following excitation by a radio
wave to produce a computer-derived picture of tissue. It is a non-invasive imaging
technique as no ionizing radiation is used. MRI is more effective in detecting
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necrotic tissue, ischaemia, malignancy and degenerative soft tissue contrast than
x-ray or CT scan (William Scarfe, 1998).
MRI is an innovative technique (Hoffman et al., 1990) that produces high-
resolution images without the use of ionizing radiation, making it especially well
suited for soft tissue. It had been used to find small changes in the upper airway
before and after nasal continuous positive airway pressure (CPAP) therapy
(Abbey et ah, 1989; Ryan et ah, 1991).
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Fig2.6 The upper airway
Upper airway can be divided into four major levels: nasopharynx, high oropharynx, low
oropharynx and hypopharynx. The nasopharynx was defined as the region between the
roofof the airway and the hard palate. The front boundary of nasopharynx is behind the
nasal septum. The high oropharynx lies between the hard palate and the tip of the soft
palate. The low oropharynx is from the tip of the soft palate to the top of the epiglottis.
The hypopharynx is between the top of the epiglottis and the base of the epiglottis.
Taken from: Goa et al. The Chinese Journal ofDental Research 1999; page29.
Xue Mei et al., (1999) used the MRI to confirm the effect of an oral appliance in
the treatment of OSAHS. They found that the most enlarged part of the airway
was the oropharynx during oral appliance therapy although there was also an
increase in the hypopharynx. The oropharynx increased 23.7% (from 5.56mL to




Overnight polysomnography is regarded as the definitive investigation for the
diagnosis of OSAHS, permitting the physician to distinguish between simple
snoring and true obstructive sleep apnoea hypopnoea syndrome.
The investigation is undertaken in a specially equipped sleep laboratory and
designed to monitor, as non-invasively as possible, a number of variables while
the subject is asleep;
• Type, frequency and duration of apnoea and hypopnoea;
• Oxygen saturation (pulse oximetry);
• Brain (EEG), heart (ECG), muscle (EMG), and eye (EOG) activity;
• Sounds (snoring and choking);
• Oral and nasal flow;
• Abdominal and thoracic respiration.
All these variables are charted, together with body position, sleep stage, and any
leg or body movements. Blood oxygen saturation is under continuous observation
using pulse oximetry.
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POLY-MESAM (Cardiorespiratory polygraphic system)
Early diagnosis of sleep apnoea risk patients, detection of
nocturnal heart arrhythmias, imaging of periodic limb
movements, differential diagnosis of breathing disorders,
acoustic HR alarm, and long term records including an
integrated pulse oximetry.





EISAGRAPH (EEG Interval Spectrum Analysis)
One of the first polysomnographs developed by Drs Jung and Kuhl (O)
with the engineers Tonnies and Griebl to record EEG and respiration
during sleep (1967).
Taken from Respiration 1997; vol 64: pp3.
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The data is fed to a bank of viewing screens in a separate room, where a
technician scrutinizes them. Hard copy details of the total number and duration of
the apnoeic periods, nadir oxygen saturation, time during which the oxygen
saturation fell below 90% number of arousals, quantity ofREM sleep. This allows
not only a definitive diagnosis to be made, but also permits an evaluation of the
severity of any sleep apnoea identified (Battagel et al., 1996).
Patients with OSAHS will demonstrate recurrent periods of breathing cessation
with accompanying falls in blood oxygen saturation and increased abdominal and
thoracic activity. In patients with simple snoring, these signs will be absent (Johal
et al., 1998).
Johns MW, (1991) concluded that despite the complexity and time involved in
polysomnography it is an essential procedure for the diagnosis and treatment of
sleep disorders. Tan WC and Koh TH, (1991) also recognized the complexity and
cost of a full polysomnography recording.
2.7.2.5 Oximetry
Oximetry alone is often used as the first screening tool for OSAHS due to the
universal availability of cheap recording pulse oximetres. They are
spectrophometric devices that detect and calculate the differential absorption of
light by oxygenated and deoxygenated haemoglobin in blood to produce a
measurement called (SpOj). This is an assessment of the oxygen saturation of the
arterial blood arriving at the fingertip or earlobe with each pulse beat (SIGN,
2003).
Oximeters, however, have significant limitations, which must be fully appreciated
before they can be used alone to diagnose clinical problems or to influence patient
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management. They have an accuracy of± 3% between individuals and all become
less reliable if tissue perfusion is poor or if coloured nail varnish is used. They can
give false negative results if used on young, thin patients who generally fail to
desaturate during short apnoeic or hypopnoeic episodes as they maintain their
lung volumes when lying flat and their baseline oxygen saturation tends to be on
the plateau part of the oxygen dissociation curve as opposed to obese individuals
who desaturate easily in a similar situation (SIGN, 2003).
Oximeters are easy to use but they differ in probe design, sensitivity, sampling
frequency, artefact rejection computation and averaging time. There can also be
differences present in the techniques used to analyse the oximetry signals
produced. Commonly employed methods include counting the number of oxygen
desaturations (dips) per hour greater than an agreed value (often a 4% Sp02 dip
rate ofmore than 10 per hour) or alternatively the time spent during the study at
less than an agreed Sp02 level (often 90%). Thus, it can be difficult to compare
results from different centres using different machines or modes of analysis
(SIGN report on OSAHS, 2003).
Oximeters also register oscillations in Sp02 when the baseline Sp02 is low, such
as in COPD, which may be confused with dips due to OSAHS. This is because at
Sp02 values below 93%, the slope of the haemoglobin saturation curve is steep
and normal physiological variations in ventilation and Pa02 produce large
changes in Sp02. In the cheyne-stokes breathing of heart failure, oscillations in
Sp02 can be indistinquishable from those due to OSAHS (SIGN, 2003).
Oximeters, also measure heart rate and brief increases are an indirect maker of
transient arousal from sleep. With each arousal the heart rate rises by about 6-10
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beats per minute. Reviewing oximeter tracing with the accompanying pulse rate
can provide information about sleep fragmentation (SIGN, 2003).
With overnight polysomnography blood oxygen saturation is kept under
continuous observation using pulse oximetry. Cooper et al., (1991) tested the
Sensitivity and specificity of overnight recording of arterial oxygen saturation (Sa,
O2) in routine clinical practice and found oximetry allowed recognition of a
moderate to severe sleep apnoea syndrome.
Hoffrath et ah, (1991) reported short-term cyclic desaturation of oxygen could
serve to indicate recurring apnoeas whereas long-lasting phasic reductions of
oxygen saturation were predominantly seen in hypoventilation. They developed a
computer program to differentiate cyclic and phasic oxygen desaturation. The
program allowed the individual phases to be characterized in respect of gradient
and duration of the decrease in oxygen saturation.
Studies using oximetry alone to diagnose OSAHS have reached widely diverging
Conclusions. Some found oximetry useful (Series et ah, 1998; Chiner et ah, 1999;
and Vazquez et ah, 2000) while others did not (Douglas et ah, 1992; Riley et ah,
1983). These differences may be explained by differences in the oximeters
themselves, the analysis algorithm, and the diagnostic criteria used. Studies,
which require desaturation, occur before a hypopnoea could be diagnosed, found
better correlations between AHI and desaturation frequency (The Report of
American Academy of Sleep Medicine Task Force, 1999). When compared with
full PSG, oximetry alone showed a mean sensitivity of 87% (SE 4%, CI 36-100%)
and mean specificity of 65% (SE 7%, CI 23-99%), which suggests that oximetry
may be useful in selected patients with significant symptoms (AHI range 24-47%)
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(Ross et al., 1999). A trained observer can diagnose OSAHS from positive
oximetry traces, but false negative occur in up to a third of patients with OSAHS
(Douglas et al., 1992). The limitations of oximetry need to be clearly understood,
namely, oximetry can positively diagnose OSAHS but cannot be used to exclude
OSAHS (SIGN, 2003).
• A normal oximetry tracing does not exclude OSAHS.
• The characteristic oximetric tracing in OSAHS is a sawtooth pattern, however
care should be taken interpreting this pattern as it may also appear in patients
with COPD or congestive heart failure.
• Automated analysis is available for many sleep systems but the validity of this
should be checked by an experienced operator.
2.7.2.6 Fluoroscopy
Fluoroscopy has been employed in investigations of upper airway obstruction
(Suratt et al., 1983) and to study adaptive patterns of behaviour in the
oropharyngeal complex (Vig PS and Cohen AM, 1974). The dynamic effect of
mandibular advancement on the adaptive patterns of behaviour of tongue, soft
palate and airway have been described in a pilot study using high resolution
fluoroscopy in the conscious, supine, OSAHS subject (L'Estrange et al., 1996).
This indicated a wide range of individual variation in the dimensional changes of
the post-palatal and post-lingual airways in response to mandibular protrusion.
2.7.2.7 Acoustic reflectance technique
Acoustic pulse reflectometry is a relatively recent technique, which allows non¬
invasive measurement of human airways. The technique consists of guiding an
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acoustic impulse through the patients' mouth and into the airway. The resulting
reflectance or 'echo' is been analysed allowing a reconstruction of the area-
distance function.
The non-invasiveness of the technique offers significant advantages over the
established methods of cephalometric radiographs and CT scanning. The
technique can be used for investigating ENT problems and OSAHS (Marshall et
al., 1991). Airway obstructions can be confirmed by acoustic reflectance
techniques (Rivlin et al., 1984). These researchers also documented, with acoustic
reflectance technique, a widening of the pharyngeal cross sectional area in one
patient who lost 68 kg in weight suggesting that peripharyngeal fat deposits may
contribute to OSAHS.
2.7.2.8 Fibroptic and nasal endoscopy
In this technique the nasal cavity and pharynx is anaesthetized topically and the
fibroptic pharyngolaryngoscope is introduced through the nose to examine the
nasopharynx, oropharynx, hypopharynx and larynx in sequential steps. The
positions of the soft palate, base of the tongue and lateral pharyngeal wall are
noted and photographed. The base of the tongue position and its movement on
protrusion of the mandible is noted. The larynx is also examined for deformities
or masses (Riley et al., 1987). Nasendoscopy allows visualization of the entire
airway and obvious areas of narrowness will be detected.
One research group (Croft et al., 1990) for observing the pharyngeal airway in
infants and young children, using a flexible endoscope assessed nasal endoscopy.
The endoscopy performed under light anaesthesia revealed the site of the
obstruction in all cases examined.
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2.7.2.9 Nasal capnography
Measures of end-tidal carbon dioxide concentration proved to be a very
insensitive index of the degree of obstruction (Smith et al., 1993).
2.7.2.10 Questionnaires
Three studies were identified comparing questionnaires sampling in OSAHS
patients to full PSG. These reported a mean sensitivity and specificity of only
42% and 68% respectively.
Questionaires are useful in the initial assessment of the potential OSAHS patient,
but by themselves, cannot make the diagnosis (Johns MW, 1991; Shelton et al.,
1993; Pouliot et al., 1997).
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2.8 MANAGEMENT
The management ofOSAHS depends on the severity of symptoms, the magnitude
of clinical complications and the aetiology of the upper airway obstruction. The
treatment of OSAHS is divided into non-surgical and surgical procedures:
NON - SURGICAL TREATMENT




• Electrical stimulation of the upper airway
• ENT assessment plus any necessary treatment






• Pharyngeal surgery (Uvulo-palato-pharyngoplasty)
• Maxillofacial surgery





2.8.1.1 Elimination of aggravating factors
As was mentioned in the pathophysiology, a number of factors may aggravate
OSAHS. Co-existing chronic obstructive airway disease, asthma, and
hypothyroidism are known medical conditions, which will make OSAHS worse.
Adequate therapeutic control of these factors is therefore important in
management. The intake of alcohol and other CNS depressants including sleeping
tablets, will make the airway more prone to collapse during sleep and therefore
cutting down on one's alcohol intake particularly during the evening, is sensible,
if not always palatable advice (Battagel et al., 1996).
The SIGN report (2003) on OSAHS advised the following:
• Patients who smoke should be advised to stop.
• Alcohol and sedatives or sleeping tablets should be avoided.
• Non-sleepy snorers should be discouraged from sleeping on their back.
These measures may suffice in simple snorers or in those with very mild OSAHS
and few symptoms but most patients with OSAHS need additional treatment.
A Cochrane review of lifestyle modifications for OSAHS is identified no
randomised clinical trial (RCT) evidence supporting their use and concluded that
any decision to institute such interventions should not delay the institution of
therapies of proven effectiveness, such as CPAP (Shneerson J and Wight J, 2002).
95
2.8.1.2 Weight reduction
Obesity exacerbates OSAHS; fatty deposits both subcutaneously and in the
pharyngeal wall lead to further narrowing of the oropharynx, encouraging its
occlusion once the subject is supine. Because many OSAHS sufferers are obese,
weight loss is frequently suggested. This change in life style is far from easy to
accomplish and many individuals are insufficiently motivated. For those who are
committed, dietary advice should be provided. Once weight has been lost, regular
exercise is easier and this is in the subject's overall medical interests. However,
although the subject may feel fitter and less lethargic when his weight is within
normal limits, his apnoea may not show a parallel improvement (Battagel et al.,
1996).
Rajala R et ah, (1991) associated OSAHS with morbidly obese patients, and
showed that treatment with a dietary regimen significantly improved or occurred
55% of the patients with mean reduction in BMI of 27%.
The SIGN report (2003) on OSAHS stated that:
• Weight loss should be encouraged in all patients with obesity contributing to
their OSAHS.
• Attempt at weight loss should not delay the intiation of further treatment.
• Weight loss should also be encouraged as an adjunct to CPAP or intra-oral
devices as it may allow discontinuation of therapy.
2.8.1.3 Training
A pillow attached to the sleeper's back by a belt around the waist or a tennis ball
sewn into the pyjama top at the midback level are probably the two most
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commonly employed devices. Posture alarm could be tried (Cartwright et al.,
1991).
Rosalind et al., (1985) trained 10 known OSAHS patients to avoid the back sleep
position by wearing a gravity-activated position monitor / alarm on the chest. This
device emits an auditory signal if the patient remains supine for more than 15
seconds. They found the number of apnoeic events was significantly reduced, as
well the number of episodes of significant O2 desaturation.
2.8.1.4 Pharmacological therapy
The evidence base to support parmaceutical treatment as an effective therapeutic
option is small. The main systematic review of pharmacotherapy concluded that
no medication demonstrated a consistent response (Hudgel DW and
Thanakitcharu S, 1998; Smith et al., 2002). Pharmaceutical agents may on
occasion provide some relief of symptoms associated with OSAHS. Generally,
the aim of such therapy is to increase glossopharyngeal neurologic activity or to
decrease REM sleep.
There is some evidence to suggest that the addition of alerting drugs, such as
modafanil, may have a small beneficial effect on sleepiness in some patients who
remain sleepy despite good CPAP compliance. However, they may decrease
CPAP use and longer term studies of their value and risks are needed (Kingshott
et al., 2001). There is no evidence to suggest that they could be used as an
alternative to CPAP and they are not a substitute for careful attention to
improving CPAP comfort and efficacy.
Medications most frequently prescribed for the treatment of the condition include
protriptyline and theophylline. Unfortunately, these drugs are unsuitable for many
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subjects and of unproven efficacy. The search for a more appropriate alternative is
ongoing.
Pharmacological therapy should not be used as first line of therapy for OSAHS
(SIGN report on OSAHS, 2003).
2.8.1.4.1 Protriptyline
Protriptyline (a non-tricyclic antidepressant), the most commonly used and the
most studied. It may be associated with a mild reduction in apnoeic episodes
(Findley LJ et al., 1985). It was initially introduced as a treatment for OSAHS
based upon its ability to reduce the frequency of apnoeic events and oxygen
desaturations during non-REM sleep, while at the same time suppressing REM
activity (that stage during which the apnoeas tend to last the longest). Later
investigations revealed an additional benefit of specifically increasing tone of the
upper airway musculature (Borona et al., 1984). Unfortunately, severe
anticholinergic side effects are evident in approximately half of the subjects
taking the drug (Mulloy E and Nicholas WT, 1992).
2.8.1.4.2 Theophylline
Mulloy E and Nicholas WT (1992) have investigated the effect of theophylline on
OSAHS patients, and noticed a decrease in the total number of apnoeas and
hypopnoeas, as well as in AHI, but at the same time, they found that sleep quality
deteriorated significantly. Unfortunately, there appears to be no reliable means of
predicting which patients are likely to benefit from theophylline, although it is
thought that it may be those with mild disease.
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2.8.1.4.3 Oxygen administration
Nocturnal hypoxaemia in sufferers of OSAHS may contribute to the
development of cardiopulmonary morbidity. Thus, prevention of hypoxaemia is a
worthwhile therapeutic goal in these patients. Studies to date indicate that
providing supplemental oxygen during sleep is not sufficiently effective in
reducing the frequency of apnoea and increasing daytime alertness to stand alone
as therapy for most patients (Watt JG et al., 1943).
2.8.1.5 Electrical stimulation of the upper airway
Preliminary studies indicate that electrical stimulation of the submental muscle
(genioglossus), which act as upper airway dilator, will enhance luminal patency
and reduce the number of obstructive apnoeas (Miki H et al., 1989).
2.8.1.6 ENT assessment plus any necessary treatment
This is important, as airway, obstruction may originate in, or be complicated by,
obstruction in the nose or nasopharynx. Both visual and nasendoscopic
examinations should be carried out. Septal deviation, turbinate hypertrophy, nasal
polyps, or tonsillar enlargement may be found and their correction indicated. In
addition, nasendoscopy also allows visualization of the entire airway and obvious
areas narrowness will be detected.
2.8.1.7 Continuous positive airway pressure (CPAP)
CPAP is the so-called 'gold standard' of treatment of OSAHS, developed by
Colin Sullivan, in Australia in 1981. It provides dramatic relief of symptoms and
ensures airway patency during sleep (Sullivan CE et al., 1981) by elevating the
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pressure in the oropharynx. A continuous stream of air under low pressure is
filtered and delivered to the pharynx via a nasal mask. This constant flow is
sufficient to prevent the airway from collapsing regardless of the position of the
subject, but not enough to prevent expiration. The mask must fit firmly round the
nose and to secure it, a head cap and retaining straps must be worn. CPAP
should be in place for 4 to 6 hours per night, seven nights a week (Engleman et
al., 1994; Battagel etal., 1995).
A distinctive feature of CPAP therapy is the immediate and dramatic response.
Typically, within moments of its application, the patient begins to exhibit long
periods of uninterrupted sleep, marked rebound in stage 3 to 4 NREM sleep
occurs, and both the frequency and duration of this stage sleep increase
dramatically. This rebound continues over a number of nights, until, by the
seventh to the tenth night, distribution and reusability generally return to normal
levels. The daytime function of subjects is often transformed and while the loss of
daytime somnolence is the most characteristic feature, all other symptoms of
OSAHS may also be reversed.
Whilst generally extremely effective, it is appreciated that CPAP is often a
difficult device to tolerate. The pump delivering the air stream is noisy, making a
constant 'humming' reminiscent of an air-conditioning unit. The anti-social nature
of the mask and the headgear coupled with cumbersome and sometimes
impractical nature of the device are thought to be of significant importance with
regard to its acceptance and compliance.
Long term compliance with CPAP has been estimated at between 60% and
70% (Battagel et al., 1996).
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Taken from University of Chicago Sleep Medicine website, www.sleepmed.bsd.uchicago.edu
While nCPAP provides air stream pressure sufficient to exert a splinting effect
upon the upper airway, the air pressure is insufficient to prevent periodic
expiration. This addresses the complained voiced by a number of OSAHS
subjects, that they find expiration difficult with conventional CPAP. In situations
where persistent difficulty with expiration is reported, alternative approaches
include the use of Bilevel CPAP (BiCPAP), which utilizes a second tube allowing
a separate channel for expiration, and a device incorporating ramp type feature
whereby pressure does not increase until the patient is already asleep.
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Interestingly, investigations have revealed no increase in compliance with these
alternatives (Battagel JM et al., 1995).
A major concern with nCPAP as a therapeutically effective method of treatment
of OSAHS centres upon the long-term compliance of the subject. The use of the
device in the longer-term requires considerable patient commitment, and the
patients who suffer most from the symptoms associated with the OSAHS
condition are more likely to be consistent with its use. The overall long-term
compliance has been estimated to be between 50 and 70% (Walldhorn RE et al.,
1990; Westbrook PR et al., 1990; Hofstein V et al., 1992; Grundstein RR, 1995),
though this figure has been found to drop to approximately 30% for mild cases
(Rolfe I et al., 1991). Interestingly, when studies have been performed in which
the actual use of CPAP is monitored 'covertly', compliance has been found to be
significantly less than was self reported by the patients (Rauscher H et al., 1991).
The reported benefits of nasal CPAP are:
• improved quality of life;
• improved daytime cognitive function;
• reversal of daytime symptoms-in particular, sleepiness;
• elimination of snoring and other night-time symptoms;
• long term improvement in cardiovascular function, with reduction in blood
pressure;
Major side effects of CPAP use (eg. significant epistaxis, paranasal sinusitis) are
rare, but minor side effects (irritation related to the mask, nasal bridge sores
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(Sjoeholm et al.,1994), nasal congestion, dryness or excessive rhinorrhea, upper
respiratory tract infections, abdominal bloating, discomfort, noise, chest pain, and
feelings of claustrophobia) are common. Intensive efforts can achieve CPAP
uptake of up to 95% (McArdle et al., 1999) and an average nightly use of three to
five hours (Engleman et ah, 1996; Richards et ah, 1996). Nasal symptoms are
usually due to mouth leaks causing high flows of cool air through the nose.
Attempts should be made to reduce these, using chin straps or full face mask
(SIGN report, 2003). In a few patients, nasal corticosteroids can be useful (SIGN
report, 2003). A heated humidifier may help to improve comfort and compliance
(Massie et ah, 1999).
The Scottish Intercollegiate Guidelines Network report (2003) for OSAHS, which
is endorsed by the British Thoracic Society, has recommended the following:
• CPAP should be the first choice therapy for patients with moderate or severe
OSAHS that is symptomatic to require intervention.
• Bi-level ventilation should not be used routinely in OSAHS but should be
reserved for patients with ventilatory failure.
• Persistent low CPAP use (less than two hours per night) over 6 months,
following efforts to improve patient comfort, should lead to review of
treatment.
The SIGN (2003) report for OSAHS also recommended that, CPAP therapy
should not be abandoned without:
•S The attention of a trained CPAP nurse / technician.
S A titration study / use of autotitrating CPAP to troubleshoot problems.
•/ The use of heated humidification.
103
Fig 2.10 Multivariate representation of subjective physical and mental condition of
patients with sleep apnoea syndrome.
initial afte"*h*
+ nCPAP
Taken from Fischer J and Raschke F. J Respir 1997; vol.64: pp41.
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2.8.1.8 Intra-oral appliances
• Mandibular repositioning appliances
- Nocturnal airway patency appliance (NAPA)





Tongue retaining device (TRD).
Tongue locking device (TLD).
Tongue posture trainers
Tepper oralproprioceptive stimulator (TOPS).
Tongue positioner and exerciser (TPE).





Since Pierre Robin first described his monobloc appliance in 1902 for the
treatment of glossoptosis (tongue falling back and occluding the airway) in
infants, several appliances have been appeared for the treatment of upper airway
obstruction. The term 'oral appliance' is used as a generic term for devices
inserted into the mouth in order to modify the position of the mandible, the
tongue and other structures in the upper airway for the purpose of relieving
snoring or sleep apnoea.
There are five basic categories of dental appliances used in the treatment of
OSAHS: the mandibular repositioning appliances, the soft palate lifters, the
tongue repositioners, the equalizers and the magnetic appliances.
2.7.1.8.1 Mandibular advancement appliances (splints)
Like CPAP, Mandibular Advancement Appliances (MAA) are a non-invasive and
therefore reversible form of treatment, and worn only during sleep. The rationale
for the use of (MAA) is that they may increase the size of the pharyngeal airway
by drawing the tongue and soft palate forwards, and thus maintain its patency
during sleep.
Lui et al., (2000) selected twenty two patients who were confirmed with a
diagnosis of obstructive sleep apnoea based on initial nocturnal
polysomnography. The patients were fitted with a mandibular repositioner
designed to hold the mandible antero-inferiorly. Six months later, an outcome
polysomnography study was undertaken for each patient with the appliance in
place. Lateral cephalometric radiographs in the upright position were also
obtained before and after 6 months of treatment. The apnoea hypopnoea index
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decreased in 21 of the 22 patients with the appliance in place. The mean
respiratory disturbance index of the 22 patients decreased significantly from 40.3
to 11.7 events per hour (P <.01). Some 59.1% of subjects were considered a
treatment success with follow-up respiratory disturbance index <10 events per
hour. The mean minimum blood oxygen saturation level during sleep also
improved significantly from 73.4% to 81.3% (P <.01).
Mechanism ofaction
The mechanism by which these appliances work appears simple. The MAA
prevent the tongue collapsing against the posterior pharyngeal wall nocturnally.
This achieved by mechanical means in that the origin and insertion of
genioglossus is at the hyoid bone and mandibular symphyseal region respectively.
Thus, by advancing the mandible, the tongue is held in a more anterior position
nocturnally, hence increasing the airway space.
A second consideration given by Lowe et al (1994) is that, in man, voluntary
passive opening of the mandible produces definite enhancement of genioglossus
EMG through activation of receptors located in the temporomandibular joint.
Because the contraction of the genioglossus opens the airway, so airway
obstruction is prevented. It has also been proposed that the increased vertical
dimension achieved with these appliances acts to increase tonicity of the tongue,
thereby reducing the risk of airway occlusion (Lowe et al., 1990).
Ayyliance Design
The mandibular repositioning appliance has many different variations. It is
typically constructed of clear acrylic resin, together with retentive Adams' clasps.
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The guideline for the optimal amount of forward movement is between 50% and
75% of the patient's maximum protrusive distance. This forward position can be
maintained by use of a one-piece or fixed appliance that holds the maxilla and
mandible together, with retention being provided by clasps, acrylic or
thermoplastic polymer. Protrusion cannot be achieved without some concomitant
opening and it is important that appliances do not rotate the mandible downwards
and back (Lowe et al., 1994). An important feature of this appliance is that
anterior air holes are necessary to allow oral respiration, especially for those with
restricted nasal airflow. Common used designs include the cribbed activator
(Bonham et ah, 1988), vacuum-formed devices, the Nocturnal Airway Patency
Appliance (Soli et ah, 1985) and the Sleep Nocturnal Obstructive Apnoea
Reducer (Viscomi RT ah, 1988).
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Fig 2.11 Mandibular Repositioning Appliance (MRA)
MRA (Frontal view)
It is a design ofmandibular advancement appliance used within
the Orthodontic Dept. Victoria Hospital, Fife, Scotland.
2.8.1.8.1.1 Nocturnal airway patency appliance (NAPA)
Soli et al., (1985) described a modified activator that advanced the mandible 6mm
anteriorly and 9mm inferiorly for one patient and significantly reduced the AHI.
The appliance has eight Adams clasps with overlapping acrylic on the facial and
lingual surfaces of the teeth. It is designed to protrude the mandible about three
quarters of the distance between centric occlusion and full protrusion. The
mandible is opened vertically just enough to permit an airway between the
incisors. The NAPA rigidly stabilizes the mandible in both the horizontal and
vertical dimensions. The effects of the NAPA in reducing the AHI have been
documented in subsequent studies (George PT, 1987 and 1989).
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2.8.1.8.1.2 Sleep and nocturnal obstructive apnoea reducer (SNOAR)
The SNOAR open airway appliance is an acrylic mandibular advancement
appliance that advances the mandible 6 to 9mm and opens it vertically 17mm
or more.
Viscomi et al., (1988) reported in his study that, the mean AHI was reduced from
45.5 to 9.7 and snoring was absent after the SNOAR appliance was inserted.
2.8.1.8.1.3 Snore guard (Dental orthosis)
This prefabricated appliance positions the mandible 3mm behind the maximum
protrusion with 7mm opening. It covers only the anterior teeth and is lined with a
soft polyvinyl for patient comfort. It is easy to fit and adjust directly on the patient
and appears to be well tolerated.
In two initial studies (Schmidt-Nowara et al., 1988 and 1991) snoring was
decreased significantly or completely eliminated. Later reports (Dushell et al.,
1991; Menn et al., 1992) found a significant decrease in AHI, particularly among
mild apnoea sufferers.
For patients with active bruxism and / or those who feel restricted by the rigid
fixation of their jaws with the one-piece design, an alternative, more ideal, design
involves constructing separate maxillary and mandibular appliances. Connecting
the upper and lower appliances is accomplished with inter-arch elastics and
buccal tube and rod attachments (e.g. Herbst appliance, Jasper Jumper), or a
single hook and latch in the anterior region (e.g. Thorton Adjustable Positioner).
The objective of this design is to restrict all retrusive movements while still
allowing the patient to move the mandible forward and side to side, as well to
open the mouth if necessary.
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An additional advantage of the two-pieces appliances is the ability to
systematically pinpoint the exact mandibular position that benefits each patient
the most. It is possible to start at 50 % of maximum protrusion at the first
appointment and then gradually advance the mandible unit all signs and
symptoms completely disappear. On the other hand, these appliances, because of
their construction, may be difficult for the subject to manage.
The Herbst Mandibular Advancement Splint is a justifiable option in selected
subjects with sleep-related breathing disorders. (Shadaba et al., 2000).
2.8.1.8.1.4 Jasperjumper and twin block
Only one preliminary evaluation of this appliance for the treatment of OSAHS has
been completed (Coghlan MSc, 1990), in which 11 subjects with varying degrees
of OSAHS were evaluated. Seven of the 11 subjects tested before and after
appliance, insertion had reduced AHI values, but there were no significant
differences. Even after vertical elastics were added, only half of the subjects
tested showed a reduced AHI. This appliance may be more easily tolerated than
the more rigid mandibular advancement appliances, but additional studies with




2.8.1.8.2.1.1 Tongue retaining device (TRD)
The TRD is designed to reposition the tongue forward during sleep; thereby
reducing the risk of obstruction at this level (Cartwright et al., 1982). The device
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secures the tongue by means of negative pressure in a soft plastic bulb; a flange,
which fits between the lips and teeth, holds the device and tongue anteriorly in the
oral cavity. It should be noted that this appliance also modifies mandibular
pressure at least by forward rotation. The TRD has been fabricated from dental
impressions, but a prefabricated version suitable for moulding to the patient's
teeth in the clinic is now available; it can also be used in edentulous patients. For
those patients with blocked nasal passages a modified TRD with lateral airway
tubes is also available. The disadvantage of the TRD is that the tongue is not
always held forward because surface adhesion of the tongue in the bubble is lost
after time, and the patient must then awaken and relocate the tongue into the
bubble. An aesthetic drawback is that the tongue must slightly protrude between
the teeth.
The TRD is the only appliance that has been studied in various body positions and
in conjunction with other forms of therapy (Cartwright et, al., 1982). The TRD
appears useful, either alone or in conjunction with other treatments, for improving
patients with a wide range of apnoea severity, provided that the apnoea is more
severe in the supine position and the patient's weight is not greater than 50 per
cent of the ideal (Lowe A, 1994).
Compared to the most commonly performed CPAP, the TRD is the more easily
tolerated and has fewer long-term compliance problems.
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Device with tongue-retaining flange
(Shown upside down)
The flange is intended to hold the tongue out of the airway.
The patient cannot swallow when using this type of device.
In addition, the flange can cause obstruction of small upper
airways (a common finding in OSAHS). Many consider
these devices unsafe.
Taken from Vancouver Sleep Centre web site; www.sleep-
breathing,be.ca/mandib.htm
2.8.1.8.2.1.2 Tongue locking device (TLD)
This patent appliance is simple preformed elastic available in small, medium and
large sizes that provides a cavity for the tongue and holds it forward with a self-
created vacuum during sleep. Lateral breathing holes assist airflow if nasal
obstruction occurs. The TLD is simple to fit directly on patients and is
inexpensive.
Prinsell et al., 1992 studied 10 OSAHS subjects and found that five individuals
had a reduction in AHI and five subjects became worse.
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2.8.1.8.2.2 Tongue posture trainers
2.8.1.8.2.2.1 Tepper oralproprioceptive simulator (TOPS)
This appliance is fitted to the maxillary arch with a posterior tongue extension
held inferiorly with an elastic band. An anterior padded bar lingual to the incisors
is included to direct correct tongue placement. According to Dr. Tepper: its prime
use is for those patients who snore, have apnoea, have problems of abnormal
tongue posture and / or function and for those who have loss of muscle tonus of
the soft palate and pharynx. All these abnormalities are corrected by
proprioceptive means wherein the receptors are stimulated by the hinged portion
of the appliance resting on the dorsum of the tongue. By increasing the resistive
force of the elastics, we can strengthen dorsal muscles of the tongue. Thus by
correct repositioning of the entire tongue to the hard and soft palate; it is my
concept that we can increase airway space. Published data on its effectiveness for
the treatment ofOSAHS are not yet available.
2.8.1.8.2.2.2 Tonguepositioner and exerciser (TPE)
The tongue positioner and exerciser is a custom-made appliance that has been
used to treat snoring. Patients are trained to position the tongue above the ramp;
according to the inventor, this 'retrains the tongue and lip musculature to be in the
proper rest and saliva swallowing position'. Published results before and after
appliance insertion are not yet available.
2.8.1.8.3 Soft palate lifters
Paskow et al., 1991 invented the adjustable soft palate lifter (ASPL). The
appliance is designed to lift the soft palate gently and prevent it from vibrating in
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the air passage during sleep. The ASPL consists of a maxillary removable
appliance with two Adams clasps on the molars and an acrylic button that extends
distally to the midpoint of the soft palate. Patients who gag are 'desensitised' with
palatal exercises that consist of contact with the end of a spoon or toothbrush five
or six times a day. Paskow claimed 60 per cent success rate for snoring but felt the
appliance is not is not indicated for the treatment of OSAHS. However Marklund
et al., (1996) found that the soft palate lifters were insufficient for the treatment of
snoring.
2.8.1.8.4 The equalizer
This appliance is introduced by Haze in 1987; it is constructed of vinyl material
and repositions the mandible in a position of "neuromuscular balance" as
determined by a myomonitor, a transcutaneous electroneural stimulator.
2.8.1.8.5 Magnetic appliances
Very recently, a magnetic appliance has been used for treatment of snoring
patients with or without obstructive sleep apnoea (Bernhold et al., 1998). A
magnetic appliance may be more effective than the conventional 'passive'
functional appliance, because the magnet forces prevent the closing by providing
direct and continuous mandibular advancement. Long-term evaluation of the
treatment results is needed before routine use of the magnetic appliance in apnoea
patients.
The Scottish Intercollegiate guidelines Network report (2003) on OSAHS which
is also endorsed by the British Thoracic Society concluded that:
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• Intra-oral devices are an appropriate therapy for snorers and for patients with
mild OSAHS with normal daytime alertness.
• Intra-oral devices are an appropriate alternative therapy for patients who are
unable to tolerate CPAP.
• The use of intra-oral devices should be monitored following initiation of
therapy to allow device adjustment and assessment of OSAHS control and
symptoms.
Advantages ofOralAppliances
The advantages of oral appliance therapy are simplicity, reversibility and cost
effectiveness. It may also become the primary treatment in patients who are
unable to tolerate nasal CPAP or who are poor surgical risks. Most patients
readily accept it and it can even supplement other treatments in the small
percentage of cases in which the dental devices alone do not bring sufficient relief
of symptoms.
Disadvantages ofOralAppliances
Excessive salivation and transient discomfort in the muscles of mastication for a
brief time after awakening are commonly reported with initial use and may
prevent early acceptance of oral appliances (Schmidht-Nowara et al., 1991;
O'Sullival et ah, 1995), but with regular use and adjustment of fit, these
symptoms subside. Pantin et ah, (1999) reported that hypersalivation and teeth /
gum discomfort are the early side effects but usually decline if patients are able to
persevere with Intra-Oral Devices (IOD) use.
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Later complications might include TMJ discomfort and changes in occlusion, and
have been reported as reasons for discontinuing treatment (Schmidht-Nowara et
al., 1995). To prevent these changes the design should use full-arch occlusal
coverage to tie all the teeth firmly together (O'Sullivan et ah, 1995). This simply
means that the appliance will no longer fit if any individual tooth moves.
However, (Schmit-Nowara et ah, 1995) suggest that TMJ dysfunction and
occlusal changes are relatively uncommon occurrences, but the long-term risk of
these complications is not well defined.
There was one report of TMJ problems after a period of 15 months wear, witch
settled after adjustment of the splint (Joha A and Battagel J, 1999).
Efficacy ofOral Appliances
Reported success rates vary, as do the authors' criteria for its achievement. If a
reduction in the number of apnoeic events of 50% or greater is adequate, then
success rates are as high as 87%, as reported by Clark et al., (1993). The most
comprehensive review of 20 publications, reporting the effects of oral appliances
on OSAHS (Schmit-Nowara et al., 1995), showed an improvement in average
AHI with a dental appliance. Success was equated with fewer than 10 apnoeic
events per hour. When statistic were provided, the decrease in AHI was always
significant (P<0.05), and the mean AHIs before and with treatment were 42.6 and
18.8 respectively, an average reduction of 56%. An improvement in oxygen
saturations was also noted, and the time of sleep with oxygen saturation <90%
was reduced from 4.4% to 3.1%.
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Two recent prospective crossover trials (Ferguson et al., 1997; Bennet et al.,
1998) compared mandibular repositioning appliances and continuous positive
airway pressure (CPAP) in patients with mild to moderate obstructive sleep
apnoea. The success rate with the oral appliance was 55% in both trials, though
the improvement in AHI reduction was greater when the continuous positive
airway pressure was used.
A meta-analysis of patients' treatment preference (CPAP and IODs) in three
crossover studies in mild to moderate OSAHS showed a significant patient
preference for IODs (OR 9.5, 95% CI 4 to 21), despite lesser nocturnal efficasy
for breathing pauses (-7 per hour, 95% CI -10 to -5) (Wright et al., 2002). This
was not confirmed in a later study (Engleman et al., 2002). Patients' preference
for IODs is important, but it is not known if this means that they feel
symptomtically better when using IODs or whether they find the concept of an
unobstructive intra-oral device preferable to using obstructive CPAP device
(SIGN, 2003).
One group has compared the effectiveness of IOD against UPPP in a parallel
group, longitudinal follow-up study, with the latest report at four years post-
randomisation (Walker-Engstrom et al., 2002). In this, 72 of 95 patients with mild
to moderate OSAHS have returned for polysomnography, whicch showed large
effect size (>1.0 SDs) significantly favouring IOD over UPPP for improvements




A formal survey of the cost devices and services has not been performed for oral
appliances. The production cost of the device varies depending on whether a
dental laboratory is required for custom fitting or prefabricated unit can be
adapted in the clinician's practice. When cephalometric radiographs or other
airway studies are performed as part of the procedure, the cost increases
accordingly.
It is unclear wheather continuous positive airway pressure (CPAP) or intra-oral
devices (IODs) have the greater cost effectiveness and the answer may vary with
OSAHS severity. The basic cost of many IODs is less than the cost of a CPAP
machine. Some adjustable IODs are more expensive than CPAP, especially when
the cost ofmultible dental visits to adjust the IOD are included (SIGN, 2003).
Compliance
Data on long-term compliance is limited in number and is based on patient
reports. The experience with nasal CPAP, however, indicates that self - reports
may significantly overestimate objectively determined actual use (Rauscher et al.,
1991). Overall compliance rates vary from (50 to 100%) in different studies and
may be related to the length of follow - up (Schmidht-Nowara et al., 1995). The
reasons for discontinuing appliance use include the side effects and complications
noted above and lack of efficacy.
2.8.1.9 Nasal-valve dilator
Increased nasal resistance may induce sleep-related breathing disorders and
disturbed sleep (McNicholas et al., 1982; Millman et al., 1996; Zwillich et al.,
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1981). It has been shown that several devices, including nasal-valve dilators
(Nozovent; Prevancure AB; Vastra Frolunda, Sweden), reduce nasal resistance
and improve nasal breathing (Lorine et al., 1998; Metes et al., 1992). The
Nozovent device consists ofa plastic bar that dilates the anterior part of the nose,
the valve region, in order to increase the air flow. Its inventors aimed to eliminate
snoring and sleep apnoea using the device (Hoijer et al., 1992; Loth S and
Petruson B, 1996; Petruson, B, 1990; Petruson B and Theman K, 1992). They
have tested Nozovent in a number of studies and report an excellent effect on
nasal resistance, snoring, and sleep apneas (Hoijer et al., 1992; Loth S and
Petruson B, 1996; Petruson B, 1990; Petruson B and Theman K, 1992). However,
Metes et al., (1992) did not find any effect on snoring, apnoeas, hypopnoeas, or
arterial oxygen saturation (Sa, 02) in a small sample of patients, despite a
reduction in nasal resistance.
Nozovent is sold at pharmacies and is distributed worldwide as a treatment for
different indications, such as compromised nasal breathing, nocturnal asthma, and
dryness of mouth, snoring, and sleep apnoea.The potential market is huge, since
habitual snoring occurs among 15% ofmiddle-aged adults and occasional snoring
among 30% (Gislason et al., 1988).
However, Bernd Schonhofer et al., (2000) did not recommend treatment with the
Nozovent nasal dilator in patients suffering from OSAHS. The dilator has only a
slight subjective effect on snoring, but no effect on objectively measured snoring
and the other parameters of sleep-related breathing. Furthermore, when using a
nasal dilator, it is possible that the bed partner's appreciation of the reduced
snoringmay delay the initiation of the adequate treatment of sleep apnoea.
120








• Pharyngeal surgery (uvulo-palato-pharyngoplasty)
• Nasal surgery
• Maxillofacial surgery
• Adenoidectomy and tonsillectomy
• Tongue reduction
• Bariatric surgery
In the treatment of OSAHS, surgical approaches have been proposed for
identified levels of obstruction. Medical approaches are more commonly used; but
not all patients are able or willing to conform to medical treatment. This group
may be candidates for surgical intervention directed at the anatomical regions
involved. During assessment of the patient, a surgical option can be considered,
particularly in younger or middle-aged subjects, who may wish to avoid a period
of attachment to CPAP or alternative medical devices.
Pre-surgical evaluation is important, in order to identify the type of anatomic
abnormality present and the severity of the OSAHS. This will entail not only
overnight polysomnography but also other investigations, such as cephalometric
analysis, sleep nasendoscopy and three- dimensional MRI.
The American Sleep Disorders Association has produced recommendations for the
use of surgical procedures in OSAHS. Desired treatment outcomes include
resolution of the clinical signs and symptoms of OSAHS and normalisation of the
apnoea / hypopnoea index and oxyhaemoglobin saturation levels. Because of the
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complexity of airwa narrowing or collapse during sleep, any one surgical
procedure may not eradicate a patient's sleep apnoea. A stepwise approach to the
surgical management would be acceptable if the patient is advised at the onset of
treatment about the likelihood of the success of each procedure and that multiple
operations may be necessary. Once the surgical site has healed, follow-up
evaluation, including an objective measure of respiration and quality of sleep,
must be performed to ensure that the abnormalities noted in the original study
have been corrected.
2.8.2.1 Tracheostomy
Historically, the first surgical modality employed for the management of OSAHS
was the tracheostomy, which proved effective in bypassing the impaired
pharyngeal airway (Guyette RF and Waite PD, 1995).
Although improvement of the manifesting symptoms associated with the OSAHS
condition is dramatic, patients may discover a whole new set of problems post
operatively. These problems, which are associated with the surgical procedure,
include bleeding, stoma, narrowing and granulation tissue formation.
Kim et al., (1998) undertook a retrospective study of all patients who had received
a tracheostomy and who had been subjected to polysomnography since 1981 at
the Johns Hopkins Sleep Disorder Centre. They concluded that tracheostomy
effectively treated patients with 'uncomplicated' OSAHS but was considerably
less effective in the treatment of patients with overlying cardiopulmonary
decompensation.
Conway et al., (1981) published an article on the adverse effects of tracheostomy
in which they highlighted the fact that a number of patients who had undergone
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tracheostomy experienced tracheal granular malformation or stomal stenosis,
necissitating revision procedures.
This, coupled with the considerable social disadvantage of the operation, means
that tracheostomy for OSAHS id generally only used as a last resort, never as a
treatment of first choice (Meyer et al., 1990).
The problems associated with the procedure have effectively relegated to the
history books, however, in sever cases of OSAHS, which may be considered as
life threatening, the tracheostomy may still be utilized as a final resort to
treatment (Meyer JB and Knudson RC, 1990).
Postoperative wound infection and recurrent purulent bronchitis requiring
hospitalization and / or antibiotics have been seen to occur, and reported
psychological problems have include depression, substance abuse and marital
problems (Conway et al., 1981).
Tracheostomy should only be considered when all else fails in carefully selected
individual (SIGN, 2003).
2.8.2.2 Nasal surgery
The presence of nasal obstruction can both exacerbate the symptoms of OSAHS




c) Nasal polyps or chronic nasal congestion.
There is a considerable variety opf opinion in the literature as to the efficacy of
relieving nasal obstruction in OSAHS, with Olsen and Kern (1990) concluding
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that relief of nasal obstruction does not resolve OSAHS whilst EL-Sharif and
Hussein (1998) reported that 50% of 96 patients in their study obtained total
relief, with a further 40% gaining some improvement.
Kuma and Sant' Amrragio (1991) recommended that intranasal procedures were
useful in facilitating other non-surgical treatment regimens like nasal continuous
positive airway pressure (nCPAP). This view is supported by Freidmann et al.,
(2000) who, in study of 50 consecutive patients with nasal airway obstruction and
OSAHS, reported that although there was some improvement in nasal airway
resistance, nasal surgery did not consistently improve the situation but may have
contributed to a decrease in the required nCPAP pressure level and hence an
improvement in oxygen saturation.
McDonald JP, (2003) in his review article concluded that intranasal surgical
intervention is unpredictable in its effect on OSAHS.
The Scottish Intercollegiate Guidelines Network report (2003) on OSAHS
recommended that alternative surgical approaches to OSAHS are experimental
and should not be used outside the context of a randomised clinical trial (RCT).
2.8.2.3 Pharyngeal surgery (Uvulo-palato-pharyngoplasty)
The most widely used surgical treatment for Obstructive Sleep Apnoea /
Hypopnoea Syndrome (OSAHS) and indeed snoring, is uvulo-palato-
pharyngoplasty (UPPP), originally undertaken by surgical excision, more
commonly now utilising a lazer (LAUP) (Kamami et al., 1994).
The original procedure was proposed by Ikematsu T, (1964), who reported on 152
patients with 82% relif from snoring. The technique was then introduced into the
USA by Fijita et al., (1981) as an alternative to tracheostomy. The procedure was
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initially devised to excise the uvula, the tonsils (if present), and portion of the soft
palate, and to reorientate the tonsillar pillars in order to enlarge the oropharyngeal
space, and therefore decrease pharyngeal collapsibility (Riley et al., 1987).
The rationale behind such procedure follows that if the soft palate is large and
found to be the cause of pharyngeal obstruction, then its virtual removal would
prove curative.
Fijita et al., (1981) suggested that anatomical indications for UPPP were a long
uvula, redundant pharyngeal wall tissue, and / or excess tonsillar tissues.
Although subjectively it was thought to be curative procedure to many
otorhinolaryngologits and their patients, the actual success rate for the procedure
has been suggested to only 40.7% (Sher et. al., 1995).
Successful surgery was defined as a reduction in AHI to <10 or to <20 with a 50%
reduction from the patients' baseline AHI.
A mandibular-hyoid distance (MP-H) >20mm post-surgery was found to be
significantly (P=0.05) predictive of failure of UPPP (Millman et al., 2000). The
distance between the superior points of a line-constructed plane of the sphenoidale
(Parallel to Frankfurt Horizontale) and a point at the intersection of the palatal
plane perpendicular to the hyoid correlated negativity with post-surgical AHI. An
MP-H distance of <21mm, an angle created by point 'A' to Nasion to point 'B'
<3, and the presence of baseline AHI >38 enhanced the predictability of UPPP
success (Millman et al., 2000).
Walker-Engstrom et al., (2000) studied ninety-five patients with mild to moderate
obstructive sleep apnoea / hypopnoea syndrome (Apnoea Hypopnoea Index AHI
>5). These patients were randomly allocated to either a dental appliance or UPPP
treatment group. Seven patients withdrew after randomisation but before
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treatment, leaving 88 patients eligible for the study. The patients were examined
using somnography and administered the Minor Symptoms Evaluation-Profile
(MSE-P), a QOL questionnaire, before and 1 year after intervention. Thirty-seven
patients in the dental appliance group and 43 in the UPPP group completed the 1-
year follow-up. The mean values for the three dimensions vitality, contentment
and sleep improved significantly 1 year after intervention in the dental appliance
and UPPP groups. No difference in the QOL scores at baseline was noted between
the groups. One year after intervention, the UPPP group showed significantly
more contentment than the dental appliance group. In contrast, vitality and sleep
dimensions did not differ between the two treatment groups. No significant
correlations were observed between the QOL scores and somnographic values. In
conclusion, quality of life improved significantly in the dental appliance and
UPPP groups 1 year after intervention. However, the dental appliance group
showed a lower level of contentment than the UPPP group possibly due to the
continuation of the dental appliance, even though the somnographic values were
superior in the former group.
A recent meta - analysis review of LAUP suggested that the procedure should not
be used for the treatment of patients with any significant OSAHS (Verse et al.,
2000). Battagel et al., (1996) supported minimalist LAUP for those patiens who
snore loudly with no symptoms ofOSAHS.
It is important to differentiate, when using UPPP or related surgical operations,
between those patients who are 'simple snores' and those who exhibit clinical
OSAHS. The operation is widely used on the former group and it is suggested that
a sleep study assessment to exclude OSAHS is undertaken, given that there is
considerable evidence that UPPP has an adverse effect on the patient'subsequent
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ability to use nCPAP, should they subsequently develop OSAHS (Mortimer et al.,
1996; Janson et al., 2000).
However, the operation is not without side effects. A part from significant pain,
immediate post - operative inability to seal the nasal from the oral cavity is
common. Long-term fistulae, palatal stenosis, and alterations in voice have also
been reported (Riley et al., 1987 and 1990a).
More-over, the operation is not always successful (Riley et al., 1987 and 1990b)
as any obstruction may be present at more than one site or occur lower down in
the airway, thus will be unaffected by (UPPP).
Where the subjects are loud snorers, however, this symptom usually improves.
For this reason, palatal surgery, now offered as a minimal laser procedure, may be
of benefit to subjects who snore, but only after a diagnosis of OSAHS has been




A. Pre-operative photo shows an enlarged soft palate and midline
uvula can be noted.
B. Post-operative photo shows shortened soft palate together with
the Laser created 'battens' in the soft palate.
C. Three month after surgery shows the healed soft palate with the









Mandibular retrognathia has been linked with OSAHS. The link is explained by
the resulting retropositioning of the tongue and consequential obstruction of the
pharyngeal space. During the 1980's, the recognition of the importance of the
tongue position led to the application of orthognathic surgical procedures for the
management of OSAHS. The procedures involved may range from simple
geniotubercle advancement to the more complex bimaxillary advancement with or
without genioplasty and the hyoid suspension. The report ofmaxillofacial surgery
appears good, with 97% control of sleep apnoea despite some surgical mandibular
relapse (Riley et al., 1987 and 1990a).
2.8.2.4.1 Geniotubercle advancement
The geniotubercle advancement or 'geniotomy' as it is sometimes known was a
surgical approach developed by Riley et ah, (1987). The procedure is designed to
advance the tongue without having any significant effects upon lower facial
aesthetics, and is particularly useful in cases where mandibular dimensions are
'normal'. The surgery involves sectioning a central block of bone beneath the
lower incisors (including the genial tubercle), and advancing the segment
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anteriorly. As a consequence of the advancement of the attachments for the
genioglossus and the geniohyoid muscles both the tongue and the hyoid bone are
likewise advanced.
2.8.2.4.2 Hyoid suspension
Adjunctive procedures such as hyoid suspension using facial lata harvested from
the thigh are sometimes employed to advance the hyoid bone, opening up the
hypopharyngeal region via its attachments to the epiglottis, vallecula and tongue
base. Unfortunately, hyoid suspension as an isolated procedure has failed to
demonstrate any real benefit and is therefore often undertaken only in conjunction
with geniotubercle advancement (Riley et al., 1990a).
2.8.2.4.3 Advancementgenioplasty
When the chin is deficient, a standard advancement genioplasty has proven to be
quite useful in the treatment ofOSAHS. Besides the obvious aesthetic advantages,
the procedure also brings forward anterior digastric muscle attachments,
effectively providing forward traction to the hyoid bone and consequential
tendency to open up the hypopharynx.
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Fig 2.15 Genioglossal advancement with hyoid
myotomy and suspension
A. Diagramatic representation of the anterior movement of the freed
segment of mandible with the attached genioglossus to its new
position anterior to the mandible.
B. The freed segment of mandible is fixed in position anterior to the
mandible. The hyoid is freed from its inferior attachments in the
neck and suspended from the anterior mandible by strips of fascia
lata.
(Taken from Sher AE et al., The Efficacy of surgical modifications of the
upper airway in adults with OSAHS. Sleep 1996; 19: 156-177).
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2.8.2.4.4 Mandibular advancement
In those cases with a cephalometrically measured retrognathic mandible, it is
possible to use a mandibular repositioning appliance as a diagnostic aid, in order
to estalish the efficacy of moving the mandible forward before undertaking actual
surgery (Mcdonald JP, 2003).
Riley R and Powell NB (1990) found that 65% of patients under their care
improved with mandibular forward osteotomy surgery. Lowe AA, (1993) agreed
that the procedure was beneficial but only where the obstruction was in the
hypopharynx. Yu et al., (1994), however, found mandibular advancement to be an
unpredictable procedure.
The only disadvantage to this approach, is the prolonged period of pre-surgical
orthodontic treatment often necessary to decompensate the dental arches so that a
functional long - term occlusionmay be attained.
2.8.2.4.5 Bimaxillary advancement
Although traditionally bimaxillary advancement surgery was originally reversed
only for those OSAHS subjects with 'major' skeletal base discrepancy, the
simultaneous advancement of the maxilla (Le Fort I down fracture osteotomy),
and of the mandible (bilateral sagittal split osteotomy), is becoming more popular
approach for OSAHS subjects who have failed to accommodate or respond to
other more conservative treatment modalities. In fact, Riley et al., (1990a) have
demonstrated that the bimaxillary advancement procedure is the most successful
surgical procedure so far developed for the management of OSAHS. They
reported good success rate, with 97% control of the sleep apnoea despite some
postoperative surgical mandibular relapse. Furthermore, advancement genioplasty
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or geniotubercle advancement may also further augment the pharyngeal space
when undertaken together with the bimaxillary advancement surgery. Where both
jaws are advanced by the same amount, no pre-surgical orthodontic procedures
are normally required. Waite PD (1998) and Krekmanov et al., (1998) suggested
that the maxillary / mandibular advancement using Le Fort I and surgical splint
mandibular osteotomies, permitted greater forward movement of the mandible
whilst preserving the occlusion. Postoperative success has proved to be stable
over a two-year period (Conradt et ah, 1997).
In cases where unequal jaw surgery advancement is necessary, orthododntic is
essential to prepare the occlusion prior to surgery, to ensure that profile changes
are minimised and that the post surgical occlusion is acceptable (Battagel et ah,
1996).
On the evidence available, therefore, maxillary / mandibular advancement
remains largly untested (McDonald JP, 2003).
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2.8.2.5 Tonsillectomy and adenomectomy
OSAHS may also be diagnosed in children, which may frequently be associated
with tonsillar and adenoid hypertrophy. Such patients are recommended by
Linder-Aronson (1979), for tonsillectomy and / or adenoidectomy procedures to
'cure' sleep apnoea, snoring, daytime sleepiness, mouth breathing and abnormal
facial growth. Affected children tend to be shorter in stature than their peers
(Battagel et al., 1996). It has been suggested that hypertrophic tonsils alone does
not give rise to OSAHS (Battagel et al., 1996).
2.8.2.6 Tongue reduction
Djupesland et al., (1992); Midjejeig H and Trinnereim M, (1992) described an
operation termed uvulo-palato-pharyngo-glossoplasty (UPPGP) which
incorporated a modified UPPP with limited resection of the tongue base. Fujita et
al., (1990 and 1991) and Woodson et al., (1992) under took midline glossectomy
and ligualplast to create an enlarged retrolingual airway.
Chabolle et al., (1991) combined tongue base reduction with hyo-epiglossoplasty
in a small study of 10 patients and reported considerable improvement.
Tongue reduction procedures have not been popular because of its complications.
Most are done only after a tracheostomy is undertaken due to the associated
oedema. Tongue reduction surgery is reserved for unusual cases of OSAHS, such
as acromegally or marked macroglossia as in trisomy-21 children.
2.8.2.7 Bariatric surgry
Weight loss is an effective treatment for OSAHS, so it would follow that bariatric
surgery would be efficacious (Harman et al., 1982; Smith et al., 1985; Surat et al.,
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1986). Meyer et al., (1996) noted the relationship between BMI, age and upper
airway measurements in snorers and sleep apnoea patients.
Charuzi et al., (1992) reported on a case series of 47 morbidly obese subjects
followed-up after one year and again after seven years followeing surgery. They
reported a significant decrease in the number of apnoeic episodes per hour of
sleep, due primarily to the weight loss. It was noted that those individuals who
subsequently gained weight began to increase the frequency of apnoeic episodes.
Sugarman et al., (1992) reported on 126 patients treated by bariaatric surgery over
a 10-year-period. Of the 40 patients with pre- and post- weight reduction sleep
polysomnograms, the sleep apnoea index fell from 64±39 to 26±26 (P <0.0001),
and was associated with significant improvement in other measureable sleep
indices.
Dhabuwala et al., (2000) noted an improvement in co-morbidly factors following
weight loss from gastric bypass surgery.
There is, however, as yet no controlled trial available on the efficacy of bariatric
surgery in inducing weight loss and improvement in clinical outcome (McDonald
JP, 2003).
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Table 2.3 Key features in the treatment ofOSAHS
1. All patients with suspected sleep apnoea / hypopnoea syndrome and their
partners should complete an Epworth questionnaire to assess the degree
of pre-treatment sleepiness (Johns et al., 1991). If OSAHS is suspected,
then polysomnography should be undertaken to confirm the diagnosis.
2. Weight loss without resort to bariatric surgery should be encouraged
where it is contributing to OSAHS.
3. CPAP therapy is the first choice therapy for moderate to severe patients;
intra-oral devices are an appropriate therapy for snorers and mild OSAHS
suffers.
4. Use ofUPPP or LAUP for the treatment ofOSAHS, as opposed to simple
snoring is not recommended.
5. Palatal surgery can compromise later CPAP use if the patient later
develops OSAHS.
Taken from McDonal JP (2003), the Surgeons: 5: 259-264
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Surgical complications
Despite the apparent success rates of some surgical technique used to manage
OSAHS, there are also significant drawbacks. These include both intraoperative
and immediate postoperative complications such as haemorrhage, infection,
airway obstruction and anaesthetic complications. Other suggested problems
include the distortion of the abnormal loading of the temporomandibular joints,
prolonged intermaxillary fixation, a negative aesthetic impact, temporary or
indeed permanent anaesthesia, instability of the skeletal advancement and perhaps
most importantly, the inability to provide an accurate long-term prognosis due to a
lack of adequate data. It must be stressed that OSAHS patients frequently present
with other medical problems, which unlike routine orthognathic cases, may




AIMS OF THE STUDY
The aim of this study was to perform a systemic and detailed cephalometric
analysis in a group of adult patients diagnosed with OSAHS, and to compare this
with the data obtained in a control group consisting of healthy individuals without
the cardinal symptoms ofOSAHS.
To determine if there are significant differences in craniofacial morphology and
the position of the hyoid bone in relation to the cervical vertebrae and / or a fixed
point upon the anterior cranial bese.
To suggest possible skeletal morphology for the OSAHS patients.
Accordingly the aims of this investigation are: to investigate the following 'null
hypotheses'
1. The craniofacial morphology and the position of the hyoid bone in relation to
the cervical vertebrae and / or a fixed point upon the anterior cranial base,
provides no indication as to the severity ofOSAHS.
2. There are no significant differences in skeletal morphology between the





4.2 The control group.
4.3 Cephalogram.
4.4 Lateral cephalometric films.
4.5 Computer and software.
4.6 X-ray viewer (light box).
4.7 Accessories.
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The material for this study comprised the anomaly group, control group,
cephalogram, lateral cephalometric films, computer and software, x-ray viewer,
and the accessories. The sample of the anomaly and the control were not restricted
in any way by malocclusion but it was decided that due to the nature of the
variables chosen, subjects would all be dentate. This was to maintain standard
cephalometric tracing in all subjects.
4.1 The Subjects
The subjects selections were based on the following:-
• All subjects were previously diagnosed with OSAHS by polysomnographic
diagnostic sleep studies (Edinburgh Sleep Laboratory) before presenting to
the orthodontic clinic.
• The group consisted of 65 white Caucasian adults' (50 males, 15 females),
and their age ranged between 25-75 years.
• Subjects had not undergone any surgery for the treatment ofOSAHS.
4.2 The Control Group
The control group selections were based on the following:-
• All subjects were asked if they had ever been known to snore. This was
verified whenever possible by a sleeping partner.
• The group consisted of 30 white Caucation adults' (23males, 7 females)
between 25-55 years, matched for sex and ethnicity to the subjects.




All the lateral cephalogramic radiographs were taken using a Siemans Orthophos
CD at the Royal Infirmary of Edinburgh Radiography Department which has a
cephalostat with identifying screen and motorizes adjustable grid. The KVP (peak
kilovoltage) was adjusted to optimize the contrast of both hard and soft tissues.
The distance from the focus to the median plane was 60 inches, (152 cm) and the
median plane to the film was 15 cm, (Proffit, 2000).
Fig 4.1 The cephalogram
Diagrammatic Representation of The Standard Cephalometric Arrangement
By convention, the distance from the x-ray source to the subject's midsagittal plane is 5 feet,
and the distance from the midsagittal plane to the cassette is fixed for 1 foot for all patients.
Taken from 'Contemporary Orthodontics', Proffit 2000
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4.4 Lateral cephalometric films
The lateral cephalometric films used in this study were Konica, 18 x 24 cm.
Konica Europe GmbH, Friedrich-Bergius-Str., Gewerbgebiet, 85662 Honenbrunn,
Germany. The films were stored in a cool, dry place and adequately protected
from x-rays, Gamma rays and others. The internal film package was retained for
additional light protection.
Fig 4.2 The x-ray film
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4.5 Computer and software
Toshiba portable computer was used with Centrino™ mobile technology.
Microsoft® windows® XP with Microsoft Office 2003 software.
Statistical software: SPSS for windows version 10.0 (Norusis MJ), [Prentice-Hall
Inc., A Simon & Schuster Company, Upper Saddle Drive, New Jersey, USA].
Fig 4.3 The computer
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4.6 X-ray viewer
Model: light box, from RMO® by Numonics Corporation, 101 Commerce Drive,
Montgomeryville, Pa 18936, USA.
Serial no: 047776
Voltage: 220 V





Pencils (Staedtler, Noris 122, made in Germany), easy to sharpen with high break
resistance.
Eraser (Faber- Castell, made in Germany), 7092 vinyl eraser.
Ruler (Crystal, India), 20cm - 8".
Protractor 180° (Maped, China).
60° set square (Maped, China).
Pensil sharpner (Maped, China).
Celluloid adhesive tape (Eagle® TY - 895).




5.1 Subjects and controls selection








5.1 Subjects and control selection
The records of sixty five white Caucasion adult subjects (50 males, 15 females),
aged between 25 to 75 years, who had undergone polysomnographic testing at the
Edinburgh Royal Infirmary Sleep Clinic and subsequently were found to have
OSAHS, were randomly selected for assessment. All patients had a history of
disturbed sleep, characterized by heavy snoring and recurrent apnoeic periods, as
well as excessive day time sleepiness. They underwent a physical evaluation,
including head and neck and neurological examination, pulmonary and cardiac
function tests and 24-hour Halter ECG (Tilkian, 1977).
The AHI range for the subject group was between (10 and 206 per night), with a
mean value of 16.4 per hour, and a distribution approximating that of the
population examined within the sleep clinic; i.e. a greater number of subjects
displaying relatively lower AHI values as compared with extreme values of 40
and above.
Those subjects who were subsequently referred to the Victoria Hospital
(Kirkcaldy, Fife, Scotland) for treatment with Mandibular Repositioning
Appliance were 'marked' and are presumed to represent the portion of the
investigated population deemed to suffer from a mild to moderate form of
Obstructive Sleep Apnoea / Hypopnoea Syndrome (OSAHS).
All-night polysomnographic recording documented the presence of OSAHS in all
subjects. The sleep recording included electroencephalogram (EEG),
electrocardiogram (ECG), electrooculogram (EOG), electromyogram (EMG),
thoracic respiratory movements, oro-nasal flow, and oxygen saturation using
pulse oximetry (Rechtschaffen A and Kales A, 1968).
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The control group consisted of thirty (30) healthy white Caucasian adults (23
males, 7 females), free from OSAHS symptoms, selected from patients visiting
different dental clinics at Edinburgh Postgraduate Dental Institute in November
2001. Their ages ranged between 25-55 years. The demographic data are
summarized in Table 5.1.
Table 5.1 Demographic data for the OSAHS subjects and the control
OSAHS group (n=65) Control group (n=30)
Mean Range Mean Range
Age (years) 47.5 25-75 42.8 25-55
BMI (kg/m2) 28.7 23.8-44.1 24.2 21.7-26.9
PPNC (%) 101.5 95.9-121.4 95.7 83.1-110.2
5.2 Lateral Cephalometric Radiograph
All the lateral cephalograms were taken using a Siemans Orthophos CD at the
Royal Infirmary of Edinburgh Radiography Department which has a cephalostat
with intensifying screen and motorizes adjustable grid. The KVP (peak kilo-
voltage) was adjusted to optimise the contrast of both hard and soft tissues. The
distance from the focus to the median plane was (60 inches, 152cm) and the
median plane to the film was (15cm) (Proffit, 2000). The subject was standing
upright with 'natural' head position that is the 'natural' posture of the head when
standing with the visual axis being horizontal (Broca, 1862). Such a standardized
position has been investigated by Solow and Tallgren (1971), who provided a
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detailed description of the method. Initially the subject assumes the
"orthoposition" defined by Molhave (1958) as the 'intention' position from
standing to walking. The median plane parallel to the film with the maximal
intercuspation of the teeth and lips in light contact, and in natural head position
(Moorees and Kean, 1958). A possible lateral head tilt or rotation was prevented
by means of a cross-light beam projected onto the face and finally, the bilateral
ear rods were gently inserted onto the external part of the auditory meatus to
stabilize the head posture during exposure. All lateral cephalograms were taken
before any medical or surgical intervention.
Radiographs were traced, oriented with the maxillary plane horizontal and skeletal
points identified (Fig. 5.2). Definitions of the landmarks are given in the
accompanying legend. Points were digitized twice (one week interval) in a
predetermined sequence to a tolerance of 0.2 mm and the mean value taken.
The reference points and lines used in this research are given in Figs (5.3,
5.4, 5.5, 5.6, 5.7 and 5.8). The definitions are taken from Solow, 1966; Solow and
Greve, 1979; Lyberg et al., 1989. Some unfamiliar landmarks, planes and





Radiographs were traced to allow identification of specific points and planes,
which in turn allowed appropriate measurements to be made. Tracing was
performed in a darkened room on a well-illuminated viewing screen / tracing box
using good quality acetate tracing paper and a 4H pencil. Eleven hard tissue
points were identified (Table 5.2) which allowed the plotting of the six reference
planes necessary for the measurements required, (Table 5.3 and figure 5.4).
All measurements were adjusted for magnification factor, which could be
measured directly from radiographs through the inclusion of a perpendicular ruler
(Figure 5.2). This was found to be consistent at 10%.
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Fig 5.2 Cephalometric Landmarks
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Table 5.2 Anatomic landmarks
Points Description
N Nasion. The most anterior point of the frontonasal suture.
S Sella. The midpoint of the sella tursica.
Or Orbitale. The deepest point on the infra-orbital margin.
Po Porion. The uppermost, outermost point on the bony external auditory meatus
ANS Anterior Nasal Spine. The tip of the anterior nasal spine.
PNS Posterior Nasal Spine. The tip of the posterior nasal spine.
A Subspinale. The most posterior point on the anterior contour of the upper alveolar
process.
B Supramentale. The most posterior point on the anterior contour of the
lower alveolar border.
Me Menton. The lower most point on the mandibular symphesis in the midline
Gn Gnathion. The most inferior point on the mandibular symphesis.
Pg Pogonion. The most anterior point on the mandibular symphesis.
RGN Retrognathion. The most posterior point of the mandibular symphesis along a line
perpendicular to the FH (Frankfurt Horizontal) plane.
cv2sp The most posterior-superior point on the corpus of the 2nd cervical vertebra.
cv2ip The most inferior-posterior point on the corpus of the 2nd cervical vertebra.
cv3ia The most inferior-anterior point on the corpus of the 3rd cervical vertebra.
cv4ip The most inferior-posterior point on the corpus of the 4th cervical vertebra.
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Fig 5.3 Reference lines
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NSL Nasion - Sella Line. The line through points N and S.
FH Frankfurt Horizontal. The line through point Or and Po.
NL Nasal Line (Maxillary Plane). The line connecting ANS with
PNS.
MP Mandibular Plane. The line to the lower border of the
mandible joining Me and Go.
CVT Cervical Vertebra Tangent, which passes through cv2sp and
cv4ip.
OPT Odontoid Process Tangent, which passes through cv2sp and
cv2ip.
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Figure 5.4 Angular measurements
(Natural head postures and cranio-cervical variables)
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Table 5.4 Angular measurements (Natural head postures variables)
Variables Description
NSL/OPT The angle between the Sella-Nasion line and the Odontoid process tangent.
FH/OPT The angle between Frankfort horizontal and the Odontoid process tangent.
NL/OPT The angle between the nasal line and the Odontoid process tangent.
NSL/CVT The angle between the Sella-Nasion line and the cervical vertebra tangent.
FH/CVT The angle between Frankfort horizontal and the cervical vertebra tangent.
NL/CVT The angle between the nasal line and the cervical vertebra tangent.
OPT/CVT The angle between the Odontoid process tangent and the cervical vertebra
tangent.
NL/NSL The angle between the nasal line and Sella-Nasion line.
MP/NSL The angle between the mandibular plane the Sella-Nasion line.
NL/MP The maxillary mandibular plane angle.
FH/NSL The angle between Frankfurt horizontal and Sella-Nasion line.
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Table 5.5 Angular measurements (Craniofacial variables definition)
Variables Description
SNA Anteroposterior position of the maxilla.
SNB Antero-posterior position of the mandible.
ANB The difference between SNA and SNB.
Ul/Ll The angle between the long axis of the upper and lower
incisors.
Ul/NL
The long axis of the upper incisor to the maxillary (nasal)
plane, (Maxillary incisor inclination).
Ll/MP The long axis of the lower incisor to Mandibular plane,
(Mandibular incisor inclination).
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Fig 5.4 Linear measurements (Craniofacial variables)
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Table 5.6 Linear measurements (Craniofacial variables definition)
Variables Description
N-NL T Jpper anterior face height. The perpendicular distance from point N to NL.
Gn-NL Lower anterior face height. The perpendicular distance from point Gn to NL.
S-NL Upper posterior face height. The perpendicular distance from point S to NL.
Go-NL Lower posterior face height. The perpendicular distance from point Go to NL.
N-S NSL, (Nasion-Sella Line). Anterior cranial base length.
ANS-PNS Maxillary length. The tangent connecting ANS with PNS.
Me-Go Mandibular length. The tangent connecting Go to Me.
Overbite The overlapping of the lower incisors by the upper incisors.
Overjet The horizontal distance between the upper and lower incisors.
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Fig 5.5 Linear measurement (Hyoid bone variables)
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Table 5.7 Linear measurements (Hyoid bone variables definition)
Variables Description
H-Hl The linear distance along a perpendicular from
hyoid (H) to the Mandibular plane (HI).
H-H2 The linear distance between hyoid (H) and a
perpendicular to the cv3ia-RGN plane.
(H-Hl) + (H-H2) Vertical Hyoid Position.
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5.4 Method Error
Houston (1983) points out that any recorded measurements actually represent the
'True' value + Random error + Systemic error.
5.4.1 Random Error
Random error is defined as variability due to chance, and may act to attenuate a
real correlation between cephalometric measurements such as those made during
this investigation. In an effort to reduce the impact of such variability upon the
data presented here, radiographs were all taken and subsequently analyzed
maintaining a strict adherence standardized protocol, and the sample size was
made as large as was practical, in order to reduce the 'net' effect of any errors
upon results as indicated by the data. Houston (1983) suggests that quite possibly
the greatest source of random error in any investigation involving cephalometric
analysis is due to difficulty in radiographic landmark identification, for this reason
a black thick paper with a whole in the middle is used to define the landmark.
5.4.2 Systemic Error
Systemic error is defined as the tendency to overestimate or to underestimate a
parameter resulting in a 'biased' or unrepresentative sample. In the present
situation such bias may occur through structural or methodological deficiencies in
the study or through the investigator subconsciously weighting results. In an effort
to minimize the impact of such bias, patients were selected from clinic records in
order of their presentation for assessment / data of radiography, from November
2000. Only edentulous candidates and those found to have radiographs unsuitable
for this investigation, (i.e. essential landmarks not visible), were excluded.
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Tracing was performed only after the 'masking' of identifying markings such as
the name and clinic number of the patient, so as to reduce the probability of
subjective bias. All tracings and measurements were made by the author and
adjusted for the measured degree of magnification, (determined through the
inclusion ofmetal ruler in exposure, Fig. 5.1)
5.4.3 Calculations Error
An evaluation of method error was undertaken using the protocol as
recommended by Houston (1983). From the investigated population group,
twenty-five radiographs were randomly selected and both tracing and subsequent
measurement was repeated for each case, with a minimum interval of a week
between initial and repeated tracing.
Analysis of initial and repeated measurements is outlined in (Table 5.8). Systemic
error was determined according to Houston's recommendations (1983) and the't'
value for each variable were calculated. Subsequently't' value which would
correspond to P=0.05 and P=0.1 were calculated. Houston suggests that no












































































































































































































































































































All data was entered and analyzed using SPSS version 10.0 for Windows (SPSS
Inc, Chicago, IL, USA, and Microsoft Excel 2003). Evaluation of frequency
histograms reveals that all variables display suffisiently 'normal' distribution and
hence multivariate analysis and't' test procedures were utilized for data analysis.
Although a normal distribution of subject population age is not an unusual
finding, it may be explained in the present situation by the fact that OSAHS is a
condition affecting primarily the 'middle' aged and the 'elderly'.
The relationships existing between the measurement pertaining to the angles and
lines formed (between the OSAHS and the control groups) were analyzed to
determine the correlation coefficients and't' test. All tests were performed at the
95% level of significance, and consequently a p value less than 0.05 supported of




Measured variables were compared statistically using Multivariate analysis and
one sample't' test.
The descriptive lateral cephalometric data will be presented under angular and
linear measurements headings.
6.1 ANGULAR MEASUREMENTS (17 variables)
• Cranio-cervical angulations (NSL/OPT, FH/OPT, NL/OPT, NSL/CVT,
FH/CVT, NL/CVT)
• Cervical curvature (CVT/OPT)
• Maxillary inclination (NL/NSL)
• Mandibular inclination (MP/NSL)
• Maxillary mandibular relationship (NL/MP)




• Upper incisor to lower incisor (U1 /L1)
• Upper incisor to maxillary plane (U1 /NL)
• Lower incisor to mandibular plane (L1 /MP)
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Table 6.1 Angular Measurements (Multivariate analysis)
Descriptive Statistics
Group Mean Std. Deviation N
NSL/OPT
control 99.0667 8.70566 30
sample 103.8154 7.98953 65
Total 102.3158 8.47150 95
FH/OPT
control 91.2500 8.55182 30
sample 96.5385 7.17162 65
Total 94.8684 7.98043 95
NL/OPT
control 90.4667 7.86408 30
sample 95.8462 7.94951 65
Total 94.1474 8.27193 95
NSL/CVT
control 110.000 8.40874 30
sample 110.262 7.00060 65
Total 110.182 7.42947 95
FH/CVT
control 102.183 8.29362 30
sample 103.138 6.09385 65
Total 102.836 6.83374 95
NL/CVT
control 101.400 7.56626 30
sample 102.458 7.04657 65
Total 102.121 7.19105 95
OPT/CVT
control 10.6000 4.41861 30
sample 6.4615 3.17498 65
Total 7.7684 4.07758 95
NL/NSL
control 8.7833 2.42360 30
sample 8.4077 3.60001 65
Total 8.5263 3.26601 95
MP/NSL
control 36.3500 6.42751 30
sample 36.2000 6.18706 65
Total 36.2474 6.23002 95
NUMP
control 26.7167 6.76793 30
sample 28.3385 6.24006 65
Total 27.8263 6.42004 95
FH/NSL
control 8.1000 3.92472 30
sample 8.2538 3.17476 65
Total 8.2053 3.40876 95
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Continued Table 6.1
Angular Measurements (Multivariate analysis)
Descriptive Statistics
Group Mean Std. Deviation N
SNA
control 76.2500 18.99217 30
sample 82.3077 6.45700 65
Total 80.3947 12.15238 95
ANB
control 4.0333 3.70446 30
sample 4.1615 3.78020 65
Total 4.1211 3.73719 95
U1/L1
control 132.1500 12.07530 30
sample 136.7692 14.01229 65
Total 135.3105 13.53977 95
U1/NL
control 107.8000 9.17230 30
sample 106.4615 7.89645 65
Total 106.8842 8.29459 95
L1/MP
control 92.5000 9.10002 30
sample 88.7077 9.05793 65
Total 89.9053 9.19508 95
sqrt/SNB
control 8.7677 .21283 30
sample 8.8314 .32967 65
Total 8.8113 .29808 95
Due to the lack ofNormality, variable SNB has been transformed by the





NL/MPFH NSLS ABAUl/ ll/NL
FH/OPT NL/OPT NSL/CVT FH/CVT NL/CVT OPT/CVT NL/NSL MP/NSL NL/MP FH/NSL SNA SNB ANB Ul/Ll Ul/NL Ll/MP
0.889 0.000 0.901 0.000 0.860 0.000 0.757 0.000 0.754 0.000 -0.506 0.000 0.200 0.052 0.198 0.054 0.075 0.471 0.344 0.001 -0.040 0.700 -0.067 0.521 -0.010 0.924 0.206 0.046 -0.246 0.016 -0.243 0.018
0.856 0.000 0.704 0.000 0.836 0.000 0.670 0.000 -0.552 0.000 0.073 0.480 0.075 0.468 0.046 0.659 0.003 0.980 0.020 0.845 0.051 0.625 -0.074 0.474 0.265 0.009 -0.245 0.017 -0.281 0.006
Table.6.2Correlationstatistics
0.731 0.000 0.699 0.000 0.843 0.000 -0.520 0.000 -0.187 0.070 0.087 0.404 0.143 0.166 0.256 0.012 0.042 0.688 0.084 0.418 -0.062 0.551 0.233 0.023 -0.306 0.003 -0.257 0.012
0.863 0.000 0.869 0.000 -0.011 0.919 0.289 0.005 0.245 0.017 0.061 0.559 0.390 0.000 -0.269 0.008 -0.176 0.088 -0.083 0.424 0.173 0.093 -0.234 0.023 -0.171 0.098
0.811 0.000 -0.040 0.703 0.156 0.131 0.120 0.247 0.036 0.733 -0.003 0.976 -0.220 0.032 -0.058 0.578 -0.160 0.121 0.271 0.008 -0.260 0.011 -0.238 0.020
-0.013 0.903 -0.170 0.099 0.117 0.259 0.149 0.150 0.290 0.004 -0.183 0.075 -0.000 0.998 -0.169 0.101 0.188 0.067 -0.295 0.004 -0.178 0.085
0.067 0.522 0.001 0.995 -0.052 0.615 -0.026 0.804 -0.250 0.015 -0.151 0.143 -0.149 0.151 -0.104 0.318 0.073 0.484 0.200 0.052
350 000 -0.105 0.313 0.293 0.004 -0.205 0.047 -0.398 0.000 0.198 0.055 0.004 0.970 0.044 0.669 -0.036 0.732
0.773 0.000 0.288 0.005 -0.169 0.101 -0.348 0.001 0.335 0.001 -0.087 0.404 -0.244 0.017 -0.240 0.019
0.046 0.655 -0.028 0.790 -0.132 0.203 0.270 0.008 -0.021 0.842 -0.298 0.003 -0.269 0.008
-0.117 0.257 -0.229 0.026 0.105 0.311 0.019 0.857 -0.135 0.193 -0.038 0.716
0.501 0.000 0.115 0.269 -0.055 0.593 0.069 0.505 0.059 0.568
-0.264 0.010 0.037 0.725 0.096 0.356 0.003 0.975
236 021 081 433 173 093
-0.684 0.000 -0.725 0.000
0.441 0.000
NSL/OPTFH/OLNSL/CVTFH C/OPT/CVTN NSLMPL/MPFH NSLAS BAUl/ ll/NL 172
Discussionofcorrelationre ults Duetohlargenumberftests,nlyoswi hac rr lationp<0.01i lbreported.Cor lati shighl g tedsi nificant.Th closerthcorrelationefficie tis±1,bett rt r lationship,r gardle sfthp-va ue. Aswouldbeexpected,th6craniocervicalm asur srelhigh yc r ate(p<0.001).Oftht rva iables,PT/CVTghlyorr lated withNSL/OPT,FH/OPTandLbutnotitheleasrelatedoth rt r ecranioc rvicalvariables.M nyftc mparisonswith sametartpoinarcor ela ed,foex mpleNL/MPw thMP NSLh sc rel ionco ffic t( )f0.773p<0.001.S Ad sn tap ar














































































aComputedusinglpha= .05 bExactst tistic cDesign:Intercept+Group
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aComputedusingl ha= .05 bThisparameterisetoz roecautredundant.
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6.1.1 Cranio-cervical angulations
Descriptive data for the variables expressing the posture of the head and the
cervical column for the OSAHS and the control are listed in tables 6.1, 6.2 and
6.3, 6.4 and expressed in figures 6.1, 6.2, 6.3, 6.4, 6.5 and 6.6.
The cranio-cervical angles were larger in the OSAHS group than that of the
control and have shown significant correlation results with special high
significances to NSL/OPT, FH/OPT and NL/OPT.
The 'f test have shown significant result in relation to the angles formed with the
OPT than those with the CVT (NSL/OPT P=01**, FH/OPT P=002***,
NL/OPT P= 003***).
(P<0.05* P<01**, P<0.001***).


















































Figure 6.4 Cranio-cervical angulation (NSL/CVT)
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Figure 6.5 Cranio-cervical angulation (FH/CVT)
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The angle of the cervical curvature (OPT/CVT) of the OSAHS group has shown
to be smaller than that of the control group, mean 6.46° , 10.60 0 , SD 3.17498 and
4.41861 respectively, with a highly significant result P=0.000*** (Fig.6.7, tables
6.1, 6.2, 6.3, and 6.4).












NL/NSL has found to be lower in the OSAHS group than the control, mean 8.41°,
8.78°, SD 3.60001 and 2.42360 respectively, but statistically insignificant
P=0.605 (Fig. 6.8, tables 6.1, 6.2, 6.3 and 6.4).
Figure 6.8 Maxillary inclination (NL/NSL)
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6.1.4 Mandibular Inclination
MP/NSL has been found to be lower in OSAHS than that of the control group,
mean 36.20°, 36.35°, SD 6.18706, 6.42751 respectively, but with insignificant
result P=0.914 (Fig. 6.9 , tables 6.1, 6.2, 6.3 and 6.4).


















6.1.5 Maxillary Mandibular Relationship (Inter-maxillary angle)
The NL/MP angle is found to be higher in OSAHS group than the control, mean
28.34°, 26.72°, SD 56.24006 and 6.76793 respectively, but with insignificant
result P=0.255 (Fig. 6.10, tables 6.1, 6.2, 6.3 and 6.4).




















6.1.6 Frankfurt Horizontal to Nasion Sella Line
FH/NSL showed to be higher in OSAHS group than the control, mean 8.25°,
8.10°, SD 3.17476 and 3.92472 respectively, but shows insignificant result
P=0.839 (Fig. 6.11, tables 6.1, 6.2, 6.3 and 6.4).













6.1.7 Facio-skeletal Relationship (SNA)
SNA angle appeared higher in the OSAHS group when compared to the control,
mean 82.31°, 76.25°, SD 3.78020 and 3.70446 respectively, with statistically
significant result P=0.023* (Fig. 6.12, tables 6.1, 6.2, 6.3 and 6.4).

























6.1.8 Facio-skeletal Relationship (SNB)
SNB showed to be higher in the OSAHS group than the control, mean 79.17°,
76.93°, SD 8.089 and 3.709 respectively, but statistically insignificant result
P=0.336 (Fig. 6.13a and b, tables 6.1, 6.2, 6.3 and 6.4).





















Fig. 6.13b Facio-skeletal angle (Square root SNB)
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6.1.9 Facio-skeletal Relationship (ANB)
ANB angle appeared to be slightly higher in OSAHS than the control group,
mean 4.16°, 4.03°, SD 3.78020, 3.70446, but with statistically insignificant result
P=0.877 (Fig. 6.14, tables 6.1, 6.2, 6.3 and 6.4).
Figu re 6.14 Facio-skeletal angle (ANB)
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9.1.10 Upper Incisor to Lower Incisor
Ul/Ll was found to be higher in the OSAHS group than the control, mean
136.77°, 132.15°, SD 14.01229 and 12.07530 respectively, but statistically
insignificant result P=0.123 (Fig. 6.15, tables 6.1, 6.2, 6.3 and 6.4).
Table 6.15 Upper incisor to lower incisor angle (Ul/Ll)
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6.1.11 Upper Incisor to Maxillary Plane
Ul/NL has shown to be reduced in the OSAHS group than the control, mean
106.46°, 107.80°, SD 7.89645 and 9.17230 respectively, but statistically
insignificant result P=0.468 (Fig. 6.16, tables 6.1, 6.2, 6.3 and 6.4).
Figure 6.16 Upper incisor to the Maxillary (Nasal) Plane (Ul/NL)
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6.1.12 Lower Incisor to Mandibular Plane
LI /MP has been found to be smaller in the OSAHS group than the control, mean
88.71°, 92.50°, SD 9.10002 and 8.29459 respectively, but with statistically
insignificant result P=0.296 (Fig. 6.17, tables 6.1, 6.2, 6.3 and 6.4).













6.2 LINEAR MEASUREMENTS (12 variables)
• Upper anterior facial height (N-NL)
• Lower anterior facial height (Gn-NL)
• Upper posterior facial height (S-NL)
• Lower posterior facial height (Go-NL)
• Anterior cranial base (S-N)
• Maxillary length (ANS-PNS)
• Mandibular length (Me-Go)
• Overbite (OB)
• Overjet (OJ)
• Hyoid bone position (H-H1)
• Hyoid bone position (H-H2)
• Hyoid bone position (H-Hl) + (H-H2)
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Table 6.5 Linear Measurements (Multivariate analysis)
Descriptive Statistics (B)
Group Mean Std. Deviation N
N-NL
control 53.7333 2.67083 30
sample 53.9462 4.11943 65
Total 53.8789 3.71005 95
Gn-NL
control 62.6000 5.27421 30
sample 68.3923 7.40011 65
Total 66.5632 7.29334 95
S-NL
control 42.8667 3.55483 30
sample 43.6000 3.79267 65
Total 43.3684 3.71613 95
Go-NL
control 32.8833 5.09341 30
sample 36.2000 5.97639 65
Total 35.1526 5.89269 95
N-S
control 73.4333 3.31593 30
sample 73.3462 4.05906 65
Total 73.3737 3.82250 95
ANS-PNS
control 57.5833 3.36074 30
sample 54.2615 4.99539 65
Total 55.3105 4.78372 95
Me-Go
control 74.3833 5.69889 30
sample 73.2077 6.55320 65
Total 73.5789 6.28969 95
OB
control 3.4667 2.11291 30
sample 3.9308 2.80885 65
Total 3.7842 2.60692 95
OJ
control 3.4167 2.64602 30
sample 3.3154 2.60494 65
Total 3.3474 2.60429 95
H-H1
control 18.5833 4.72171 30
sample 22.8769 6.50843 65
Total 21.5211 6.30430 95
H-H2
control 8.6667 5.99904 30
sample 12.2077 6.22614 65
Total 11.0895 6.34302 95
(H-H1)+ (H-H2)
control 26.5833 9.02113 30
sample 35.1000 11.67670 65








































































































































































































































































































































































































































































































































































































































































































6.2.1 Upper Anterior Facial Height
N-NL has appeared longer in the OSAHS group than the control, mean 53.95mm,
53.73mm, SD 4.11943 and 2.67083 respectively. It shows insignificant result
P=0.191 (Fig. 6.18, tables 6.5, 6.6, 6.7 and 6.8).
Figure 6.18 Upper anterior facial height (N-NL)
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6.2.2 Lower Anterior Facial Height
Gn-NL has shown to be longer in the OSAHS than the control group, mean
68.39mm, 62.60mm, SD 7.40011 and 5.27421 respectively. It shows highly
significant result P=0.000*** (Fig. 6.19, tables 6.5, 6.6, 6.7 and 6.8).
Figure 6.19 Lower anterior facial height (Gn-NL)
201
6.2.3 Upper Posterior Facial Height
S-NL has found to be increased in the OSAHS group when compared to the
control, mean 43.60mm, 42.87mm, SD 3.79267 and 3.55483 respectively, but it is
statistically insignificant P=0.374 (Fig. 6.20, tables 6.5, 6.6, 6.7 and 6.8).
Figure 6.20 Upper posterior facial height (S-NL)
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6.2.4 Lower Posterior Facial Height
Go-NL has shown to be longer in the OSAHS than the control, mean 36.20mm,
32.88mm, SD 5.97639 and 5.09341 respectively. Statistically, it is highly
significant P=0.010* (Fig. 6.21, tables 6.5, 6.6, 6.7 and 6.8).




6.2.5 Anterior Cranial Base Length
N-S length has appeared to be shorter in the OSAHS than in the control group,
mean 73.35mm, 73.43mm, SD 4.05906 and 3.31593 respectively. They are highly
correlated, but statistically insignificant P=0.918 (Fig. 6.22, tables 6.5, 6.6, 6.7
and 6.8).















ANS-PNS has shown to be shorter in the OSAHS group than the control, mean
54.26mm and 57.58mm, SD 4.05906 and 3.31593 respectively, and a highly
significant result P=0.000*** (Fig. 6.23, tables 6.5, 6.6, 6.7 and 6.8).
Figure 6.23 Maxillary length (ANS-PNS)
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6.2.7 Mandibular Length
Mandibular plane (Me-Go) has appeared shorter in the OSAHS group than the
control, mean 73.21mm, 74.38mm, SD 6.55320 and 5.69889 respectively, and
with a high statistical significance P=0.002** (Fig. 6.24, tables 6.5, 6.6, 6.7 and
6.8).















Overbite has shown to be deeper in the OSAHS group than the control, mean
3.93mm, 3.47mm, SD 2.80885, 2.11291 respectively, but statistically




Overjet has shown to be reduced in the OSAHS group than the control, mean
3.32mm, 3.42, SD 2.60494 and 2.64602 respectively, but statistically insignificant























6.2.10 Hyoid Bone Position
6.2.10.1 Hyiod Bone Position (H-Hl)
Hyoid bone has been found to be more inferiorly positioned in the OSAHS
subjects than the control, mean 22.88mm, 18.58, SD 6.50843 and 4.72171
respectively, with high statistical significance P=0.002** (Fig. 6.27a, tables 6.5,
6.6, 6.7 and 6.8).











6.2.10.2 Hvoid Bone Position (H-H2)
H-H2 also appeared to be inferiorly positioned in the OSAHS than the control,
mean 12.21mm, 8.67mm, SD 6.22614 and 5.99904 respectively with high
significant result P=.011 (Fig. 6.27b, tables 6.5, 6.6, 6.7 and 6.8).








6.2.10.3 Hyoid Bone Position (H-Hl) + (H-H2)
(H-Hl) + (H-H2) is inferiorly positioned in the OSAHS dubjects than the control,
mean 35.10mm, 26.58mm, SD 11.67670 and 9.02113 respectively, and a high
significant result P=.001** (Fig. 6.27c, tables 6.5, 6.6, 6.7 and 6.8).





















Cephalometric radiography has a long tradition as a diagnostic and follow-up
technique in the study of cranio-facial morphology (Broadbent, 1931) and in the
surgical management of cranio-facial deformities (Burstone et al., 1978).
Availability of normative data and the possibility of superimposition of long-term
serial records have given this method a unique position (Burstone et al., 1975;
Behrents 1985a and 1985b).
Recently, several reports regarding the deviated cephalometric data of OSAHS
patients have been published with some controversies (Maltais et al., 1991;
Davies and Straddling, 1990 and 1991). Consequently, a comprehensive study of
the subject to solve some of these controversies is needed.
The characteristic appearance of the typical patient severely affected by
obstructive sleep apnoea / hypopnoea syndrome led Osier (1901) to characterize
this condition as 'Pickwickian' according to the novel by Charles Dickens (1836)
in which such a condition was described. Subsequently the term 'Pickwick
syndrome' has sometimes been used for OSAHS. Although no formal description
of the head posture in this condition has been made, an extended head posture is
generally recognized by clinicians as being a characteristic feature of the
appearance of patients with obstructive sleep apnoea (Cote, 1988).
In the field of Orthodontics, the natural head posture is of interest from two
aspects:
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1. In the diagnostic assessment of facial aesthetics in orthodontic and
orthognathic surgery treatment plan.
2. In the assessment of the role of head posture in postnatal facial
morphogenesis.
In assessment of facial aesthetics, emphasis is laid on the posture of the head in
relation to a gravity-determined true vertical.
Several cephalometric analyses have been developed for the purpose of
performing such aesthetic assessments of the maxillary and mandibular protrusion
in relation to a gravity-determined true vertical (Moorees et al., 1976; Cooke and
Wei, 1988; Lundstrom and Lundstrom, 1989).
AngularMeasurement
It may be noted, however, that widely differing means of the cranio-cervical
angulation have been reported by different authors. A survey by Solow and
Tallegran (1971a) ofmeans for NSL/VER in five different studies showed a range
from 89.6° to 102.4°. This can be taken to indicate that the cranio-vertical angle is
particularly very sensitive to differences in methodology for recording of head
posture.
Assessment of facial protrusion in relation to a gravity-determined vertical thus
would seem to require further standardization of the positioning procedures used
in such studies.
The role of head posture in facial development has been demonstrated in a series
of studies which provide for the existence of a sequence of events comprising:
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1. Obstruction of the upper airways;
2. Increase in the cranio-cervical angulation;
3. Vertical direction of the facial development.
It is important to notice, however, that the posture involved in this sequence of
events is the position of the head in relation to the cervical column. Changes in
this angle are mediated by changes in the cranio-vertical and in the cervico-
horizontal angles. An increase in cranio-cervical angulation thus can be mediated
by an extension of the head in relation to the true vertical, by a forward inclination
of the cervical column or by a combination of both.
An increase in the cranio-cervical angle can be triggered by various types of
obstruction of the upper airway. One reason for this physiological mechanism
could be that such a change in posture will increase the diameter of the airway and
thus reduce the airway resistance. Another reason could be that, observed by
Ricketts (1968), an increase in the cranio-cervical angle will lift the head away
from the hyo-mandibular complex and thus, facilitate the transition from nasal
breathing to mouth breathing which occurs in many subjects with a larger upper
airway resistance caused by nasal or naso-pharyngeal obstruction.
Studies of head posture in subjects with adenoidal obstruction have demonstrated
an average increase in cranio-cervical angulation of about 2° (Solow B and Greve
E, 1979; Woodside D and Linder-Aronson S, 1979). This increase is mediated by
an increase in the cranio-vertical relationship, whereas the average cervical
inclination is not affected. After adenoidectomy this extended head posture in the
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obstructed children has shown to normalize. Thus, in individual children a
reduction of the cranio-cervical angle of up to 9° has been found (Solow B and
Greve E, 1979).
It has long been known that various kind of craniofacial anomalies are closely
related to upper airway obstruction which may lead to the OSAHS condition.
Craniosynostosis syndrome such as Crouzon or Apert (Schafer ME, 1982), Pierre
Robin syndrome (Lapidot A and Ben-Hur N, 1975), and Treacher Collins
syndrome (Johnston et al., 1981) were among these.
This present study provides further evidence for the suggestion that obstruction of
the upper airway may trigger an increase in the cranio-cervical angulation. Six
cranio-cervical angles were statistically different in the OSAHS group when
compared to the control with special significance to the angles formed with the
OPT. The large difference in cranio-cervical angulation was mediated by a
forward inclination of the cervical column. A physiological requirement for a
major increase in cranio-cervical angulation due to airway obstruction therefore
can only be met by a forward inclination of the cervical column.
A similar mechanism, in head tilting mediates minor changes in head posture
whereas larger changes are mediated by changes in cervical inclination, was
observed in a study of how subjects produced the change in head posture from the
self-balance position to the mirror position (Solow B and Tallegran A, 1971b).
The angle of the cervical curvature (OPT/CVT) has shown to be reduced in the
OSAHS group (mean 6.46°, SD 3.17), when compared to the control (mean 10.6°,
SD 4.42). This further shows forward positioning of the head. Solow et al. (1993)
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also found this angle to be lesser in the OSAHS group mean 4.5° and SD 2.91.
Tangugsorn et al., (1995) got a different result, increased (OPT/CVT) angle in the
OSAHS (100 patients, mean 3.55°, SD 2.96) than the control (36 patients, mean
1.08°, SD 2.96). Sakakibara et al., (1999) found (OPT/CVT) to be also reduced in
the obese OSAHS group (mean 1.1°, SD 2.6), than the control (mean 1.5°, SD
3.1), and they have also found this angle to be more reduced in the non-obese
OSAHS group (0.9°, SD 1.9).
The angle of maxillary inclination (NL/NSL) or the angle describing the vertical
dimension of the upper face showed about the same values in patients and control
(Lyberg et al., 1989), whereas in this present study appeared to have been lesser in
the OSAHS group (mean 8.41°, SD 3.60) when compared to the control, (mean
8.8°, SD 2.42), which indicates a downward and forward rotation of the cranio-
maxillary complex, and a shorter upper face.
Lyberg et al., (1989) found the angle describing the vertical dimension of the
lower face (MP/NSL) was significantly greater (P<0.05) in the patients, indicating
more cranial positioning of the gonial angle. Our study showed the angle of
mandibular inclination (MP/NSL) appeared to be minimally reduced when
comparing the OSAHS group (mean 36.20°, SD 6.19) with the control group
(mean 36.35°, 6.43), which explain the downward and backward rotation of the
mandible and more caudally positioning of the gonial angle which could be due to
increase in ramus length.
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This present study showed the inter-maxillary angle (NL/MP) to be increased in
the OSAHS group (mean 28.34°, SD 6.24) when compared to the control, (mean
26.72°, SD 6.77), this confirm the downward and forward rotation of the maxilla
and downward and backward rotation of the mandible. Battagel and L'Estrange
(1996) found the maxillary mandibular plane angle to be increased in the OSAHS
group than the control, mean 26.5° and 24.2° respectively. Tangugsorn et al.,
(1995) also found the (NL/MP) angle to be increased in the OSAHS (mean 2.78°),
when compared to the control (mean 2.11°).
A slight depression of the sphenoidal complex in the clivus region was observed,
when considering (FH/NSL) angle which was increased in the OSAHS group
mean 8.25°, SD 3.17 when compared to control mean 8.10°, SD 3.92 (Tangugsorn
et al., 1995). This present study found (FH/NSL) to be similar to those of
Tangugsorn et al., (1995), with a mean higher in the OSAHS group than that of
the control, 9.35° and 8.10° respectively. When the (FH/NSL) angle was taken
into consideration, the whole structure of the cranial base was rotated slightly
counter-clockwise in the sagittal plane in the OSAHS group; this was worsened
by the retrognathic position of the maxilla and the mandible, (Tangugsorn et al.,
1995).
Battagel and L'Estrange (1996) found that the (SNA) to be increased in the
OSAHS group when compared to the control, mean 81.6° and 80.6° respectively.
Tangugsorn et al., found the SNA to be smaller in the OSAHS (mean 80.34°) than
the control group 81.79°. Sakakibara et al., (1999) found SNA to be increased in
the obese OSAHS group (mean 83.7°, SD 4.0) than the control (mean 82.5°, SD
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4.3), but reduced in the non-obese OSAHS group (82.1°, SD 4.6). Our data in
relation to (SNA) proved to be increased in OSAHS group (mean 82.31°, SD
6.46) than the control group (mean 76.25°, SD 18.99) with a difference of 6.06°
which is similar to the results of Battagel and L'Estrange (1996).
Battagel and L'Estrange, (1996) found that (SNB) was increased in the OSAHS
group than the control, mean 79.2° and 78.6° respectively, while Tangugsorn et
al., (1995) found SNB to be smaller in the OSAHS group (mean 77.56°) when
compared to the control group (mean 79.69°). Sakakibara et al., (1999) found
SNB to be increased in the obese OSAHS group (mean 79.2°, SD 4.1) than the
control (mean 78.8°, SD3.4) but reduced in the non-obese OSAHS group (mean
77.7°, SD 4.6). A smaller (SNB) angle has long been used to indicate mandibular
retrusion relative to Nasion (Riley et al., 1983; Jamieson et al., 1986; Hochban
and Brandenburg, 1994). Obviously, factors other than mandibular retrusion
should be well controlled when explaining the significance of a decreased (SNB)
angle.
This present study showed (SNB) to be increased in the OSAHS group (mean
79.1°, SD 8.09) when compared to the control (mean 76.9°, SD 3.71) respectively,
with a difference of 2.2°. This explains that the retrognathic position of the
mandible in the OSAHS group was less than the control which indicates
clockwise rotation of the mandible, which is clearly due to the concomitant
shortening of the cranial base in the OSAHS patients.
Battagel and L'Estrange (1996) found the (ANB) angle to be increased in the
OSAHS group than the control, mean 2.1°, 1.9° respectively. Tangugsom et al.,
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(1995) also found ANB angle increased in the OSAHS group mean (2.78°), when
compared to the control mean 2.11°. Sakakibara et al., (1999) found this angle to
be increased in the obese OSAHS group (mean 4.6°, SD 2.7) and also increased in
the non-obese OSAHS group (mean 4.5°, SD 2.7) than the control (mean 3.6°, SD
2.7).
The present study showed minimal increase of the (ANB) angle in the OSAHS
group (mean 4.16°, SD 3.78), when compared to the control, (mean 4.03°, SD
3.70) with a difference of 0.13°. This indicates a more skeletal class II cases than
the skeletal class III cases among the OSAHS group.
Battagel JM and L'Estrange PR (1996), found the upper incisors to maxillary
plane (Ul/NL) mean 108.9° to be reduced in the OSAHS than the control mean
110°, and the lower incisors to mandibular plane (LI/MP) mean 90.9°, to be
increased in the OSAHS than the control mean 89.1.°
This present study showed that the upper incisors to maxillary plane angle Ul/NL
(mean 106.46°, SD 7.90) and the lower incisors to mandibular plane angle Ll/MP
(mean 88.71°, SD 9.06) to be reduced in the OSAHS group, than the control
Ul/NL (mean 107.80°, SD 9.17), Ll/MP (mean 92.50°, SD 9.10). The results in
our study showed to be similar to that by Battagel and L'Estrange in relation to
(Ul/NL), and different to the same study in relation to (Ll/MP), this could be due
to the severity of the OSAHS condition in our group and also could be due to
proclination of the lower incisors in the control.
Our data showed the inter incisal angle (Ul/Ll) to be increased in the OSAHS
group (mean 136.77°, SD 14.01) than the control (mean 132.15°, SD 12.08),
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which confirms the reduced angles of Ul/NL and LI/MP. Dental relationship
explains the downward and forward rotation of the maxilla and downward and
backward rotation of the mandible.
LinearMeasurement
Lyberg et al., (1989) found the upper anterior facial height (N-NL) to be increased
in the OSAHS group (mean 56.4mm, SD 3.0) than the control (mean 54.7mm, SD
3.1), whereas Battagel JM and L'Estrange PR (1996) found the (N-NL) to be
decreased in the OSAHS group (mean 52.7mm, SD 3.3) than the control (mean
54.4mm, SD 3.3). Tangugsorn et al., (1995) found the upper anterior facial height
to be reduced in the OSAHS group (100 patients, 55.97mm, SD 3.39) when
compared to the control (36 controls, mean 57.07mm, SD 3.53). This present
study found (N-NL) to be similar to that of Lyberg et al., (1989), increased in the
OSAHS group (65 subjects, mean 53.95mm, SD 4.12), than the control (30
controls, mean 53.73mm, SD 2.67), which indicates inferiorly positioned Nasion.
Lyberg et al., (1989) found increased lower anterior facial height (Gn-NL) in the
OSAHS group (mean 73.4mm, SD 5.1) when compared to the control (mean
70.9mm, SD 5.5). Battagel JM and L'Estrange PR (1996) found reduced lower
anterior facial height in the OSAHS group (mean 67.6mm, SD 7.2) when
compared to the control (mean 69.2mm, SD 5.5). Tangugsorn et al., (1995) found
the lower anterior facial height to be increased in the OSAHS group (mean
75.93mm, SD 6.34) than the control (mean 72.22mm, SD 4.70).
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This present study showed an increase in the lower anterior facial height in the
OSAHS group (mean 68.39mm, SD 7.40) when compared to the control (mean
62.60mm, SD 5.27) similar to that of Lyberg et al., (1989) and Tangugsorn et al.,
(1995) which is highly significant.
Lyberg et al., (1989) found the upper posterior facial height (S-NL) to be
increased in the patients (25 patients, mean 45.2mm, SD 3.2) when compared to
the control (10 controls, mean 44.0mm, SD 2.9). Tangugsorn et al., (1995) found
that the S-NL to be reduced in the OSAHS group (mean 43.91mm, SD 3.34) when
compared to the control (mean 45.25mm, SD 2.99).
This present study report similar results to the work of Lyberg et al (1989),
increased upper posterior facial height in the OSAHS group (mean 43.60mm, SD
3.79) when compared to the control (mean 42.87mm, SD 3.55) but statistically
insignificant.
Tangugsorn et al., (1995) found the lower posterior facial height to be reduced in
the OSAHS group (mean 41.37mm, SD 5.99) when compared to the control
(mean 43.32mm, SD 3.89). Lyberg et al., (1989) also found (Go-NL) to be
reduced in the OSAHS group (mean 41.8mm, SD 5.9) when compared to the
control (mean 42.6mm, SD 3.4). Our data were different from the above studies, it
appeared increased in the OSAHS group (mean 36.20mm, SD 5.98) than the
control (mean 32.88mm, SD 5.09), which indicate a clockwise rotation of the
maxilla and a more caudally placed gonial angle which could be due to increase in
ramus length.
221
The present study reported shorter anterior cranial base length (S-N) in the
OSAHS group (mean 73.35mm, SD 4.06) when compared to the control (mean
73.43mm, SD 3.32). Tangugson et al., (1995) found the S-N to be shortened in the
OSAHS group (mean 71.18mm, SD 3.3) than the control (mean 74.23mm, SD
3.16). The same findings also reported by Battagel JM and L'Estrange PR (1996),
OSAHS (mean 70.0mm, SD 2.6) and the control (mean 72.4mm, SD 3.0).
Sakakibara et al., (1999) found also shortened (S-N) in the OSAHS group (mean
71.9mm, SD 3.8) than the control (mean 73.5mm, SD 3.4). A recent study by
Randall et al., (2000) in an age group 7-14 years found the (S-N) also to be
shortened in the OSAHS group than the control. The fact that snorers had
shortened cranial base (S-N) and maxilla (ANS-PNS) may suggest a narrowing in
the sagittal dimension (Randall et al., 2000).
This present study showed maxillary length (ANS-PNS) to be shorter in the
OSAHS group (mean 54.26mm, SD 5.00) when compared to the control (mean
57.58mm, SD 3.36), which is statistically highly significant P=.001, and confirm
the decreased antero-posterior facial distance at (ANS-PNS). Lyberg et al., (1989)
found the maxilla to be shorter in the OSAHS group (mean 55.7mm, SD 3.1) than
the control (mean 56.8mm, SD 1.9). Tangugsorn et al., (1995) found the maxilla
to be shortened in the OSAHS group (mean 54.86mm, SD 3.54) when compared
to the control (mean 56.98mm, SD 3.89). More recently Sakakibara et al., (1999)
found the ANS-PNS distance to be reduced in the obese OSAHS group (mean
52.6mm, SD 5.0), and more reduced in the non-obese OSAHS group (mean
51.5mm, SD 5.1) when compared to the control (mean 54.5mm, SD 4.4).
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One of the most widely published deviating cephalometric data in OSAHS
patients is the size and position of the mandible. Mandibular micrognathia and
retrognathia has been frequently described (Valero A and Alroy G, 1965;
Tammeling et al., 1972; Coccagna et al., 1978). Lyberg et al., (1989) found
mandibular length to be shortened in the OSAHS group (mean 77.0mm, SD5.2)
when compared to the control (mean 78.2mm, SD 2.5). Tangugsorn et al., (1995)
found also mandibular length to be shorter (Go-Gn) in the OSAHS group
(mean72.85mm, SD 5.09) than the control (mean 74.65mm, SD 5.29). The same
result also found by Battagel JM and L'Estrange PR (1996) with a (mean
69.7mm, SD 5.7) in the OSAHS group and a (mean 72.8mm, SD 5.5) in the
control group. More recently Sakakibara et al., (1999) found the mandibular
length (Me-Go) distance to be reduced in the obese OSAHS group (mean
75.0mm, SD 5.6), and more reduced in the non-obese OSAHS group (mean
73.3mm, SD 5.3) when compared to the control (mean 77.0mm, SD 5.5). Our data
found the mandibular length shorter in the OSAHS group (mean 73.21 mm, SD
6.55) when compared to the control (mean 74.38mm, SD 5.70), same results of
previous studies. Bear SE and Priest JH, (1980) described a case ofOSAHS and a
class II malocclusion with retrognathic mandible. Bilateral osteotomies on the
horizontal part of the mandible with interposition of iliac bone grafts after
advancement of the mandible resulted in normalization of sleep patterns and
amelioration of symptoms like snoring and excessive daytime sleepiness. Riley et
al., (1984) described a surgical procedure combining advancement of an inferior
mandible/chin fragment with anterior suspension of the hyoid. In essence, the
effect of all these procedures is an anterior repositioning of the tongue and
enlargement of the posterior airway space (PAS), i.e. the space between the base
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of the tongue and posterior pharyngeal wall. In contrast, setback of the mandible
for correction of mandibular prognathism can precipitate OSAHS (Guilleminault
et al., 1985). In a recent study of habitually snoring and apnoeic children,
retroposition of the mandible was not essential to the development of upper-
airway obstruction, but rather contributed by posterior crossbite caused by a
reduced growth of the maxilla after continuous oral breathing, and anterior open-
bite with lip incompetence, owing to a forward tongue position (Zucconi et al.,
1999). Studies in adults have also demonstrated a significant reduction in the
sagittal dimension of the anterior cranial base in apnoeic patients (Bacon et al.,
1990), a reduction in cranial base and mandible in snorers, and a shorter maxilla
in apnoeic patients (Zucconi et al., 1993). These studies suggest that habitual
snorers might have an anatomic predisposition to airway obstruction. On the
contrary, there are reports which indicate that cephalograms of OSAHS patients
and those of simple snorers do not differ from one another (El-Sheikh et al., 1996;
Andersson et al., 1991).
Tangugsorn et al., (1995) study found the overbite to be averagely the same in the
OSAHS (mean 3.73mm, SD 2.03) and the control (mean 3.43mm, SD 1.29),
which was insignificant. Battagel and L'Estrange (1996) found the overbite to be
normal in the OSAHS (mean 3.4mm, SD 2.5) and the controls (mean 3.6mm, SD
2.2), which also demonstrated insignificant result.
This present study showed overbite to be deeper in the OSAHS group (mean
3.93mm, SD 2.81) when compared to the control (mean 3.47mm, SD 2.1), but
statistically insignificant.
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Tangugsorn et al., (1995) study found the overjet to be averagely the same in the
OSAHS (mean 3.63mm, SD 2.49) and the control (mean 3.71mm, SD 1.96),
which was insignificant. Battagel JM and L'Estrange PR, (1996) found the overjet
to be normal in the OSAHS (mean 3.4mm, SD 3.0) when compared to the
controls (mean 3.0mm, SD 1.6), which also demonstrated insignificant result.
This present study showed reduced overjet in the OSAHS group (mean 3.32mm,
SD 2.60) when compared to the control (mean 3.42mm, SD 2.65). The oveijet and
overbite appeared to be of little or no significance in relation to the severity of the
OSAHS condition.
The literature pertaining to the hyoid bone position and its relationship to the
sleep apnoea condition is extensive. Bibby RE and Preston CB, (1981) concluded
from a review of cephalometric studies of the hyoid that its position generally
exhibited 'large' intra- and inter-individual variation. They suggested that this
variation could be explained on the basis that most of the reviewed studies had
related the hyoid position to the cranial base, rather than more local structures,
and that the vertical position of the hyoid relative to the cranial base was strongly
influenced by changes in head posture. To overcome limitations of measuring
hyoid position relative to distant anatomic structures, they introduced the concept
of describing the hyoid position using the 'Hyoid Triangle', which related the
hyoid to the most inferior and anterior point on the third cervical vertebra (CV3ia),
and the most inferior and posterior point upon the mandibular symphysis (RGN).
The horizontal position of the hyoid within this triangle has been consistently
reported to be extremely stable throughout life, and this is proposed to be a
reflection of the physiological maintenance of upper airway patency (Bibby and
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Preston, 1981). It was therefore presumed that the hyoid position in the horizontal
plane would be unlikely to exhibit any relationship to OSAHS severity and
subsequently the present investigation focused upon vertical relationship between
the hyoid and anatomic points and planes.
A lower hyoid position has been frequently reported in OSAHS subjects as
compared with 'normal' subjects (Djupesland et al., 1987; Maltais et al., 1991;
Tuchiya et al., 1992; Tangugsorn et al., 1995; Battagel JM and L'Estrange PR,
1996) and non apnoeic snorers (Michizuki et al., 1996; Lowe et al., 1997). A
meta-analysis undertaken by Miles et al., (1996), calculated that the mean
difference in mandibular plane to hyoid distance between 'normal' and OSAHS
subjects was 6.2mm. This difference was significantly greater than the observed
'normal' increase in the same distance of 2.8 with increasing age.
A relationship between NHP, craniofacial structure and hyoid bone position,
which also reflects the vertical position of the tongue (Behfelt et al., 1990), has
been demonstrated by Tallegran and Solow (1987). Correspondingly, Ozbek et al.
(1998), found a higher correlation between a lower hyoid bone position in relation
to the mandibular plane and increases in cranio-cervical extension (P<0.001). As
suggested by Thurow (1977), a low hyoid with a low tongue posture puts the
geniohyoid at a mechanical disadvantage by creating a need for tongue elevation,
which results in more downward and backward postural forces on the mandible.
These, together with a large tongue, may cause an increase in the mandibular load
and thereby an interruption of the postural balance of the cranio-mandibular
region (Thurow 1977). The increased load on the postural muscles of the
mandible (mandibular closing muscle) and the head (post-cervicals) may cause a
CCE (cranio-cervical extension).
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This present study demonstrates that there is statistically significant result
between OSAHS and inferior position of the hyoid bone.
H-Hl (hyoid bone to mandibular plane) found to be more inferiorly positioned in
the OSAHS (mean 22.88mm, SD 6.51), than the control (mean 18.58mm, SD
4.72, P=.002).
H-H2 (hyoid bone to the plane RGN-Cv3ia) also found to be inferiorly positioned
in the OSAHS (mean 12.21mm, SD 6.23), than the control (mean 8.67mm, SD
6.00, and P=.011).
(H-H1)+(H-H2) has also found to be inferior in the OSAHS group (mean
35.10mm, SD 11.68,) than the control (mean 26.58mm, SD 9.02), with high
statistical significancy (P=. 001).
A Bon Ferroni correction could also be used to achieve the same significancy.
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The value of the cephalometric radiograph in the study of the head and neck is a
valuable tool in the evaluation of OSAHS patients, giving important information
relating to the hard and soft tissue morphology of the cranio-cervico-facial
complex, and guidance towards a rational treatment modality. It is widely
accessible and relatively inexpensive in comparison to alternative imaging
procedures.
Our results indicate that there are significant cranio-cervico-facial differences
between OSAHS group and the control.
These differences could be summarized as follows:-
1. Increased cranio-cervical angulations (NSL/OPT), (FH/OPT), (NL/OPT),
(NSL/CVT), (FH/CVT) and (NL/CVT).
2. Decreased cervical curvature (CVT/OPT), which shows further forward
positioning of the head.
3. Minimally decreased maxillary inclination.
4. Minimally decreased mandibular inclination.
5. Increased maxillary mandibular plane angle.
6. Clockwise rotation of the craniofacial complex.
7. An increased tendency for CL II skeletal cases suffer from OSAHS when
compared to CL III (Increased SNA, SNB, and ANB).
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8. The relationship between the maxilla and the mandible (increased MMP
angle, decreased Ul/NL and LI/MP and increased Ul/Ll), can lead to
downward and backward rotation of the maxillary / mandibular complex.
9. A minimally longer upper anterior facial height (N-NL) and a significantly
longer lower anterior facial height (Gn-NL).
10. A longer upper (S-NL) and lower (Go-NL) posterior facial height.
11. A shorter anterior cranial base length (S-N).
12. A shorter maxillary length (ANS-PNS).
13. A shorter mandibular length (Me-Go).
14. Deeper overbite (OB).
15. Minimally reduced overjet (OJ).
16. Inferiorly positioned hyoid bone, increased length of (H-Hl), (H-H2) and
(H-Hl) + (H-H2).
The 'null hypothesis' as follows:
I. The craniofacial morphology and the position of the hyoid bone in relation
to the cervical vertebrae and / or a fixed point upon the anterior cranial base,
provides no indication to the severity ofOSAHS. This statement found to be
false.
II. There are no significant differences in skeletal morphology between the
OSAHS group and the controls matched for sex, age and ethnicity. This is
also found to be false.
Orthodontists may therefore find themselves in a position to assist in the early
identification of patients with OSAHS. The ready availability of the lateral
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cephalograms may help to identify the patient at risk who can then be referred for
further investigation. In addition, treatment options for the subject with OSAHS
may involve the provision of mandibular advancement splints. The orthodontist is
uniquely placed to provide these appliances. Finally, where maxillo-facial surgery
is recommended, the orthodontist will be involved in the pre-surgical co¬
ordination of the occlusion. The limitations will be in the younger age group in
the orthodontic population, as most of the OSAHS patients are above 40 years of
age. To overcome this problem, there should be a close relationship between an
ENT, a neurologist, a cardio-respiratory specialist, maxillo-facial surgeon,
orthodontist and a sleep laboratory.
I recommend further studies in the use of lateral cephalometric radiograph
analysis of the hard (cranio-cervico-facial morphology and hyoid bone position)
and soft tissues (pharyngeal width, tongue and soft palate length) using different
cephalometric analysis to further aid in the diagnosis and treatment ofOSAHS.
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• Angular measurements (Subjects n=65)
• Angular measurements (Control n=30)
• Linear measurements (Subjects n=65)
• Linear measurements (Control n=30)
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FH/OPT
NL/OPT
NSL/CVT
FH/CVT
NL/CVT
CVT/OPT
NL/NSL
MP/NSL
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SNB
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109.5
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34
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111
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92.5
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104.5
104.5
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79
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108
99
97
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31
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33
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87
11
119
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5.5
9
37
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9.5
120
117
99
3
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103.5
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114
107.5
105
4
9
34.5
25.5
7
77
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2
130
106
96
4
99
98
92.5
105
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98.5
6
7
23.5
16.5
2.5
85
80
5
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5
93
89
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9
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44
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6
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104
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4
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141
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7
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39
31
5
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96
123.5
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13
15
36
23
11
77
74
3
140
104
86
9
103.5
88.5
96
110
95
102.5
6.5
7.5
41
33.5
15
87
72.5
14.5
132
104
91.5
10
113
106.5
103
123
116.5
113
10
10
41
31
7
79
76
3
114
115
100
11
75
73.5
67.5
94
92.5
86.5
19
7.5
35
27.5
2
79
80
-1
130
119
104
12
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105.5
100
119
116.5
111
11
7.5
30
23
2
84
80
4
152.5
100
84
13
100.5
87.5
92.5
112.5
99.5
104.5
12
8.5
30.5
22.5
14
82.5
81
1.5
130
110
94
14
84
79
76.5
100
95
92.5
16
7.5
25.5
18
4.5
78
73.5
4.5
120
119
104
15
100.5
92.5
92
106.5
98.5
98
6
8
33
25
8
85
80
5
101.5
125.5
108
16
95
85.5
82.5
103.5
94
91
8.5
12.5
46
34
9
77
75
2
141
105
80
17
88
76
80
98
86
90
10
8
34
26.5
11.5
81
75
6
142
96
95
18
96
90
88
109
103
101
13
8
34
25
5
85
80
5
139
103
92
19
106
100.5
96
110.5
105
100.5
4.5
5
40
3
10
82
82
0
132.5
108
88.5
20
94
82
88
104
92
98
10
7
27
22
12
86
80
6
118
114
106
21
101.5
91.5
88.5
124
114
111
22.5
14
45
30
11
78
71
7
132
110
87
22
93
85
82
102
94
91
9
10.5
33
23
8
80
77
3
134
111.5
90.5
23
93
89
87
113.5
109.5
107.5
20.5
7
28.5
22
4.5
84.5
83
1.5
135
111
91
24
91
83
86
98.5
90.5
93.5
7.5
8
37
21
9.5
85
83
2
137
107
84
25
107.5
94
97
121
107.5
110.5
13.5
10.5
43
32
13
73
71
2
136
102
90
26
107
94
96
122
109
111
15
11
39.5
28
13
80
76
4
129.5
111
91
27
108
94
96
116
102
104
8
12.5
42
31
14
77
74
3
139
106
86
28
110
107
101
117
114
108
7
10
40
30
3
80
73
6.5
158
95
84
29
96
86
89
114
104
107
18
8
31
23.5
10
77.5
75.5
2
130
105
101
30
104.5
96
97
116.5
108
109
12
7.5
39
31
8
78.5
73.5
5.5
138
97
92.5
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Subjects
N-NL
Gn-NL
S-NL
Go-NL
N-S
ANS-PNS
Me-Go
OB
OJ
H-H1
H-H2
(H-H1)+(H-H2)
1
51.5
62.5
39
35
65.5
44.5
64.5
5
2
18
9.5
27.5
2
44
61
39
27
64.5
37.5
62
4.5
-2.5
11
6
17
3
50
63
44
34.5
70
47
69.5
4
2.5
28
16
44
4
54
64.5
44
29
70
52
69
2
4
27
16.5161310.5
43.5
5
54.5
74.5
46
39.5
73
59
62.5
3
5
27
43
6
48
63
44
35
73.5
48
71
10
7
33
46
7
53
70
46
39
75
56
62
2
3
18
28.5
8
54
72
44.5
37
73
51
73
5
5
17
3
20
9
56
61
42
39.5
71.5
56
72
2
2
11.5
5
16.5
10
52
79
46
41
76.5
58
70
-7
2
18
12
30
11
54
60.5
38.5
29
64
53
66
5
5
25
5.5
30.5
12
57
64
32
40
69.5
54.5
68
2
2
15
11
26
13
54
68.5
41
35
77.5
52.5
67.5
9
5.5
31
18.5
49.5
14
51
64
43
25
70
58
68.5
2
2
17
10
27
15
47.5
66
44.5
34
72
48.5
65
0
0
27
10.5
37.5
16
56
69
45.5
35.5
67
47
68
2.5
1
26.5
12
38.5
17
48
68.5
42
38.5
69
49.5
69
2.5
2
12.5
2
14.5
18
51
63
43
33.5
69
55
65
6
7
21
12.5
33.5
19
46
69
45.5
27
68
51
69
3.5
5
15
6
21
20
53
67
47
30
73
52
72
6
5
27
12
39
21
54
71
46
32.5
72.5
49
75.5
5.5
1
16
3
19
22
51
69
49
29.5
73
52
65
4
3.5
23
3.5
26.5
23
59
56
40.5
39.5
78.5
58
73
5
4
17.5
9.5
27
24
50
69
45
33
72
54
75.5
4
2
24
13
37
25
53
64
41
36
69
52
69
6.5
4
24.5
21
45.5
26
52
60
39
34.5
74
42.5
64
9
1.5
20
3.5
23.5
27
50
77
43
30.5
74
53
70
6
5
20
7.5
27.5
28
46
68.5
37.5
30
71
55
71.5
7
3
23
13
36
29
49
57
45
35.5
72
51
67
5
3.5
33
17.5
40.5
30
53
82
47.5
43.5
81.5
59
77
4
3
21
10
31
31
52
62
43
23
68
47
64.5
6.5
6
26
4
30
32
47.5
53.5
35.5
40.5
71
50
72
2
-2
22
10.5
32.5
33
59
72
45
34.5
73
61
72
4
4
27
16.5
43.5
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Jnear
measurements
(Subjects
n=65
Subjects
N-NL
Gn-NL
S-NL
Go-NL
N-S
ANS-PNS
Me-Go
OB
OJ
H-H1
H-H2
(H-H1)+(H-H2)
34
54
73
47
31
72.5
58
66
0
0
31.5
12
43.5
35
59
60
40
25
71
60
80
4
5
37
23
60
36
55.5
74
48
41.5
73.5
61.5
74
10
10
28
25.5
53.5
37
59
65
42
42
74
59
74
3.5
3
30
23
53
38
56
66
48
44
74
53
88
4.5
3
30.5
21
51.5
39
53
72.5
43
38
80
61
882
4
4
12
6.5
18.5
40
57
55
46
36
72
58
72
3
3
21
14
35
41
56.5
65.5
36
31
74
51
76
5.5
5
14
2
16
42
61.5
76
40
41
76
57
74
6
2
28
15
43
43
59
71
39.5
48
75
59
79
3
3
33
24
57
44
61
71
44
36
76
58.5
85
3.5
3
11
5
16
45
55
70
47
41.5
78.5
64
89
4
3
19
13.5
32.5
46
57
71
44
40
83
62
80
4
4
29
26
55
47
51
67
47.5
40
75
61
80
7
2
9.5
9
18.5
48
57.5
67.5
43
40
69
50
70
1
2
17.5
13
30.5
49
58
77
53
39
79.5
58
80
3
1
29.5
18.5
48
50
58
82.5
46
39.5
78
59
79
0
2
33
12
35
51
50
72
45
25
70
50
74
6
7
29
14
43
52
47.5
77
41.5
43.5
77
57
74
6
3
19
11
30
53
61
77
45
41
78.5
57
78
2
2
21
11
33
54
55
69
39
31
70.5
55
69
4
3
23
16.5
39.5
55
55
72.5
45
42.5
77
54.5
82
-2
1
19.5
7
26.5
56
52
73
41
48
75
52
82
0
1
19
12.5
31.5
57
57.5
82
47
43
78
59
85
2.5
6.5
31
26.5
57.5
58
55.5
69.5
50
37
77.5
58
83
4.5
4
24.5
20
44.5
59
59.5
73
47.5
39
79
56
80
4
1.5
29
8
37
60
55
69.5
41.5
30
77
54
81
2
3
21
6
27
61
58
65
44
44
75
55
73
5
3.5
22
11.5
33.5
62
49.5
67
48.5
27
69
52
79
2
2
22
5
27
63
55
62
40
32
73
53
73
10
1.5
30
19
49
64
59
82
41.5
44.5
78
56
77
2
2
18
10
28
65
59
65
50
45
71
55
71
4
2.5
23
12.5
35.5
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Linear
measurements
(Control
n<
01
Control
N-NL
Gn-NL
S-NL
Go-NL
N-S
ANS-PNS
Me-Go
OB
OJ
H-H1
H-H2
(H-H1)+(H-H2)
1
55
62
46
35
75.5
61
77
3
3
18
11
29
2
51.5
59
41.5
27
69
60
74
3
3
16
10
26
3
54
56
43
28
73
62.5
78
5
5
20
10
30
4
50
53
41.5
34
76.5
58.5
77.5
4
3
16
4
20
5
57
69
46
24.5
74
58
77.5
9
2
19
13
32
6
54
77
51
30
75.5
59
83
-2
1
23.5
16
39.5
7
51
69
42
27.5
77
59.5
85
3
3
20.5
16
36.5
8
57
62
37
37
78
56
85
5
2
18.5
3
21.5
9
53
62.5
44
26
71
60.5
72
2
13
8
-3
5
10
50
65
37
35
70
58
67
2
3
22.5
9
31.5
11
55.5
69
46
35
75
62.5
80
3
2
27
26
53
12
50
61
40.5
35
71
57
76
2
3.5
18.5
3
21.5
13
53
54.5
43
30
71
54
79
2.5
2
13
4
17
14
53
59
44
40
73
60.5
69
4.5
8
13
9
22
15
56
66
45
35
74
59
78
4
6
12
3
15
16
55
65
39
30
73.5
50
67
2.5
2
15
6.5
21.5
17
54
62
44.5
34.5
72.5
55
66.5
4
2
11.5
6
17.5
18
53
62
42
34
77
56
76
5
2
19
7.5
26.5
19
52
65
41
33.5
66.5
59
66
-1
-2
23
10
33
20
49
55
41
32
72
53
69
4
5
16
8
24
21
56
67
39
35
78
56
67
3.5
7
27.5
13.5
41
22
57
64
42.5
36
76
58
78
5
4
21
10.5
31.5
23
61
67
53
44
77
61
78.5
2
4
21
14
35
24
56
62
47.5
40.5
78
59
70
6
2
24
18
42
25
53
57
40
23
70
50
70
4
2
18
2
20
26
55
61
41.5
31.5
73
59
73
6
4
16
3
19
27
54.5
58
41
27
67.5
53
74.5
5
3
21
7
28
28
52.5
57
41.5
30
68
53
65
5
5
19
4
23
29
54
64
44
41
76.5
61
78
1
1
14
2
16
30
50
68
41
32.5
73.5
58.5
75
2
2
26
14
40
274
